0001079973-22-000963.txt : 20220812 0001079973-22-000963.hdr.sgml : 20220812 20220812110909 ACCESSION NUMBER: 0001079973-22-000963 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 49 CONFORMED PERIOD OF REPORT: 20220630 FILED AS OF DATE: 20220812 DATE AS OF CHANGE: 20220812 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ENCISION INC CENTRAL INDEX KEY: 0000930775 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 841162056 STATE OF INCORPORATION: CO FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-11789 FILM NUMBER: 221158604 BUSINESS ADDRESS: STREET 1: 6797 WINCHESTER CIRCLE CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: 3034442600 MAIL ADDRESS: STREET 1: 6797 WINCHESTER CIRCLE CITY: BOULDER STATE: CO ZIP: 80301 FORMER COMPANY: FORMER CONFORMED NAME: ELECTROSCOPE INC DATE OF NAME CHANGE: 19960502 10-Q 1 ecia_10q-063022.htm FORM 10-Q
0000930775 false --03-31 2023 Q1 0000930775 2022-04-01 2022-06-30 0000930775 2022-07-31 0000930775 2022-06-30 0000930775 2022-03-31 0000930775 2021-04-01 2021-06-30 0000930775 us-gaap:ProductMember 2022-04-01 2022-06-30 0000930775 us-gaap:ProductMember 2021-04-01 2021-06-30 0000930775 us-gaap:ServiceMember 2022-04-01 2022-06-30 0000930775 us-gaap:ServiceMember 2021-04-01 2021-06-30 0000930775 2021-03-31 0000930775 2021-06-30 0000930775 ecia:LeasePaymentMember 2022-04-01 2022-06-30 0000930775 ecia:EIDLPaymentMember 2022-04-01 2022-06-30 0000930775 ecia:USBankPaymentMember 2022-04-01 2022-06-30 0000930775 ecia:LeasePaymentMember 2022-06-30 0000930775 ecia:SBAMember 2021-08-01 2021-08-04 0000930775 ecia:EIDLMember 2020-08-01 0000930775 ecia:EIDLMember 2020-07-30 2020-08-01 0000930775 ecia:PPPLoanMember 2020-04-17 0000930775 ecia:PPPLoanMember 2020-10-01 2020-12-31 0000930775 ecia:PPPLoanMember 2020-12-01 2020-12-31 0000930775 ecia:PPPLoanMember 2021-02-08 0000930775 ecia:PPPLoanMember 2021-07-01 2021-09-30 0000930775 ecia:EIDLPaymentMember 2022-06-30 0000930775 ecia:USBankPaymentMember 2022-06-30 0000930775 us-gaap:CostOfSalesMember 2022-04-01 2022-06-30 0000930775 us-gaap:CostOfSalesMember 2021-04-01 2021-06-30 0000930775 us-gaap:SellingAndMarketingExpenseMember 2022-04-01 2022-06-30 0000930775 us-gaap:SellingAndMarketingExpenseMember 2021-04-01 2021-06-30 0000930775 us-gaap:GeneralAndAdministrativeExpenseMember 2022-04-01 2022-06-30 0000930775 us-gaap:GeneralAndAdministrativeExpenseMember 2021-04-01 2021-06-30 0000930775 us-gaap:ResearchAndDevelopmentExpenseMember 2022-04-01 2022-06-30 0000930775 us-gaap:ResearchAndDevelopmentExpenseMember 2021-04-01 2021-06-30 0000930775 srt:DirectorMember 2022-04-01 2022-06-30 0000930775 srt:DirectorMember 2021-04-01 2021-06-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

 

                 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 21549

 

Form 10-Q

 

  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2022

OR

  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________ to________

 

Commission file number: 001-11789

 

ENCISION INC.

(Exact name of registrant as specified in its charter)

 

Colorado 84-1162056

 (State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer Identification No.)

 

 

6797 Winchester Circle

Boulder, Colorado 80301

(Address of principal executive offices)

 

(303) 444-2600

(Registrant’s telephone number)

 

Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:

 

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, no par value ECIA OTC Bulletin Board

 

Securities registered under Section 12(g) of the Act: None

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes     No

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes     No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer     Accelerated filer  
Non-accelerated Filer     Smaller reporting company  
    Emerging growth company  

 

If an emerging growth company, indicate by check mark if the registrant has elected to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes    No 

 

Indicate the number of shares outstanding of each of the issuer’s classes of common equity, as of the latest practicable date:

 

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, no par value ECIA OTC Bulletin Board

 

Securities registered under Section 12(g) of the Act: None

 

Indicate the number of shares outstanding of each of the issuer’s classes of common equity, as of the latest practicable date:

 

Common Stock, no par value 11,719,543 Shares
(Class)  (outstanding at July 31, 2022)

 

 

 
 
 

 

 

ENCISION INC.

 

FORM 10-Q

 

For the Three Months Ended June 30, 2022

 

 

INDEX

    Page Number
PART I. FINANCIAL INFORMATION  
ITEM 1 - Condensed Interim Financial Statements:  
  -       Condensed Balance Sheets as of June 30, 2022 and March 31, 2022 3
  -       Condensed Statements of Three Months Ended June 30, 2022 and 2021 4
  -       Condensed Statements of Cash Flows for the Three Months Ended June 30, 2022 and 2021 5
  -       Notes to Condensed Interim Financial Statements 6
     
ITEM 2 - Management’s Discussion and Analysis of Financial Condition and Results of Operations 12
ITEM 4 - Controls and Procedures 19
     
PART II. OTHER INFORMATION  
ITEM 1 - Legal Proceedings 20
ITEM 1A - Risk Factors 20
ITEM 2 - Unregistered Sales of Equity Securities 20
ITEM 3 - Defaults on Senior Securities 20
ITEM 4 - Mine Safety Disclosures 20
ITEM 5 - Other Information 20
ITEM 6 - Exhibits 21
SIGNATURE 22

 

 

 

 

2 
 
 

PART I FINANCIAL INFORMATION

 

ITEM 1 - Condensed Interim Financial Statements

 

Encision Inc.

Condensed Balance Sheets

(Unaudited)

         
   June 30, 2022   March 31, 2022 
ASSETS          
Current assets:          
Cash   827,944   $949,645 
Accounts receivable   921,123    947,623 
Inventories, net of reserve for obsolescence of $34,948 at June 30, 2022 and
$36,000 at March 31, 2022
   1,798,655    1,584,321 
Prepaid expenses and other assets   101,287    120,133 
Total current assets   3,649,009    3,601,722 
Equipment:          
Furniture, fixtures and equipment, at cost   2,499,871    2,468,949 
Accumulated depreciation   (2,265,202)   (2,279,652)
Equipment, net   234,669    189,297 
Right of use asset   715,349    786,407 
Patents, net of accumulated amortization of $290,077 at June 30, 2022 and $282,081 at March 31, 2022   177,589    180,719 
Other assets   42,198    34,240 
TOTAL ASSETS   4,818,814   $4,792,385 
LIABILITIES AND SHAREHOLDERS’ EQUITY          
Current liabilities:          
Accounts payable   388,077   $576,381 
Secured notes   23,154    21,491 
Accrued compensation   221,678    190,853 
Other accrued liabilities   114,835    125,179 
Accrued lease liability   370,677    362,487 
Total current liabilities   1,118,421    1,276,391 
Long-term liability:          
Secured notes   200,806    205,809 
Accrued lease liability   476,761    564,321 
Total liabilities   1,795,988    2,046,521 
Commitments and contingencies (Note 4)          
Shareholders’ equity:          
Preferred stock, no par value: 10,000,000 shares authorized; none issued and outstanding            
Common stock and additional paid-in capital, no par value: 100,000,000 shares authorized; 11,719,543 issued and outstanding at June 30, 2022 and March 31, 2022   24,287,544    24,275,183 
Accumulated (deficit)   (21,264,718)   (21,529,319)
Total shareholders’ equity   3,022,826    2,745,864 
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY   4,818,814   $4,792,385 

 

The accompanying notes to financial statements are an integral part of these condensed statements.

 

 

3 
 
 

 

Encision Inc.

Condensed Statements of Operations

(Unaudited)

 

           
   Three Months Ended 
   June 30, 2022   June 30, 2021 
NET REVENUE:          
Product  $1,696,029   $1,718,404 
Service   458,333    290,040 
Total revenue   2,154,362    2,008,444 
           
COST OF REVENUE:          
Product   869,905    838,426 
Service         143,050 
Total cost of revenue   869,905    981,476 
GROSS PROFIT   1,284,457    1,026,968 
OPERATING EXPENSES:          
Sales and marketing   502,967    528,474 
General and administrative   344,119    326,721 
Research and development   170,469    176,875 
Total operating expenses   1,017,555    1,032,070 
OPERATING (LOSS) INCOME   266,902    (5,102)
Interest expense, net   (2,363)   (1,806)
           
Other income (expense), net   61    66 
Interest expense, extinguishment of debt income and other income (expense), net   (2,302)   (1,740)
(LOSS) INCOME BEFORE PROVISION FOR INCOME TAXES   264,601    (6,842)
Provision for income taxes            
NET (LOSS) INCOME  $264,601   $(6,842)
Net (loss) income per share—basic and diluted  $0.02   $0.00 
Weighted average shares—basic   11,719,543    11,582,641 
Weighted average shares—diluted   12,021,280    11,582,641 

 

 

The accompanying notes to financial statements are an integral part of these condensed statements.

 

 

4 
 
 

 

Encision Inc.

Condensed Statements of Cash Flows

(Unaudited)

 

 

           
Three Months Ended  June 30, 2022   June 30, 2021 
Cash flows (used in) operating activities:          
Net income  $264,601   $(6,842)
Adjustments to reconcile net income to net cash (used in) operating activities:          
Depreciation and amortization   20,087    26,783 
Stock-based compensation expense related to stock options   12,361    8,340 
(Recovery from) doubtful accounts, net change         (25,000)
(Recovery from) provision for inventory obsolescence, net change   (1,052)   (49,000)
Change in operating assets and liabilities:          
Right of use asset, net   (8,312)   (4,687)
Accounts receivable   26,500    (91,601)
Inventories   (213,282)   (96,813)
Prepaid expenses and other assets   10,888    44,049 
Accounts payable   (188,304)   131,938 
Accrued compensation and other accrued liabilities   20,481    (65,216)
Net cash (used in) generated by operating activities   (56,032)   (128,049)
Cash flows (used in) investing activities:          
Acquisition of property and equipment   (57,463)   (6,720)
Patent costs   (4,866)   (7,561)
Net cash (used in) generated by investing activities   (62,329)   (14,281)
Cash flows from financing activities:          
(Paydown of) secured notes   (3,340)   (3,340)
Net cash (used in) generated by financing activities   (3,340)   (3,340)
           
Net (decrease) increase in cash   (121,701)   (145,670)
Cash, beginning of fiscal year   949,645    1,474,339 
Cash, end of fiscal quarter  $827,944   $1,328,669 
           
Supplemental disclosures of cash flow information:          
Cash paid during the three months for interest  $2,363   $1,806 

 

The accompanying notes to financial statements are an integral part of these condensed statements.

 

 

5 
 
 

 

 

ENCISION INC.

 

NOTES TO CONDENSED INTERIM FINANCIAL STATEMENTS

 

JUNE 30, 2022

(Unaudited)

 

Note 1. ORGANIZATION AND NATURE OF BUSINESS

 

Encision Inc. is a medical device company that designs, develops, manufactures and markets patented surgical instruments that provide greater safety to, and saves lives of, patients undergoing minimally-invasive surgery. We believe that our patented AEM® (Active Electrode Monitoring) surgical instrument technology is changing the marketplace for electrosurgical devices and instruments by providing a solution to a patient safety risk in laparoscopic surgery. Our sales to date have been made principally in the United States.

 

We have an accumulated deficit of $21,264,718 at June 30, 2022. A significant portion of our operating funds have been provided by issuances of our common stock and warrants, the exercise of stock options to purchase our common stock, loans, and (in some periods) by operating profits. Shareholders’ equity increased by $276,962 since March 31, 2022 as a result of our net income of $264,601 and share-based compensation of $12,361. Should our liquidity be diminished in the future because of operating losses, we may be required to seek additional capital.

 

Our strategic marketing and sales plan is designed to expand the use of our products in surgically active hospitals and surgery centers in the United States.

 

We have been actively monitoring the coronavirus (“COVID”) situation and its impact globally. Our production facilities continued to operate during the year as they had prior to the COVID pandemic with minimal change, other than for enhanced safety measures intended to prevent the spread of the virus. The remote working arrangements and travel restrictions imposed by various governments had limited impact on our ability to maintain operations during the year, as our manufacturing operations have generally been exempted from stay-at-home orders. However, we cannot predict the impact of the progression of the COVID pandemic on future results due to a variety of factors, including the continued good health of our employees, the ability of suppliers to continue to operate and deliver, our ability and our customers to maintain operations, continued access to transportation resources, the changing needs and priorities of customers, any further government and/or public actions taken in response to the pandemic and ultimately the length of the pandemic. We will continue to closely monitor the COVID pandemic in order to ensure the safety of our people and our ability to serve our customers and patients worldwide.

 

Note 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation. The condensed interim financial statements included herein have been prepared by us, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles accepted in the United States (“GAAP”) have been condensed or omitted pursuant to such rules and regulations, although we believe that the disclosures made are adequate to make the information presented not misleading. The condensed interim financial statements and notes thereto should be read in conjunction with the financial statements and the notes thereto included in our Annual Report on Form 10-K for the fiscal year ended March 31, 2022 filed on July 13, 2022.

 

The accompanying condensed interim financial statements have been prepared, in all material respects, in conformity with the standards of accounting measurements and reflect, in the opinion of management, all adjustments necessary to summarize fairly the financial position and results of operations for such periods in accordance with GAAP. All adjustments are of a normal recurring nature. The results of operations for the most recent interim period are not necessarily indicative of the results to be expected for the full year.

 

Use of Estimates in the Preparation of Financial Statements. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions. Such estimates and assumptions affect the reported amounts of assets and liabilities as well as disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of sales and expense during the reporting period. Actual results could differ from those estimates.

 

 

6 
 
 

 

Cash and Cash Equivalents. For purposes of reporting cash flows, we consider all cash and highly liquid investments with an original maturity of three months or less to be cash equivalents.

 

Fair Value of Financial Instruments. Our financial instruments consist of cash, trade receivables, payables and Economic Injury Disaster Loan (“EIDL”) loan. The carrying values of cash and trade receivables approximate their fair value due to their short maturities.The fair values of the EIDL Loan approximates the carrying value based on estimated discounted future cash flows using the current rates at which similar loans would be made.

 

Concentration of Credit Risk. Financial instruments, which potentially subject us to concentrations of credit risk, consist of cash and accounts receivable. From time to time, the amount of cash on deposit with financial institutions may exceed the $250,000 federally insured limit at June 30, 2022. We believe that our cash on deposit that exceeds $250,000 with financial institutions is financially sound and the risk of loss is minimal.

 

We have no significant off-balance sheet concentrations of credit risk such as foreign exchange contracts, options contracts or other foreign hedging arrangements. We maintain the majority of our cash balances with one financial institution in the form of demand deposits.

 

Accounts receivable are typically unsecured and are derived from transactions with and from entities in the healthcare industry primarily located in the United States. Accordingly, we may be exposed to credit risk generally associated with the healthcare industry. We maintain allowances for doubtful accounts for estimated losses resulting from the inability of our customers to make required payments. The net accounts receivable balance at June 30, 2022 of $921,123 and at March 31, 2022 of $947,623 included no more than 12% from any one customer.

 

Inventories. Inventories are stated at the lower of cost (first-in, first-out basis) or net realizable value. We reduce inventory for estimated obsolete or unmarketable inventory equal to the difference between the cost of inventory and the net realizable value based upon assumptions about future demand and market conditions. If actual market conditions are less favorable than those projected by management, additional inventory write-downs may be required. At June 30, 2022 and March 31, 2022 inventory consisted of the following:

 

          
   June 30, 2022   March 31, 2022 
Raw materials  $1,318,891   $1,083,387 
Finished goods   514,712    536,934 
Total gross inventories   1,833,603    1,620,321 
Less reserve for obsolescence   (34,948)   (36,000)
Total net inventories  $1,798,655   $1,584,321 

 

Property and Equipment. Property and equipment are stated at cost, with depreciation computed over the estimated useful lives of the assets, generally five to seven years. Depreciation expense for the three months ended June 30, 2022 and 2021 was $12,091 and $14,877, respectively. We use the straight-line method of depreciation for property and equipment. Leasehold improvements are depreciated over the shorter of the remaining lease term or the estimated useful life of the asset. Maintenance and repairs are expense as incurred and major additions, replacements and improvements are capitalized.

 

Long-Lived Assets. Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. A long-lived asset is considered impaired when estimated future cash flows related to the asset, undiscounted and without interest, are insufficient to recover the carrying amount of the asset. If deemed impaired, the long-lived asset is reduced to its estimated fair value. Long-lived assets to be disposed of are reported at the lower of their carrying amount or estimated fair value less cost to sell.

 

Patents. The costs of applying for patents are capitalized and amortized on a straight-line basis over the lesser of the patent’s economic or legal life (20 years from the date of application in the United States). Capitalized costs are expensed if patents are not issued. We review the carrying value of our patents periodically to determine whether the patents have continuing value and such reviews could result in the conclusion that the recorded amounts have been impaired.

 

 

7 
 
 

Income Taxes. We account for income taxes under the provisions of FASB Accounting Standards Codification (“ASC”) Topic 740, “Accounting for Income Taxes” (“ASC 740”). ASC 740 requires recognition of deferred income tax assets and liabilities for the expected future income tax consequences, based on enacted tax laws, of temporary differences between the financial reporting and tax bases of assets and liabilities. ASC 740 also requires recognition of deferred tax assets for the expected future tax effects of all deductible temporary differences, loss carryforwards and tax credit carryforwards. Deferred tax assets are then reduced, if deemed necessary, by a valuation allowance for the amount of any tax benefits, which, more likely than not based on current circumstances, are not expected to be realized. As a result, no provision for income tax is reflected in the accompanying statements of operations. Should we achieve sufficient, sustained income in the future, we may conclude that some or all of the valuation allowance should be reversed. We are required to make many subjective assumptions and judgments regarding our income tax exposures. At June 30, 2022, we had no unrecognized tax benefits, which would affect the effective tax rate if recognized and had no accrued interest, or penalties related to uncertain tax positions.

 

Revenue Recognition. We record revenue at a single point in time, when control is transferred to the customer. We will continue to apply our current business processes, policies, systems and controls to support recognition and disclosure. Our shipping policy is FOB Shipping Point. We recognize revenue from sales to stocking distributors when there is no right of return, other than for normal warranty claims. We have no ongoing obligations related to product sales, except for normal warranty obligations. As presented on the Statement of Operations our revenue is disaggregated between product revenue and service revenue. As it relates specifically to product revenue, we do not believe further disaggregation is necessary as substantially all of our product revenue comes from multiple products within a line of medical devices. Our engineering service contracts are billed on a time and materials basis and revenue is recognized over time as the services are performed.

 

Research and Development Expenses. We expense research and development costs for products and processes as incurred.

 

Stock-Based Compensation. Stock-based compensation is presented in accordance with the guidance of ASC Topic 718, “Compensation – Stock Compensation” (“ASC 718”). Under the provisions of ASC 718, we are required to estimate the fair value of share-based payment awards on the date of grant using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods in our statements of operations.

 

Stock-based compensation expense recognized under ASC 718 for the three months ended June 30, 2022 and 2021 was $12,361 and $8,340, respectively, which consisted of stock-based compensation expense related to grants of employee stock options.

 

Segment Reporting. We have concluded that we have two operating segments, product and service. Product designs, develops, manufactures and markets patented surgical instruments. Service performs electrical engineering activities for external entities.

 

                              
  

Three Months Ended

June 30, 2022

  

Three Months Ended

June 30, 2021

 
  

 

Product

  

 

Service

  

 

Total

  

 

Product

  

 

Service

  

 

Total

 
Net revenue  $1,696,029   $458,333   $2,154,362   $1,718,404   $290,040   $2,008,444 
Cost of revenue   869,905          869,905    838,426    143,050    981,476 
Gross profit   826,124    458,333    1,284,457    879,978    146,990    1,026,968 
Operating income (loss)   (191,431)   458,333    266,902    (152,092)   146,990    (5,102)
Depreciation and amortization   20,087          20,087    26,783          26,783 
Patent and capital expenditures   62,329          62,329    14,281          14,281 
Equipment and patents, net  $412,258   $     $412,258   $370,016   $     $370,016 

 

 

8 
 
 

 

Recently Issued Accounting Pronouncements. In June 2016, the FASB issued ASU 2016-13, “Measurement of Credit Losses on Financial Instruments”. ASU 2016-13 adds a current expected credit loss (“CECL”) impairment model to U.S. GAAP that is based on expected losses rather than incurred losses. Modified retrospective adoption is required with any cumulative-effect adjustment recorded to retained earnings as of the beginning of the period of adoption. ASU 2016-13 is effective for fiscal years beginning after December 15, 2019, excluding smaller reporting entities, which will be effective for fiscal years beginning after December 15, 2022. We will adopt ASU 2016-13 beginning April 1, 2023 and do not expect the application of the CECL impairment model to have a significant impact on our allowance for uncollectible amounts for accounts receivable.

 

Note 3. Basic and Diluted Income and Loss per Common Share

 

We report both basic and diluted net income (loss) per share. Basic net income or loss per common share is computed by dividing net income or loss for the period by the weighted average number of common shares outstanding for the period. Diluted net income or loss per common share is computed by dividing the net income or loss for the period by the weighted average number of common and potential common shares outstanding during the period if the effect of the potential common shares is dilutive. The shares used in the calculation of dilutive potential common shares exclude options to purchase shares where the exercise price was greater than the average market price of common shares for the period.

 

The following table presents the calculation of basic and diluted net income (loss) per share:

 

          
   Three Months Ended 
    June 30, 2022   June 30, 2021 
Net (loss) income  $264,601   $(6,842)
Weighted-average basic shares outstanding   11,719,543    11,582,641 
Effect of dilutive securities   301,737       
Weighted-average diluted shares   12,021,280    11,582,641 
Basic net income (loss) per share  $0.02   $0.00 
Diluted net income (loss) per share  $0.02   $0.00 
 Antidilutive employee stock options   756,263    1,036,000 

 

Note 4. COMMITMENTS AND CONTINGENCIES

 

We have a noncancelable lease agreement for our facilities at 6797 Winchester Circle, Boulder, Colorado. The lease expires October 31, 2024.

 

In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) ("ASU 2016-02"), which modified lease accounting for both lessees and lessors to increase transparency and comparability by recognizing lease assets and lease liabilities by lessees for those leases classified as either finance or operating leases under previous accounting standards and disclosing key information about leasing arrangements. We adopted Topic 842 on April 1, 2019, using the alternative modified transition method, which requires a cumulative effect adjustment, if any, to the opening balance of retained earnings to be recognized on the date of adoption with prior periods not restated. There was no cumulative effect adjustment recorded on April 1, 2019. The primary impact for us was the balance sheet recognition of right-of-use (“ROU”) assets and lease liabilities for operating leases as a lessee.

 

We determine if an arrangement contains a lease at inception. We currently do not have any finance leases. Operating lease ROU assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. ROU assets also include any initial direct costs incurred and any lease payments made at or before the lease commencement date, less lease incentives received. We use our incremental borrowing rate based on the information available at the commencement date in determining the lease liabilities as our leases do not provide an implicit rate. Lease expense is recognized on a straight-line basis over the lease term.

 

 

 

9 
 
 

The minimum future lease payment, by fiscal year, as of June 30, 2022 is as follows:

 

       
Fiscal Year   Amount 
 2023   $281,542 
 2024    386,667 
 2025    232,139 
 Total   $900,348 

 

During January 2021, we canceled our relationship with Crestmark Bank. We had no borrowings and incurred a $20,000 exit fee.

 

On August 4, 2020, we received $150,000 principal in loan funding from the U.S. Small Business Administration (“SBA”) under the Economic Injury Disaster Loan (“EIDL”) program administered by the SBA, which program was expanded pursuant to the CARES Act. The EIDL is evidenced by a promissory note, dated August 1, 2020 in the original principal amount of $150,000 with the SBA, the lender. Under the terms of the Note, interest accrues on the outstanding principal at the rate of 3.75% per annum. The term of the Note is thirty years, though it may be payable sooner upon an event of default under the Note. Under the Note, we will be obligated to make equal monthly payments of principal and interest of $774 beginning on August 1, 2023 through the maturity date of August 1, 2050. The Note may be prepaid in part or in full, at any time, without penalty.

 

During January 2021, we entered into a note agreement with U.S. Bank for $92,000. The note is for five years at a 5% interest rate and the proceeds were used to purchase equipment. The note is secured by the equipment.

 

On April 17, 2020, we entered into an unsecured promissory note under the PPP for a principal amount of $598,567. The PPP was established under the Consolidated Appropriations Act of 2020, enacted December 27, 2020. Under the terms of the CARES Act, a PPP loan recipient may apply for, and be granted, forgiveness for all or a portion of loans granted under the PPP. Such forgiveness will be determined based upon the use of loan proceeds for payroll costs, rent and utility costs, and the maintenance of employee and compensation levels. In the quarter that ended December 31, 2020, we achieved the requirements for forgiveness, and all of the $598,567 was forgiven. We recognized the forgiveness as extinguishment of debt income of $598,567.On February 8, 2021, we entered into a second unsecured promissory note under the PPP for a principal amount of $533,118. This was our second PPP loan. During the quarter that ended September 30, 2021, we achieved the requirements for forgiveness of the second note and recognized the forgiveness as extinguishment of debt income of $533,118.

 

The minimum future EIDL payment, by fiscal year, as of June 30, 2022 is as follows:

 

       
Fiscal Year   Amount 
 2023   $1,546 
 2024    3,208 
 2025    3,331 
 2026    3,457 
 Thereafter    148,018 
 Total   $159,560 

 


During January 2021, we entered into a note agreement with U.S. Bank for $92,000. The note is for five years at a 5% interest rate and the proceeds were used to purchase equipment. The note is secured by the equipment.

 

The minimum future principal U.S. Bank payment, by fiscal year, as of June 30, 2022 is as follows:

 

       
Fiscal Year   Amount 
 2023   $13,800 
 2024    18,400 
 2025    18,400 
 2026    13,800 
 Total   $64,400 

 

 

Aside from the operating lease, EIDL loan and U.S. Bank loan, we do not have any material contractual commitments requiring settlement in the future.

 

We are subject to regulation by the United States Food and Drug Administration (“FDA”). The FDA provides regulations governing the manufacture and sale of our products and regularly inspects us and other manufacturers to determine compliance with these regulations. We believe that we were in substantial compliance with all known regulations at June 30, 2022. FDA inspections are conducted periodically at the discretion of the FDA. Our latest inspection by the FDA occurred in October 2019.

 

10 
 
 

 

 

Note 5. SHARE-BASED COMPENSATION

 

The provisions of ASC 718-10-55 requires the measurement and recognition of compensation expense for all share-based payment awards made to our employees and directors, including employee stock options and RSUs, based on estimated fair values. The following table summarizes stock-based compensation expense related to employee stock options for the three months ended June 30, 2022 and 2021, which was allocated as follows:

 

          
   Three Months Ended 
   June 30, 2022   June 30, 2021 
Cost of sales  $158   $918 
Sales and marketing   1,656    1,218 
General and administrative   9,429    5,658 
Research and development   1,118    546 
Stock-based compensation expense  $12,361   $8,340 

 

Share-based compensation cost for stock options is measured at the grant date, based on the fair value as calculated by the Black-Scholes-Merton ("BSM") option-pricing model. The BSM option-pricing model requires the use of actual employee exercise behavior data and the application of a number of assumptions, including expected volatility, risk-free interest rate and expected dividends. There were no stock options granted, exercised or forfeited during the three months ended June 30, 2022 and 2021.

 

As of June 30, 2022, approximately $182,000 of total unrecognized compensation costs related to nonvested stock options is expected to be recognized over a period of five years.

 

Note 6. RELATED PARTY TRANSACTION

 

We paid consulting fees of $13,728 and $28,816 to an entity owned by one of our directors during the three months ended June 30, 2022 and 2021 respectively.

 

Note 7. SUBSEQUENT EVENTS

We evaluated all of our activity as of the date the condensed interim financial statements were issued and concluded that no subsequent events have occurred that would require recognition in our financial statements or disclosed in the notes to our condensed interim financial statements.

 

11 
 
 

ITEM 2 - MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Certain statements contained in this section on Management’s Discussion and Analysis are not historical facts, including statements about our strategies and expectations with respect to new and existing products, market demand, acceptance of new and existing products, marketing efforts, technologies and opportunities, market and industry segment growth, and return on investments in products and markets. These statements are forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and involve substantial risks and uncertainties that may cause actual results to differ materially from those indicated by the forward looking statements. All forward looking statements in this section on Management’s Discussion and Analysis are based on information available to us on the date of this document, and we assume no obligation to update such forward looking statements. Readers of this Form 10-Q are strongly encouraged to review the section entitled “Risk Factors” in our Form 10-K for the fiscal year ended March 31, 2022.

 

General

 

Encision Inc., a medical device company based in Boulder, Colorado, has developed and markets innovative technology that provides unprecedented outcomes and patient safety in minimally-invasive surgery. We believe that our patented Active Electrode Monitoring (“AEM®”) AEM EndoShield™ Burn Protection System is changing the marketplace for electrosurgical devices and laparoscopic instruments by providing a solution to a well-documented hazard unique to laparoscopic surgery. The Center for Medicare and Medicaid Services has published its Hospital-Acquired Condition Reduction Program. The program has begun to levy as much as a 1% penalty on Medicare reimbursements to hospitals in the lower quadrant of performance for selected quality indicators, including accidental puncture and laceration (“APL”). Examples of APL include the use of a cautery device (electrosurgery) or scissors to dissect a tissue plane that errantly causes an injury to underlying bowels. A Safety Communication was released by the FDA on May 29, 2018. It is on the FDA's website at: https://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm608637.htm. The Safety Communication states that, "In addition to serving as an ignition source, monopolar energy use can directly result in unintended patient burns from capacitive coupling and intra-operative insulation failure. If a monopolar electrosurgical unit (“ESU”) is used: Do not activate when near or in contact with other instruments.”

 

We address market opportunities created by the increase in minimally-invasive surgery (“MIS”) and surgeons’ use of electrosurgery devices in these procedures. The product opportunity exists in that monopolar electrosurgery instruments used in laparoscopic procedures provide excellent clinical results, but are also susceptible to causing inadvertent collateral tissue damage outside the surgeon’s field of view due to insulation failure and capacitive coupling. The risk of unintended electrosurgical burn injury to the patient in laparoscopic surgery has been well documented. This risk poses a threat to patient safety, including the risk of death, and creates liability exposure for surgeons and hospitals, as well as increased and preventable readmissions.

 

Our patented AEM technology provides surgeons with the desired tissue effects, while capturing stray electrosurgical energy that can cause unintended and unseen tissue injury that may result in death. AEM Surgical Instruments are equivalent to conventional instruments in size, shape, ergonomics, functionality and competitive pricing, but they incorporate “Active Electrode Monitoring” technology to dynamically and continuously monitor the flow of electrosurgical current, thereby helping to prevent patient injury. With our “shielded and monitored” instruments, surgeons are able to perform electrosurgical procedures more safely, effectively and economically than is possible using conventional instruments or alternative energy sources.

 

AEM technology has been recommended and endorsed by many groups involved in MIS. Surgeons, nurses, biomedical engineers, the medicolegal community, malpractice insurance carriers and electrosurgical device manufacturers advocate the use of AEM technology. We have focused our marketing strategies to date on expanding the market awareness of the AEM technology and our broad independent endorsements and have continued efforts to improve and expand the AEM technology penetration.

 

When a hospital or surgery center changes to AEM technology, we receive recurring revenue from sales of replacement instruments. We believe that there is no directly competing technology to supplant AEM products. The replacement market of reusable and disposable AEM products in hospitals and surgery centers that use our AEM technology represented over 90% of our product revenue during the three months ended June 30, 2022. This revenue stream is expected to grow as the base of accounts using AEM technology expands. In addition, we intend to further develop disposable versions of more of our AEM products in order to meet market demands and expand our sales opportunities.

 

 

12 
 
 

We have an accumulated deficit of $21,264,718 at June 30, 2022. A significant portion of our operating funds have been provided by issuances of our common stock and warrants and the exercise of stock options to purchase our common stock. Should our liquidity be diminished in the future because of operating losses, we may be required to seek additional capital.

 

During the three months ended June 30, 2022, we used $62,329 of cash in our operating activities and used $57,463 for investments in property and equipment. As of June 30, 2022, we had $827,944 and at March 31, 2022 we had $949,645 in cash available to fund future operations, a decrease of $121,701 from March 31, 2022. Our working capital was $2,530,588 at June 30, 2022 compared to $2,325,331 at March 31, 2022.

 

Historical Perspective

 

We were organized in 1991 and spent several years developing the AEM monitoring system and protective sheaths to adapt to conventional electrosurgical instruments. We have invested heavily in an effort to protect our valuable technology, and, as a result of this effort, we have been issued 16 unexpired relevant patents that together form a significant intellectual property position. Our patents relate to the basic shielding and monitoring technologies that we incorporate into our AEM products.

 

Our AEM Surgical Instruments have been engineered to provide a seamless transition for surgeons switching from conventional laparoscopic instruments. AEM technology has been integrated into instruments that have the same look, feel and functionality as conventional instruments that surgeons have been using for years. The AEM product line encompasses the full range of instrument sizes, types and styles favored by surgeons. Additionally, we continue to improve quality and add to the product line. These additions include more disposable versions, the introduction of hand-activated instruments, our enhanced scissors, our eEdge™ scissors, our EM3 AEM Monitor, our AEM EndoShield Burn Protection System and the recent introduction of our AEM 2X enTouch® Scissors. Hospitals can make a complete and smooth conversion to our product line, thereby advancing patient safety in MIS with optimal convenience.

 

Outlook

 

Installed Base of AEM Monitoring Equipment: We believe that sales of our installed base of AEM products will increase as the inherent risks associated with monopolar laparoscopic electrosurgery become more widely acknowledged and as we focus on increasing our sales efficiency and continue to enhance our product line. We expect that the replacement sales of electrosurgical instruments and accessories will also increase as additional facilities adopt AEM technology. We anticipate that the efforts to improve the productivity of sales representatives carrying the AEM product line, along with the introduction of next generation products, may provide the basis for increased sales and profitable operations. However, these measures, or any others that we may adopt, may not result in either increased sales or profitable operations.

 

We believe that the unique performance of the AEM technology and our breadth of independent endorsements provide an opportunity for continued market share growth. In our view, market awareness and awareness of the clinical credibility of the AEM technology, as well as awareness of our endorsements, are improving, and we expect this awareness to benefit our sales efforts for the remainder of fiscal year 2023. Our objectives for the remainder of fiscal year 2023 are to optimize sales execution, to expand market awareness of the AEM technology and to maximize the number of additional hospital and surgery center accounts switching to AEM instruments while retaining existing customers. In addition, acceptance of AEM products depends on surgeons’ preference for our instruments, which depends on factors such as ergonomics, quality and ease of use in addition to the technological and safety advantages of AEM products. If surgeons prefer other instruments to our instruments, our business results will suffer.

 

We have been actively monitoring the COVID situation and its impact. Our primary objectives have remained the same throughout the pandemic: to support the safety of our team members and their families and continue to support patients. Our production facility continued to operate during the year as it had prior to the COVID pandemic with very little change, other than for enhanced safety measures intended to prevent the spread of the virus. Our capital and financial resources, including overall liquidity, remain strong. The remote working arrangements and travel restrictions imposed by various governments had limited impact on our ability to maintain operations during the year, as our manufacturing operation has generally been exempted from stay-at-home orders. However, we cannot predict the impact of the progression of the COVID pandemic on future results due to a variety of factors, including the continued good health of our employees, the ability of suppliers to continue to operate and deliver, our ability and our customers to maintain operations, continued access to transportation resources, the changing needs and priorities of customers, any further government and/or public actions taken in response to the pandemic and ultimately the length of the pandemic. We will continue to closely monitor the COVID pandemic in order to ensure the safety of our people and our ability to serve our customers and patients worldwide.

 

 

13 
 
 

On April 20, 2020, we entered into a Master Services Agreement (“MSA”) with Auris Health, Inc. (“Auris Health”), which is based in Redwood City, CA and a part of Johnson & Johnson Medical Devices Companies. The MSA (and the initial related Statement of Work thereunder) were effective as of March 3, 2020. Under the MSA, we and Auris Health collaborated on the development of equipment designed to enable the compatibility of our AEM technology with monopolar instruments produced by Auris Health. The MSA had a term of up to three years, but either party could terminate the MSA sooner upon 10 business days’ prior written notice. On August 23, 2021, we entered into a Supply Agreement with Auris Health, Inc. On May 5, 2022, the parties mutually agreed to terminate all of our agreements.

 

Possibility of Operating Losses: We have an accumulated deficit of $21,264,718 at June 30, 2022. A significant portion of our operating funds have been provided by issuances of our common stock and warrants, and the exercise of stock options to purchase our common stock. Should our liquidity be diminished in the future because of operating losses, we may be required to seek additional capital. We have made strides toward improving our operating results but due to the ongoing need to develop, optimize and train our direct sales managers and the independent sales representative network, the need to support the development of refinements to our product line, and the need to increase sustained sales to a level adequate to cover fixed and variable operating costs, we may operate at a net loss. Sustained losses, or our inability to generate sufficient cash flow from operations to fund our obligations, may result in a need to raise additional capital.

 

Revenue Growth: We expect to generate increased product revenue in the U.S. from sales to new customers and from expanded sales to existing customers as the medical device industry stabilizes and our network of direct and independent sales representatives becomes more efficient. We believe that the visibility and credibility of the independent clinical endorsements for AEM technology will contribute to new accounts and increased product revenue in fiscal year 2023 . We also expect to increase market share through promotional programs of placing our AEM monitors at no charge into hospitals that commit to standardize with AEM instruments. However, all of these efforts to increase market share and grow product revenue will depend in part on our ability to expand the efficiency and effective coverage range of our direct and independent sales representatives, as well as maintain and in some cases, improve the quality of our product offerings. The omission or delay of elective surgeries would negatively impact the extent and timing of revenue growth. Service revenue represents design, development and product supply revenue from our agreements with strategic partners.

 

We also have longer-term initiatives in place to improve our prospects. We expect that development of next generation versions of our AEM products will better position our products in the marketplace and improve our retention rate at hospitals and surgery centers that have changed to AEM technology, enabling us to grow our sales. We are exploring overseas markets to assess opportunities for sales growth internationally. Finally, we intend to explore opportunities to capitalize on our proven AEM technology via licensing arrangements and strategic alliances. These efforts to generate additional sales and further the market penetration of our products are longer term in nature and may not materialize. Even if we are able to successfully develop next generation products or identify potential international markets or strategic partners, we may not be able to capitalize on these opportunities.

 

Gross Profit and Gross Margins: Gross profit and gross margins can be expected to fluctuate from quarter to quarter as a result of product sales mix, sales volume and service revenue. Gross margins on products manufactured or assembled by us are expected to improve at higher levels of production and sales.

 

Sales and Marketing Expenses: We continue to refine our domestic and international distribution capability, and we believe that sales and marketing expenses will decrease as a percentage of net sales with increasing sales volume.

 

Research and Development Expenses: Research and development expenses are expected to increase to support quality improvement efforts and development of refinements to our AEM product line and new products, which will further expand options for surgeons and hospitals.

 

 

14 
 
 

Results of Operations

 

For the quarter ended June 30, 2022 compared to the quarter ended June 30, 2021.

 

Net Product revenue. Net product revenue for the quarter ended June 30, 2022 was $1,696,029 compared to $1,718,404 for the quarter ended June 30, 2021, a decrease of 1%. The decrease of AEM product net revenue is attributable to business lost from hospitals that used AEM technology during the year. 

 

Net Service revenue. Net service revenue for the quarter ended June 30, 2022 was $458,333 compared to $290,040 for the quarter ended June 30, 2021, an increase of 58%. Net service revenue for the quarter ended June 30, 2021 was for engineering services performed under a Master Services Agreement with Auris Health. Net service revenue for the quarter ended June 30, 2022 was for engineering services performed under a Supply Agreement with Auris Health.

 

Gross profit. Gross profit for the quarter ended June 30, 2022 of $1,284,457 represented an increase of 25% from gross profit of $1,026,968 for the quarter ended June 30, 2021. Gross profit increased as a result of higher total revenue and higher margined service revenue. Gross profit on product revenue as a percentage of sales (gross margins) was 49% for the quarter ended June 30, 2022 and 51% for the quarter ended June 30, 2021. Gross profit on product revenue decreased as a result of higher material costs.

Sales and marketing expenses. Sales and marketing expenses of $502,967 for the quarter ended June 30, 2022 represented a decrease of 5% from sales and marketing expenses of $528,474 for the quarter ended June 30, 2021. The decrease was the result of lower trade samples.

 

General and administrative expenses. General and administrative expenses of $344,119 for the quarter ended June 30, 2022 represented an increase of 5% from general and administrative expenses of $326,721 for the quarter ended June 30, 2021. The increase was the result of an increase of outside services.

 

Research and development expenses. Research and development expenses of $170,469 for the quarter ended June 30, 2022 represented a decrease of 4% compared to $176,875 for the quarter ended June 30, 2021. The decrease was the result of a decrease of test and prototype materials.

 

Net income. Net income was $264,601 for the quarter ended June 30, 2022 compared to net loss of $6,842 for the quarter ended June 30, 2021. The net income increase was principally a result of service revenue generated.

 

The results of operations for the three months ended June 30, 2022 are not necessarily indicative of the results of operations for all or any part of the balance of the fiscal year.

 

Liquidity and Capital Resources

 

To date, a significant portion of our operating funds have been provided by issuances of our common stock and warrants, the exercise of stock options to purchase our common stock, loans, and (in some periods) by operating profits. Common stock and additional paid in capital totaled $24,287,544 from inception through June 30, 2022.

 

During January 2021, we canceled our relationship with Crestmark Bank. We had no borrowings and incurred a $20,000 exit fee.

 

On August 4, 2020, we received $150,000 principal in loan funding from the U.S. Small Business Administration (“SBA”) under the Economic Injury Disaster Loan (“EIDL”) program administered by the SBA, which program was expanded pursuant to the CARES Act. The EIDL is evidenced by a promissory note, dated August 1, 2020 in the original principal amount of $150,000 with the SBA, the lender. Under the terms of the Note, interest accrues on the outstanding principal at the rate of 3.75% per annum. The term of the Note is thirty years, though it may be payable sooner upon an event of default under the Note. Under the Note, we will be obligated to make equal monthly payments of principal and interest of $774 beginning on August 1, 2023 through the maturity date of August 1, 2050. The Note may be prepaid in part or in full, at any time, without penalty.

 

During January 2021, we entered into a note agreement with U.S. Bank for $92,000. The note is for five years at a 5% interest rate and the proceeds were used to purchase equipment. The note is secured by the equipment.

 

 

15 
 
 

On April 17, 2020, we entered into an unsecured promissory note under the PPP for a principal amount of $598,567. The PPP was established under the Consolidated Appropriations Act of 2020, enacted December 27, 2020. Under the terms of the CARES Act, a PPP loan recipient may apply for, and be granted, forgiveness for all or a portion of loans granted under the PPP. Such forgiveness will be determined based upon the use of loan proceeds for payroll costs, rent and utility costs, and the maintenance of employee and compensation levels. In the quarter that ended December 31, 2020, we achieved the requirements for forgiveness, and all of the $598,567 was forgiven. We recognized the forgiveness as extinguishment of debt income of $598,567.On February 8, 2021, we entered into a second unsecured promissory note under the PPP for a principal amount of $533,118. This was our second PPP loan. During the quarter that ended September 30, 2021, we achieved the requirements for forgiveness of the second note and recognized the forgiveness as extinguishment of debt income of $533,118.

 

Our operations used $56,032 of cash during the three months ended June 30, 2022 on net revenue of $2,154,362. The amounts of cash provided by operations for the three months ended June 30, 2022 are not necessarily indicative of the expected amounts of cash to be generated from or used in operations in fiscal year 2023. At June 30, 2022, we had $827,944 in cash available to fund future operations. Our working capital was $2,530,588 at June 30, 2022 compared to $2,325,331 at March 31, 2022. Current liabilities were $1,118,421 at June 30, 2022 compared to $1,276,391 at March 31, 2022. We have a noncancelable lease agreement for our facilities at 6797 Winchester Circle, Boulder, Colorado. The lease expires October 31, 2024.

 

In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) (“ASU 2016-02”), which modified lease accounting for both lessees and lessors to increase transparency and comparability by recognizing lease assets and lease liabilities by lessees for those leases classified as operating leases under previous accounting standards and disclosing key information about leasing arrangements. The primary impact for us was the balance sheet recognition of right-of-use (“ROU”) assets and lease liabilities for operating leases as a lessee.

 

Operating lease ROU assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. ROU assets also include any initial direct costs incurred and any lease payments made at or before the lease commencement date, less lease incentives received. We use our incremental borrowing rate based on the information available at the commencement date in determining the lease liabilities as our leases do not provide an implicit rate. Lease expense is recognized on a straight-line basis over the lease term.

 

The minimum future lease payment, by fiscal year, as of June 30, 2022 is as follows:

 

Fiscal Year   Amount 
 2023   $281,542 
 2024    386,667 
 2025    232,139 
 Total   $900,348 

 

The minimum future EIDL payment, by fiscal year, as of June 30, 2022 is as follows:

 

Fiscal Year   Amount 
 2023   $1,546 
 2024    3,208 
 2025    3,331 
 2026    3,457 
 Thereafter    148,018 
 Total   $159,560 

 

The minimum future principal U.S. Bank payment, by fiscal year, as of June 30, 2022 is as follows:

 

Fiscal Year   Amount 
 2023   $13,800 
 2024    18,400 
 2025    18,400 
 2026    13,800 
 Total   $64,400 

 

Aside from the operating lease, EIDL loan and U.S. Bank loan, we do not have any material contractual commitments requiring settlement in the future.

 

As of June 30, 2022, the following table shows our contractual obligations for the periods presented:

 

   Payment due by period 
Contractual obligations  Totals  

Less than

1 year

   1-3 years   3-5 years  

More than

5 years

 
Operating lease obligations  $900,348   $378,209   $522,139   $—     $—   
EIDL loan   159,560    3,150    6,664    6,788    142,958 
U.S. Bank loan   64,400    18,400    36,800    9,200    —   
Total  $1,124,308   $399,759   $565,603   $15,988   $142,958 

 

 

16 
 
 

Our fiscal year 2023 operating plan is focused on increasing new accounts, retaining existing customers, growing revenue, increasing gross profits and conserving cash. We are investing in research and development efforts to develop next generation versions of the AEM product line. We have invested in manufacturing property and equipment to manufacture disposable scissors inserts internally and to reduce our cost of product revenue. We cannot predict with certainty the expected revenue, gross profit, net income or loss and usage of cash for fiscal year 2023. If we are unable to manage our business operations in line with budget expectations, it could have a material adverse effect on our business viability, financial position, results of operations and cash flows.

 

Income Taxes

As of March 31, 2022, net operating loss carryforwards totaling approximately $7.7 million are available to reduce taxable income in the future. The net operating loss carryforwards expire, if not previously utilized, at various dates beginning in the fiscal year ending March 31, 2023. We have not paid income taxes since our inception. The Tax Reform Act of 1986 and other income tax regulations contain provisions which may limit the net operating loss carryforwards available to be used in any given year if certain events occur, including changes in ownership interests. We have established a valuation allowance for the entire amount of our deferred tax asset since inception due to our history of losses. Should we achieve sufficient, sustained income in the future, we may conclude that some or all of the valuation allowance should be reversed. If some or all of the valuation allowance were reversed, then, to the extent of the reversal, a tax benefit would be recognized which would result in an increase to net income.

 

Critical Accounting Policies and Estimates

 

Our discussion and analysis of our financial condition and results of operations are based upon our financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, sales and expenses, and related disclosure of contingent assets and liabilities. On an on-going basis, we evaluate our estimates, including those related to bad debts, inventories, sales returns, contingencies and litigation. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. We believe the following critical accounting policies affect the more significant judgments and estimates used in the preparation of our financial statements.

 

We record revenue at a single point in time, when control is transferred to the customer, which is consistent with past practice. We will continue to apply our current business processes, policies, systems and controls to support recognition and disclosure. Our shipping policy is FOB Shipping Point. We recognize revenue from sales to stocking distributors when there is no right of return, other than for normal warranty claims. We have no ongoing obligations related to product sales, except for normal warranty obligations. We evaluated the requirement to disaggregate revenue, and concluded that substantially all of its revenue comes from multiple products within a line of medical devices. Our engineering service contracts are billed on a time and materials basis and revenue is recognized over time as the services are performed. We record deferred revenue when funds are received prior to the recognition of the associated revenue. We record a contract liability to deferred revenue which includes customer prepayments and is included in other accrued liabilities.

 

We maintain allowances for doubtful accounts for estimated losses resulting from the inability of our customers to make required payments. If the financial condition of our customers were to deteriorate, resulting in an impairment of their ability to make payments, additional allowances would be required, which would increase our expenses during the periods in which any such allowances were made. The amount recorded as a provision for bad debts in each period is based upon our assessment of the likelihood that we will be paid on our outstanding receivables, based on customer-specific as well as general considerations. To the extent that our estimates prove to be too high, and we ultimately collect a receivable previously determined to be impaired, we may record a reversal of the provision in the period of such determination.

 

We provide for the estimated cost of product warranties at the time sales are recognized. While we engage in extensive product quality programs and processes, including actively monitoring and evaluating the quality of our component suppliers, we have experienced some costs related to warranties. The warranty accrual is based on historical experience and is adjusted based on current experience. Should actual warranty experience differ from our estimates, revisions to the estimated warranty liability would be required.

 

 

17 
 
 

We reduce inventory for estimated obsolete or unmarketable inventory equal to the difference between the cost of inventory and the estimated realizable value based on assumptions about future demand and market conditions. If actual market conditions are less favorable than those projected by management, additional inventory write-downs may be required. Any write-downs of inventory would reduce our reported net income during the period in which such write-downs were applied. To the extent that our estimates prove to be too high, and we ultimately utilize or sell inventory previously determined to be impaired, we may record a reversal of the provision in the period of such determination.

 

We recognize deferred income tax assets and liabilities for the expected future income tax consequences, based on enacted tax laws, of temporary differences between the financial reporting and tax bases of assets and liabilities. Deferred tax assets are then reduced, if deemed necessary, by a valuation allowance for the amount of any tax benefits, which, more likely than not based on current circumstances, are not expected to be realized. Should we maintain sufficient, sustained income in the future, we may conclude that all or some of the valuation allowance should be reversed.

 

Property and equipment are stated at cost, with depreciation computed over the estimated useful lives of the assets, generally five to seven years. We use the straight-line method of depreciation for property and equipment. Leasehold improvements are depreciated over the shorter of the remaining lease term or the estimated useful life of the asset. Maintenance and repairs are expensed as incurred and major additions, replacements and improvements are capitalized.

 

We amortize our patent costs over their estimated useful lives, which is typically the remaining statutory life. From time to time, we may be required to adjust these useful lives of our patents based on advances in technology, competitor actions, and the like. We review the recorded amounts of patents at each period end to determine if their carrying amount is still recoverable based on our expectations regarding sales of related products. Such an assessment, in the future, may result in a conclusion that the assets are impaired, with a corresponding charge against earnings.

 

We currently estimate forfeitures for stock-based compensation expense related to employee stock options at 40% and evaluate the forfeiture rate quarterly. Other assumptions that are used in calculating stock-based compensation expense include risk-free interest rate, expected life, expected volatility and expected dividend.

 

18 
 
 

 

ITEM 4 — Controls and procedures

 

Management’s Evaluation of Disclosures Controls and Procedures

 

Our management, comprised of our Chief Executive Officer (CEO) and Principal Financial and Accounting Officer (PFAO) evaluated the effectiveness of our disclosure controls and procedures as of June 30, 2022. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Based on that evaluation, and taking the matters described below into account, the Company’s CEO and PFAO have concluded that our disclosure controls and procedures over financial reporting were not effective during reporting period ended June 30, 2022.

 

Remediation Activities Regarding Material Weakness 

 

As disclosed in our Annual Report on Form 10-K for the March 31, 2022 fiscal year, management determined that (i) we had a material weakness over our entity level control environment as of March 31, 2022 and (ii) our internal control over financial reporting was not effective as of March 31, 2022. Our preventive and review controls failed to detect errors related to the valuation of inventory and cutoff of service revenue.

 

Management has been actively engaged in remediating the above described material weaknesses. The following remedial actions have been taken:

 

·We have made changes in our policy regarding how contract revenue and related costs are booked. Under the revised policy, such revenue and costs are now booked in the same month as the related work is performed.

 

·We have changed our policy regarding reserves for slow moving inventory. Under our revised, policy we now book additional inventory reserves for all inventory older than 18 months, even if management believes such inventory is still salable.

 

The Company will design and implement additional procedures during fiscal 2023 in order to assure that audit/accounting personnel are more involved with the Company’s inventory activities and service revenue to monitor and earlier identify accounting issues that may be raised by the Company’s ongoing activities.

 

While progress has been made to enhance our internal control over financial reporting, we are still in the process of implementing these processes, procedures and controls. Additional time is required to complete implementation and to assess and ensure the sustainability of these procedures. We believe the above actions will be effective in remediating the material weaknesses described above and we will continue to devote significant time and attention to these remedial efforts. However, the material weaknesses cannot be considered remediated until the applicable remedial controls operate for a sufficient period of time and management has concluded that these controls are operating effectively.

 

Changes In Internal Control Over Financial Reporting

 

Other than the applicable remediation efforts described above, there were no significant changes in our internal control over financial reporting during the quarter ended June 30, 2022 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

 

 

19 
 
 

 

PART II.

 

Item 1.  Legal Proceedings

 

From time to time, we may become involved in legal proceedings arising in the ordinary course of our business. We are not currently aware of any such proceedings or claims that we believe will have, individually or in the aggregate, a material adverse effect on our business, financial condition or results of operations.

 

Item 1A.  Risk Factors

 

In addition to the information set forth in this Form 10-Q, you should carefully consider the risk factors disclosed under the heading “Risk Factors” in Part I, Item 1A of our Annual Report on Form 10-K for the year ended March 31, 2022. There have been no material changes to our risk factors from those included in our Annual Report on Form 10-K for the year ended March 31, 2022.

 

Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds

 

None.

 

Issuer Purchases of Equity Securities

 

We did not repurchase any of our equity securities during the three and nine months ended December 31, 2021.

 

Item 3.   Defaults Upon Senior Securities

 

None.

 

Item 4.  Mine Safety Disclosures

 

None.

 

Item 5.   Other Information

 

None.

 

 

20 
 
 

 

Item 6. Exhibits

 

The following exhibits are filed with this report on Form 10-Q or are incorporated by reference:

3.1Articles of Incorporation of the Company, as amended. (Incorporated by reference from Registration Statement #333-4118-D dated June 25, 1996).
3.2Bylaws of the Company. (Incorporated by reference from Current Report on Form 8-K filed on October 30, 2007).
3.3First Amended and Restated Bylaws (incorporated by reference to Exhibit 3.1 to our Current Report on Form 8-K filed on May 31, 2017).
4.1Form of certificate for shares of Common Stock. (Incorporated by reference from Registration Statement #333-4118-D dated June 25, 1996).
4.2Description of Capital Stock. (Incorporated by reference from Annual Report on Form 10-K filed on June 14, 2019).
10.1Lease Agreement dated June 3, 2004 between Encision Inc. and DaPuzzo Investment Group, LLC (Incorporated by reference from Quarterly Report on Form 10-QSB filed on August 12, 2004).
10.2Encision Inc. 2007 Stock Option Plan (Incorporated by reference from Proxy Statement dated June 30, 2007). †
10.3Encision Inc. First Amended and Restated 2014 Stock Option Plan (Incorporated by reference from Proxy Statement dated July 6, 2020. †
10.4Employment Agreement, dated November 14, 2016, between Encision Inc. and Gregory J. Trudel (Incorporated by reference to Exhibit 10-1 to our Current Report on Form 8-K filed on November 18, 2016). †
10.5Fifth Amendment to Office Building Lease dated November 9, 2017 (Incorporated by reference to Exhibit 10.1 to Quarterly Report on Form 10-Q filed February 12, 2018).
10.6PPP Promissory Note dated as of April 17, 2020 (incorporated by reference to Exhibit 10.1 to our Current Report on Form 8-K filed on April 23, 2020).
10.8Economic Injury Disaster Loan dated as of August 1, 2021 (incorporated by reference to Exhibit 10.1 to our Quarterly Report on Form 10-Q filed on August 14, 2021).
10.9

US Bank Note dated January 21, 2021

10.10PPP Promissory Note dated as of February 8, 2021 (incorporated by reference to Exhibit 10.1 to our Quarterly Report on Form 10-Q filed on February 12, 2021).

10.11Supply Agreement dated August 23, 2021 between Auris Health, Inc. and Encision Inc. (incorporated by reference to Exhibit 10.1 to our Quarterly Report on Form 10-Q filed on November 15, 2021).+
31.1Certification of President and CEO under Rule 13a-14(a) of the Exchange Act (filed herewith).
31.2Certification of Principal Financial and Accounting Officer under Rule 13a-14(a) of the Exchange Act (filed herewith).
32.1Certifications of President and CEO and Principal Financial and Accounting Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (filed herewith).
101The following materials from Encision Inc.’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2022, formatted in XBRL (Extensible Business Reporting Language): (i) the unaudited Condensed Balance Sheets, (ii) the unaudited Condensed Statements of Income, (iii) the unaudited Condensed Statements of Cash Flows, and (iv) Notes to Condensed Financial Statements, tagged at Level I.

+   Certain portions of the exhibit have been omitted pursuant to Rule 601(b)(10) of Regulation S-K. The omitted information is (i) not material and (ii) would likely cause competitive harm to the Company if publicly disclosed.

 

21 
 
 

 

SIGNATURE

 

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

  Encision Inc.
   
   
August 12, 2022  By: /s/ Mala Ray
Date   Mala Ray

Controller

Principal Accounting Officer &

Principal Financial Officer

 

 

 

22

EX-10.9 2 ex10x9.htm EXHIBIT 10.9

Exhibit 10.9

 

 

 
 
 

 

 
 
 

 

 
 
 

 

 

EX-31.1 3 ex31x1.htm EXHIBIT 31.1

Exhibit 31.1

 

CERTIFICATIONS

 

I, Gregory Trudel, certify that:

 

1.I have reviewed this quarterly report on Form 10-Q of Encision Inc.;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and,

 

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

 

 
Dated: August 12, 2022  
  By: /s/ Gregory Trudel
   

Gregory Trudel

President and CEO

 

 

 

EX-31.2 4 ex31x2.htm EXHIBIT 31.2

Exhibit 31.2

 

 

CERTIFICATIONS

 

I, Mala Ray, certify that:

 

1.I have reviewed this quarterly report on Form 10-Q of Encision Inc.;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and,

 

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

 
Dated: August 12, 2022  
  By: /s/ Mala Ray
   

Mala Ray

Controller, Principal Accounting Officer and

Principal Financial Officer

 

 

 

EX-32.1 5 ex32x1.htm EXHIBIT 32.1

Exhibit 32.1

 

 

CERTIFICATIONS OF PERIODIC REPORT

 

 

I, Gregory Trudel, President and CEO of Encision Inc. (the “Company”), hereby certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that:

 

the Quarterly Report on Form 10-Q of the Company for the three and nine months ended December 31, 2021 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and

 

the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the period covered by the Report.

 

 

 
Dated: August 12, 2022  
  By: /s/ Gregory Trudel
   

Gregory Trudel

President and CEO

 

 

 

I, Mala Ray, Controller and Principal Accounting Officer of Encision Inc. (the “Company”), hereby certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that:

 

the Quarterly Report on Form 10-Q of the Company for the three and nine months ended December 31, 2021 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and

 

the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the period covered by the Report.

 

 

 

Dated: August 12, 2022  
  By: /s/ Mala Ray
   

Mala Ray

Controller, Principal Accounting Officer and

Principal Financial Officer

 

 

 

 

GRAPHIC 6 image_001.jpg GRAPHIC begin 644 image_001.jpg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�R-):VXD1AM1< -SSSNZ +6G"-# L8+9?8O( .S'S=6(Y],C%=710!QK/XHM86FD=W56:0JRH2 M H''!Y!.>.M:-W=^(%M[46MJKRS1JTC87$3<[A@D>JX^AKH:* ./>?QA&Q6* M"%LB0EF"MR!A> W'0<>I-6H+OQ*8KSSK9 PBB:'"KG/'F ?-ACU(Z#/%=-10 M!QWF>+PLLL<:F0X&QPFP ACE>V#BNEHH XX2^+H;'8L(>X &"P1U;GDD[@<^PXI1<^,8WP MUM T15B[+M+CYOX>0,@< '\37844 5[#SAI]N+G/GB-1)GJ6QS^M6*** "BB MB@ HHHH **** "BBB@ HHHH *S9_$6D6T[PSZE:QRH<,C2@%3[UI5Y[J_P . M;[4-:O+R*]ME2>0N%=6R*N"BW[SL3)R6R.L_X2K0_P#H+6?_ ']%+_PE6A_] M!:S_ ._HKAO^%7:E_P _]G_WRU'_ J[4O\ G_L_^^6K3DI?S$OVK']Z%42*1\[.=QS_%\_Z"L.;X?S M6TPBGUK2XI3CY'YJ"/2?#,N/2CDI?S!S3 M[&G91:'8^(Q=QZSIGV,2&8(6&_S,, !V"@-V]/7FA+#PTLMQ+-X@MIGFR@2:!)I\VNV:O/())624$ Y5!GG:!@#\^]4H].T6)8@OB' M3^'.XL$8E/X0<_>/RIUZ8.*RO^$&VH';7]'"-G:QEX..N*E/P_F"NQUK2PJ, M%8ECA2>@/H31R4OY@YI]C8AT_P -6\Z21^(X3A3'\YC?Y>__ CTQS@]JR4^'%W)%'(FK:_ M0_E1!\.+JZ5FM]6TV94.&,9+ 'WQTHY*7\P(M!M;6&"/5K39$@1?R_#V>!-\VL:9&FXIN9B!N].>_M4G_"M+X2+'_: M5AO<%E7YLD>H%')2_F#FGV.[_P"$JT+_ *"UG_W]%+_PE.A_]!:S_P"_HK@$ M^&]Y(5V:KIS;B57!)R1U ^E,'@*0PO,-;THQ(=K/O.U3Z$]J.2E_,'-/L>A? M\)5H?_06L_\ OZ*/^$JT/_H+6?\ W]%/>G M?\*WO-[K_:FG[HQN *KIX!DE\PQZWI3>4,OM?.P>_I1R4OY@YI]CLM?\2:1<:)E+%\/ M;B9&DBUG3)$1=S,K$@#U)[#@T2L%CU33W8KO 7))7U^GO1R4OY@YI]CO/^$JT/_H+ M6?\ W]%'_"5:'_T%K/\ [^BO/H?A_-/.8(=:TN249RB.2PQUX%2GX:WN]U_M M/3]T0W./FRH]3Z4[W*/[5T_H]Z.2E_,'-/L=]_PE6A_]!:S_ ._HI?\ MA*M#_P"@M9_]_17GZ_#NX,;2#6--*KCG/OVI#\/IUF>%M8TP2HNYT+ M'?0?#^:Y#F M#6=+E"#1-=TAD3&]A)D+GID]J.2E_,'-/L>B?\)5H? M_06L_P#OZ*/^$JT/_H+6?_?T5YZ/ $IMC?_ /"O;@JS#6-,*KMW$,<#=]W/U[>M M+)\.;J,2E]6TU!#CS"Q(V9]?3\:.2E_,'-/L=_\ \)3H?_06L_\ OZ*/^$JT M/_H+6?\ W]%><_\ "#X3=_;^C[0<;O-XSZ4]? A_\)5H?_06L_\ OZ*/^$JT/_H+6?\ W]%<-_PJ[4O^?^S_ .^6 MH_X5=J7_ #_V?_?+4KC?"?@J[\/ZL]W<74$BM$8]L8.3R#SGZ5V59223]UW+BVU MJ%%%%24%%%% !117$:KXWU"SUR_LX;:R%M9D;YYW90,@8Z=22> !51BY;"G21I(D>Z.1R&+ D8_ .=802F6VTN+9*\0W MRN [J,D ]._4!%4$LQR.G!Z9H]FP]HCO:* M\YO/B+JEG'#)]ETZ:*8-LDB=\':<'K@U-+XYUZ**R8Z;9,UZ=L2*[;L\$ CL M2&!^AI^QD+VD3T"BO/QX]U62:.*"#29G=BA"3.-F 22<@?* .HR.*6+QWJEQ M/Y<$6E2KY;2M(DDF%53@Y&-V>1CCG-+V4A^TB=+JND+>^(-*NFM8I8X3)YSL MJG V?+UZ\URD_A75SIEHI6:&>#2XFM)?*E5I)"0QSC& $C$H>25RCICRPI93]]7XQCE:FN-*UI_&']M1PIY4*SW\>ZTFG0WK:?8>7/($5?,8OSG:2.P.#CZ5+-XTU^&[F MM_[,L&EBE2([96(9G&1@_0$GTQ1[*0>T1%#X?U:-H8&TQ";>*XCEN,)FX+*X M#AL[LG(R"*K3>#M3M[1HUMVN6:.V96C$:% C9="O +#.03G/>KL?CO59KF.& M&'292[,I:.9R$VJ6.>,D8!Y&6P8Y!W??R1QUQS4I\*:DMOK<$\ N@UK%#9.VTDA<\ M<]QG&:H?\+4U'_H'VG_?34?\+3U'_H'VG_?34>PF'MHG9Z]I37%EIUO8VR&. M&Z#F-2$55V.#TZVB$/@W7$M+2V"?NEM)3M9P/+D M8C=&2#T;;QCU-7K[PW>:Q>+)#I!TN%GAC*HZ!DVEB90%..,@#O5'_A:FH_\ M0/M/^^FH_P"%J:C_ - ^T_[Z:CV$P]M$NV>A:M:/]KU'2H]18M<*UOO7&]V! M$N&.,'&/4"K4NC:R-;LM1AM(HX=.6&&.!)VB;FGP:CI6K17D>CWD\9M&A*GR$D5O,W=% M(7&/2J\.CZZ^J7NI36RJNIQ3PR0[P7C7;^ZWVB2V7A_5[9HK@:9<,81;;XW,*NQ23)";3C&.[N15V7P[?7"V/DV\ MD,=RGV74!,(U?RU?>&PGRY/(X[-61_PM34?^@?:?]]-1_P +3U'_ *!]G_WT MU'L)A[:)KKH-\;@6W]FHMPNH&Z&I!U \O<2!_>SCY<8Q3(=(U6WTHVMOH<$% MVELUJUZ)5W2,[ %ACDKC+$MSGI67_P +4U'_ *!]I_WTU'_"T]1_Z!]I_P!] M-1["8>VB77\.ZM;Z;9V,EH\L=E>N\9M2C_NF0_=$G'#$CFI_#VF:KX>U"*:3 M2Y9T:T\G]RZ93]ZS?-D@9P1G''I67_PM34?^@?:?]]-1_P +3U'_ *!]G_WT MU'L)A[:)O>$=)O-.OL7=E<1'][\[+!Y8RV1AA\^<>OO4$6CZZ-9O=2>",KJ* MS0O%O^9%VGRMV>,?*.G]ZLC_ (6GJ/\ T#[/_OIJ/^%IZC_T#[/_ +Z:CV$P M]M$E;PIJ]O;BW%J;FWBM8O)0LI96\Q'>/)/8AL>QK>30[RXT;7DBM4L#J!_< M6Q887"@'.W@;CG.*YS_A:>H_] ^S_P"^FH_X6IJ/_0/M/^^FH]A,/;1-:[TK M4;^SN+:ST&WTU+QXH93O&3&N2Q8*:.*7<"D MIW+M'KADR.?2LW_A:FH_] ^T_P"^FH_X6GJ/_0/L_P#OIJ/83#VT0'@W65MY M'2 J6%M$\!=<2HJJ6[\%64?K6S;Z#=F\M;:32HPT-^]Q+J!=2)8R6.W^\200 MI!XXK&_X6IJ/_0/M/^^FH_X6IJ/_ $#[3_OIJ/83#VT3L-%T4V.E:E%]DBAE MGFGV!54;D).SIVP>E<=%X4U7[ 0NGS*Z6L43+((0699%8A-O!& ?O^U+_P + M4U'_ *!]I_WTU'_"T]1_Z!]G_P!]-1["8>VB=GH]B3HH?Y3G!YJC_P +3U'_ *!] MG_WTU'_"T]1_Z!]G_P!]-1["8>VB:_?47U 0'R_MT,IMBL0=D"K\P;L0 M0>.AP:S=-\':S;:A:O/"?(@D9U 9< N&W'\POYTG_"U-1_Z!]I_WTU'_ M3 M4?\ H'VG_?34>PF'MHCCX.UM;21HXL,[6TN 0R_EFMO1-%U6W MUZ:\U&V@>VU/S#<1[MQCYRF\'@X'R\5A?\+4U'_H'VG_ 'TU'_"U-1_Z!]I_ MWTU'L)A[:)=E\,7T.F:*%T]S-!).;G[.L);YB=I^?Y3Q^5.NM U">2_A32#N MO4MUANI&B'V MPF'MHGI-G+++!F>)XG#%=KD$D X#<>N,_C4]>7_\+4U'_H'VG_?34?\ "U-2 M_P"@?:?]]-1["8>VB>H45Y?_ ,+4U+_H'VG_ 'TU'_"U-2_Z!]I_WTU'L)A[ M:)ZA17E__"U-2_Z!]I_WTU'_ M34O\ H'VG_?34>PF'MHGJ%%>7_P#"U-2_ MZ!]I_P!]-1_PM34O^@?:?]]-1["8>VB>H45Y?_PM34O^@?:?]]-1_P +4U+_ M *!]I_WTU'L)A[:)ZA17E_\ PM34O^@?:?\ ?34?\+4U+_H'VG_?34>PF'MH MGJ%%@X^4>E2:]I5]-XKM+VUM9)@OE@,SCRU )W=P4.#VR& M[U?MGV)]DCC(="\11II_E:/./LC&10Q'SL6W,*"<^IQS6H-!U>%;,-IIGNE\GR97DRMNJ?>4G<-I)YR,YS MBF)X9U^&2)=CR6XWNJM*,H3.I(Z]"J[OQ-#KM]!>R72IX[9'XUH1>&?$$ M8565Y(O(E.PS!2"T@+19ST(7@_[1K=T33KV/1]:B^P_9([@N;2#(5E!3&" Q M"\^_O2]KY#]GYG%WFA>(=2NK:XO=(NI62-$E!=?WFWOU^7(QGWYJS)9>)9KB M*6305WQW)N (U50&-:%J4>RF";H"R*T:DE0VXA=Q4]1R>3 M6U96.IVBW\,&G30_;+:*.*56C58'"%22H;C!.>,T_;/L'LEW.5B\/ZE;3J;/ MP[=>28WBE$DZL[JPP0",!<=N/K4EKHFLV,LQM-"OX5DB$8=+D+*/FW$ENG., M8 '%:DOAW53:[]*T]["2&.,&)I1^^ER5=Q@X^ZQY/)XK<\)Z#?Z3]O2[E8X MM[20MN/EKD@_FWZ4>W?;\P]FCC3IGBI$E6UL;Z-I)O->1IE=S\H !;/;GGWJ MLOAKQ ;![=M(N&$LZS22;URX ( Z_P"TQS[UNMX:U-[ P0ZW",!')D?+M7/R#U'UI^W?9"] MDNYR=JYSR,'%1QV7B6..T5]&=VMYVD9F909=P M("GGL&;'UK;L-(UO1EMA);M>1V=T9T$,W^L5XR& W$M,L8>.2[ %L3C8, M;$<%0I.TXR.3UIR^&]86^@GAA9;?S+59+>0J!L09+84X!!!''8U2KM:V$Z29 MR?\ PAVOG(&ESY'NO^-'_"&Z_P#] N?\U_QKLI/"-U$';3X%MIVO;@B56QB% MD8)SGIDCCWI)-!U&ZTEM/L=(&F)<.GG%KO((53D_*3C+8Y')[T_K,NPO81.. M_P"$-U__ *!<_P":_P"-'_"&Z_\ ] JX_-?\:[B;P]=7YCNKNP0WG]FRQ2DO MR9QA48'/4@=>PJBGASQ +LO&YCCDDE;:7&(F\G:KCGD$DC\ :/K,NP>PBGW5CJ-X[:7]AM6AC4*7RS2 ?, M?O$-G^]P3WK(ET#Q#<1ZE]HBP-3"RD13 M"ZR J.>GRY'&1Q1]9EV#V$3E/^ M$-\0?] J?\U_QH_X0WQ!_P! J?\ -?\ &N_MM)U@^%==M;L![VX>3R2& #C: M &'IDC/UJ#3-.O\ 3+FQN(].NG2(R"9 L*'YD4# #X/*]2U,>CBS6/4$>;E5V-L* M\@=L M\J5R!_=)%.;P]J5Q,DVEV4VE0K-&\43RC]VZHVYR,D88[5]3UH^LR[![")R9 M\':^!DZ7, .Y*_XT?\(;X@_Z!4_YK_C746GAS6%$4NH:>UW"/+\^S\U1YA", M,]<':2.I_E6YJ.C7=]X7L+**W6"1)XB\9D,HB4$YR2?G &,C/M1]9EV#V$3S MO_A#=?\ ^@5PBFZ)J*:K!-]@N(91=1R&YEG4D0K&JLAP?F)(/;WH^L MR[![")Q@\':^1G^RKC_QW_&C_A#M?_Z!<^?JO^-=[KVCZO=ZIJ,EH66WDBM@ MJ @^:5?+#D_+@=QUK(C\*ZE)9R1-:21SRW*EI66/'EB7=DMNW-QV('2CZS+L M'L(G,_\ "&^(/^@5/^:_XT?\(=K^HYI]SX?U*03K#I\J7A6Y,]T9ABY5\^6H.>2/EZ@8Q1] M9EV#V$3E?^$-\0?] J?\U_QH_P"$-\0?] J?\U_QKU/1(6TDQZ8Z>8YB,[31 MQ!$!R!M(R>?YX-2[?W2.GT[4EAX2OXX;I+ZV\X7%E($4,!LF#$KNY^8]"&[=*/K,N MP>PB:!(85@@S;&4 ML04&$?S&9<\\E?K38KNTM?%%@]E'<7.DF58M\:[8!=$;0ZCOP#P.,\T?69=@ M]A$Y?_A#?$'_ $"I_P U_P :/^$-\0?] J?\U_QKT/Q'X:&H:F\\-FLA:RG! M;=C,V (\\]>O-9=WX=\02K):+)YL=U#;I)*[",)L#$K\N3UVC('-'UF78/81 M.0_X0[7_ /H%S_FO^-'_ ANO_\ 0*G_ #7_ !KT&RT&>XU'1[S4[%#/# ZW M+D@YE7:$;KSP"15K5= DN_$5O<1[A:NI>Y&[Y3(G^I)'L2>G]T9H^LR[![") MYI_PANO_ /0+G_-?\:/^$-U\?\PJ?\U_QKISX"+_2Y?/&+U MPZL"ISR>"07C 521D;N"2!T'6CZS+L M'L(G*_\ "':__P! N?\ -?\ &C_A#M?_ .@7/^:_XUU<_A;7;E)+%I=\-P(? M,N)"$VB-.%PO/WB/RYJS_8.L7E[;-PB<4/!^O-]W3)C]&4_UH_X0_7L$_P!F38'4[E_QKT/P1I-QI%E+%=V3V\K* MFYF$0W$ @X*=?JW/-T1M!(9HXF9(M@ 99,L'!.';&,,?<4?69= M@]A$P/\ A#M?(S_9IPAV\]..U4;/PI?C4[>2]TZ22$Q)&Q'E,$Y;.=QR.#_#S1]9EV M#V$3F?\ A#M?_P"@7/\ FO\ C2#P?KQ&1IDI'J&3_&NDM_"6NF19;I=_F*XF M3S!P8T*0_GFGVGAJ[M[6SCN-#FGBB=FEA+0INS'M!!4\X/<\T?69=@]A$YG_ M (0WQ!_T"I_S7_&C_A#=?SC^RY\_5?\ &O1;S2M6E\%6FDJ5>ZD"0W$C2<(G M5N>IX ''K6%?^'?$-W; JN+B&R%H0) 5N%$A'<\';M8$T?69=@]A$Y?_ (0[ M7SG&ESDCKRO^-)_PAVOYQ_93VEH8II;E9(]1,HPD8C"E<=>3V_P */K,NP>PB M<3_PAVOGII?3*@C*]-W-'UF78/ M81.+_P"$.U_&?[,FQZ[E_P :7_A#M?! .ES GH,K_C75/X7U&^E6./38-/M! M,'2-PK*N$8''-2BOK:2>PN',=M'$#OB?:ZJP/S,<@9. M?E[8H^LR[![")RP\'Z\WW=,F;Z%3_6C_ (1#73G&FRG'7#)_C7H/@;1[G2;6 M:&]L7@=D0,S>5AL9X!4Y/7JU49/",L!OVM].C:%]01_LZ.%,]L ,IG. -W.# MUQ1]9EV#V$2O\/=!U/2M9N9K^SD@C>WVJS8P3N!['VKT.L;PQ93V-C.DT)MX MWG9X++VU*73H[+ M1UE^U7+X,D;;?+4#).[H.P_&M^H9;NV@D2.:XACD?[J.X!;Z#O0!R%KK-Z5O M%O(K^.>YL8U@40.0DP5P^"!\IW8K7L+A=<\->46OHYXX$61BKPR;PH/!(!/( M[5L27EM%$9)+B)(P Q9G '3.:'O+9-N^XA7<0JY<#)/( ]\$4 >?K%J4%WI M2SW.JB-[6.68,T[GS"WS#Y.AP.AXJ)[7Q)Y5P1+J(-RL@B*2.2")@!N!^YA> M01U%>B_;;;S%C^T0[W&57>,L/8=^AIWGP;=WFQ[=H;.X8QV/TH \R\WQ-);W M$UV^H1A_+.U$R1"6=O, 9-H M& S\#)8C([@&NL:ZMU0NT\05026+C X/Y4^.2.5 \;*Z,,AE.0?QH \^FN_ M$5S?//'#=K:7,]L/+PP,1V@L0/[I.0?PK0\+'4RDFUK\C[$/,-[NP+KGA=W. M/7MTKLZ* .!1+Z.S0E-=4-Y1U)G8Y/)W^6.O7&=O&WIS5:]/B-;-IM.^W_9D MAG\M)=WF&(L OOO R1WP*]'HH \XNX]='VHVIUHW)DE!)+>7Y6SY=O;=NQC' M-7[K3M2AU'4)()M4:-9+4V^9G*-N8>;Q[?I7<44 >=3+K4EM,+8ZL+[R9?MA M.[8'WCR_+[=,_=[5%?'Q)Y+FZ^W>;'E44 < MGXE:Z,UL9QJ"V9M6.VSW%Q<\;0Q7GIG';--\.Z?K4FK-=ZK-,$B"+L:9P&;R MUSA1\I&2?QKKNE% '$76G:M;ZG>O93:@VR\MQ;^=-(T>PD&3([J#U]!5"X77 M6M[S[5)?JH/)C1RF//;. #NV[0.G.,5Z-10!QMS+K5SX/L+2TAO4O[D[&ZY,(99[?4TG:&'[/%#O1=PSYN[:"-V1QNXQ7H6** M /,[N+Q' MS*)=159Q.(A&TCG(D& 1_#\H)!'4<4Z5M0*Z>L=SJ)C/G>8^VZ MP6RN!_?Z9]NM>E44 >8S2>)C>R(GV\VJW9F5@6#;2Q15''08S3M/.O/:6AM) MKZ:Z69'F$PF"X"$[6W\8)X.WCI7IE% '#:+::E>W%[XEMM4OKA8IOL]S"]M:%B, M>8B_*^W^'<0W/3D5ES:AJFQE@FU);(R1#S)'E+9"'=GC=R<9QQ7=:[/_ *3! M%DC +\?E7*7FH76DZDSR22SVDJDQJ3]UO3\ZX*F*E[5TX=/Q.VA@W55[[EC4 M=2U:ZT#3[/3/.%S*NYI 61@$YY9N>3CKR>:CN+OQ!7DX']TDD'W J72!>2V33WLSOY_*H?X5KM-,D,NGQ%CDXQD]\56&Q#G-TY;H MG$X=4M4SE_"3Z@XD*MJ+Q_8E\PWN[BY[A=W;'IQ62!K,EJ%L)-66=XHQ=M/N MQ'<&1?NY_AQNSMXQ7I%%=IR'#[];O/"DV];F&^EU/:55F7:F\ @-U"=>1VJ. MX/B#39["$&ZNDL")KIT8D2*[X"9/+[5SVSGK7>44 ><7,^N"2=(UU1[TPW'G MX+A%//E[!C;C[N,'.3S7.W+:MK=LBA;RYT^"0LK!9'$\P &W)!(QTY&,YKO/ M$FNRW6HC0-+E\N5E9[RX49\B(#) _P!HC\LBI7N-]K#H?AMA B1CSKI1D6L9 M&>O0R$?EG)H H:SK(NO$&G65E=7B2VQ1KP0 M'$./E<*.2>G/ &:R;-M8O/% M$NMR6DSZ?<-]F'0@0LIVX7J1RISTZYK=\+:3&-%U:[L%"?;F=+>Z8?$4:_P!EQW%U M]GMXH3+Y).^V1G#$;?4#<,>F:ZAM.>+PI>7*V@A)(?3E9Y&/S3-YARQ]3EOUK6O]9BLIUMHHI+J\<96"$9; M'JQZ*/XLS=W-W_;*7,\C+:I$"(BC)\@QZY//?(K6F;6[N5XH- M3:6Z4_-%9Q*D,)]&D;)/TZ^U8F@7&N^(M:,EQ/#<+:;X4N1'A+=LX+A>A^V74\WD1^1'-]E$I"ML.5.WG(_BQW-7+C6CINJPQR7]Y#.7M MO(65G6-HS_K"P;ISGKS77ZS<#PUX?6/3407$DBP6X?G=(Y^\WKW)^E9MKIEA M/!*PVR6$;&6\OYAN>[=>2 W]P$IZQ::E?+;3BWB>XA\CS-V6 M"KN9EQQL'>LC2-#UY%@MO>1W0==TD;3J=WE%B$#-W; &1UZ9K<'-87]G^(9,&36;:+G)$-F#_Z M$:1;3Q-;8(U&PO ,Y26W,>?3E3Q^5 &]163'J>I1#%YHTN0/O6TRR GV!P?T MI4\1V/G313E[9H5W/YP "^V1QGGI0!JT50.N::HCW7<:^8<+NR.^.?3GCFK] M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %7(C5Y7$*,44G"DD\GH>G84 M 8%KH<5A/#+%J>GW"0HBK!/,-A;YMV3SQEMPXX.:EN=+258S'?:3O5LC]YA4 MRB*0%Y!7Y?NGMCD5/<7_ (>ACA/]BPNLT<, !\[M.L]$M[2QN[0:M9M%-9I;QAI ?+(W%N_P!W+$@=NE+_ &YX6,1=-,@<^84V MBV3/$>_.#VQQ]:E.H: )K>-M'M ;@KMVI"V=S;1C!Y.>H'0=: *O]AQ)*)(] M5L' +2&*24%6]9E MU/X=L[E89=.M 6N1;;OLZ8W$ G\!E<_6F+=:"VGW=W_8\ CM6"NI@C#9)QT[ M?CB@#?\ [3L?^?VV_P"_J_XTO]IV/_/[;?\ ?U?\:YE-3\/2R,BZ1:Y52['R MXL$ L/E_O_=/3-*FI: [*!HUH"T7G#Y(3\O/3GD\'@4 =+_:=C_S^VW_ ']7 M_&D_M.Q_Y_;;_OZO^-0O^%)_86E?] RR_P"_"_X4 2_VG8_\_MM_W]7_ !H_ MM.Q_Y_;;_OZO^-1_V%I/_0,LO^_"_P"%)_86D_\ 0,LO^_"_X4 9NKS6\URD MD5S X"X(653CGZ^]76IN-9SA%ML]##XCV<% MJKH;HFI*\+V5PRK<6_'+#E\MPW)P95XY^M<@;C2MT*S6*6 MZS% KO%&<*P+!C@Y4''?'45JIJ/AYH)S%H\$IMK=)W7R8]VQ@"<9ZD9&?K6V M%I6DZC5KF>*K^TT1U'V^T*[OM4&/7S!3/[3L>/\ 3;;GI^]7G]:YVYOM"M+7 MS9]&A0^>UN4,$?#J/7ICWI]C=:#?7,4$6CVJL_.7CA ^\R_+S\W*GEF7D"7=PNYYRZE8(^[=>3Z"K.I:#;M9NNFZ= MIBW#$!6F@4JOJV .3BF:5X0TG3+)8#9V]P^2TDLL2DNQZ]N![#I0!S,$+V.J MWMIIK01K(B1+?3S*R",\R-U^:1F)XZ=*FBM[W3M)?0-.ETM+-V*"_-R-XC;J MS)W?MG.*ZW^P=)_Z!=E_WX7_ H_L+2O^@99?]^%_P * "RGTZRL8;:"[M_) M@18U'FKP ,#O6(W]D7OC)IG-D5M8 VYF7#RL>O7D@+^&:V_["TK_ *!EE_WX M7_"LK1=$TV6ZU65].LR!=F-%\E2%"JHXXXSUH +Y&6ZMMB6 4/YRX+ M%R<=?:LG1O$2Z;:217%K+<:Q*Y:Y9'C".V>"'+8"XQCTK2TS1],N/$&KO_9M MGY4+1PH/(7&0NYB./]H#\*U_["TG_H%V7_?A?\* .EV85!M&85)Q]2.: ,F"Y&HV MXMUN(-)TU1M"+.GGR#\#A,]>Y^E9WAKQ1I&@:!%I=U.!>VCM$T,8W-*=QPRD M<'((YS75C0=) P-+LL?]<%_PH_L#2!TTNQ_\!U_PH XG7]1AO]5TFX\12VMO MI:22,+>.7S&#!?E,A7U]!Q[U9UAIO$^AS):W-M968"FVM&F5&G (.'P?E4C@ M+^==8- TD'/]EV6?^N"_X4O]@Z3_ - NQ_\ =/\* ,--0U2]00K>:5I%NB[ MF:WQJ= M@ !]MM>/^FR_XTJZ78(N%LK8#T$2_P"%96L2VVFSQQ_V19S121R2%CM4@(NX M\;?3'>@#5_M.Q_Y_;;_OZO\ C1_:EA_S^VW_ ']7_&L*SN+.XU&.U;1K.-7= M5#J%;DQ&0'&T=ACKUJUHKV>L(]Q_9=K&%)0'RP3U([J!V[$T :?]J6'_ #^V MW_?Y?\:/[4L/^?VV_P"_J_XTO]FV/_/G;?\ ?I?\*1=+L%SBQMAGDXB7_"@ M_M2P_P"?VV_[^K_C1_:EA_S^VW_?Y?\ &G?V;8_\^=O_ -^E_P *3^S;'_GS MMO\ OTO^% "?VI8?\_MK_P!_E_QH_M2P_P"?VV_[^K_C2C3+$?\ +E;?]^E_ MPI?[-L?^?.W_ ._2_P"% #?[4L/^?ZU_[_+_ (T?VI8?\_MM_P!_5_QI?[-L M?^?*V_[]+_A2_P!FV/\ SYV__?I?\* )D=9$#QLK(PR&4Y!IU(B+&@2-0JC@ M*HP!2T %%%% !1110 54N]+M;V=)IT8NH X8C< <@''4 \X-6Z* ,C_A%M*\ MIXO(?8W!'FM]W!&T<_=P3\O2K,NBV]+%X9>?3H$NKF2VN(;A[F,VF L+-GY5!!R!D]J@\.VVH^1J[K?1O- M)=NB2R6^/F3"%B 1G@=..E &K)X=TZ29I?*=&<$.(Y757!))! .",D\>YJC( MNDW;6-RL<^V=S91['9%8+OX96%'TR:[<0I T:6*1C?'(R-O9>G! MZ!0N?7CTJKK']CZ7?6UC#ILD][<*%5+0D2(BYVL3G@6]O+S?;!8F*R*549R!_#@Y'7BKFIW]W9>%7OYH$@U"1!&SJF?+W-@,>I MP "X=@71PH*8(&<@0\D3%I)0 %=U ) .6(SU M//I6G%;IK5_>R);SQ6%S:&":1D,9G;/# 'G@9&2.GJ:NSZ98/KL6G16<01[$K<%<@K&K#RU!!X.[)SU^6 MLF#Q7-IT$<<5U9ZK'& BPQH\=TW8#;@C([]*NW^M)H&K:E>WD3J;JWA-H'4@ M.0&RA;L&]+0L?LJMD;<.Q8!<$;1D\##'CWHB\-Z5#"8H[.-4 M*-&<9R5;J">I' Z^@K @N=?_ 'RR_;C*L28S"1_"N_&%V%OO8^;KCBGQW6MM ME5340BMBU+Q\R_O/^6F5! V^N._4XH WY= T^:[:YD@+2,0QR[;=V1\P7. ? ME'/M2QZ%917JW4*212CM'*RJ>2<%0<$98G&.YKGX&\2K!+(6F67;&T<8W4#V' _"M.BB@ HHHH **** "BBB@ HHHH **** M "BBB@"EJ^IQZ/IDU[-'+*D0R4B32[@JQ0]23W)/0>]>@% M0V&JIKB1L=+D&=[K3[9U2TN&'WDV\KG^+:>,T 1>)5BA:PMHK2 MRW7=P%$UR#Y<;*OR].2Q' I;.VNM"OX5*64L=[)M<6\!B<-@G=C)! [].OX5 MM:A:V]Y92PW< GA93NC*YSCGCW],5QOA[Q!?7-Y)IFFJ)XP&>%[YR)8$& 5D M R>IXR02!0!VXGB,OE>:GFXSLW#=^76I*X:V\/ZQ8WL;SV<5^T,QGCGAD2$N MQR3YC,"_?&!Q@#K3KG5-9U"YDT:2S,EU#*7N/LLOE 1$ Q@.>G)Y(Y^4\;N5;2UBM[<@1^<79KG/0)M& 2>,T2>\9; M?*AF5CG9GM^!.,UR\&K17VO37.H)=.]G*R6EA';.Q7'!E;C!8]N< &IK;4ET M[Q#?WFOQFR-PB+:/+RHC Y7<,@-GDCZ>E &W?WUX/)72K:*Y,REA+)(1$H'J M0#G.>*SK/Q!+=Z=J+7DMO8M:3^1]IC/F1LW!.W(&2,XQZUD7%_)%I]R;&1K+ M3+V^V)=E"!%&4R[J,< L" >F234(FSYNR.O\)/8]^G!K;KF;W46\26WV M'3;.["221F2ZEB,2QJ&#$C=@LW'&!WKIJ "BBB@ HHHH #TKBO$=W:0:PZ&* M=G\OS'V7PKM:X;6M7TC^W+JS>.[>ZV>3(L=OYG&,G'/^T>:F M:FU[FXXN*?O%!KNT9MP2\",N\E;V8K&N0,G#G')''-(NM:9' DTT-WL;.,7D MF< 9)(\SKTP.OM4$=QI#W @VZQ+-&N&B-LQ)7((##=TR!P:0:CX?2W9)$U&2 M*,F,B2V)$9(QM^]P>./I67L\07STNYI1W=E)>?9525I5D1&'VJXQ\RD]V[8( M^M332V=O=""6VN 2C2^8MW+MV+]X_?SD9K-,FBS[9H[350]NS S1VS!@W?( MW$;\<,2,U7LL3?K;Y"]I2+4FM:3'Y3/%-&DBEQF]E8\8R/EQMW_ M 'MC=Q+YAC)>\EY/&?\ EI[CDU6CN= O+3!>3>5.+=PMU)PYX!Y?H3W]C5:XO=)N+] MBUKJJ7# 2,J6K*S+P.<-]W@>V12V]]HPDQ!8ZB6AVHP6S/!4[ES\W)R<\^M3 M[/$V_P"&%STB0ZII@B9Q:W8$>5E;[7*1&V3A3\_?!_2FIJNGO9RW@CD,,>PL M?M-QD;^G&[MWJL;K1)K:2X6WU(V\982E;9MN>Y,5QLA8(S)<3>&AE3;7RQB/S&C^S$*5[,1 MO_VC@^]*UWX;\J+;:ZA&L[,8V2V*^;DD$ [N1R1^-6J5==_P)1D;_2N.77/# M<4P9FO6"N6\N2#<@)SGY2V.YKH;3QCI>E:9;J++5$M\!(W:V.#Z#D_E5TZ=5 M/WD0YPZ,W/\ A'-/_NW7_@9-_P#%4?\ ".:?_=NO_ R;_P"*K';XCZ0@D+0: M@OEML?,&-K<\'G@\'\J?_P + TXSK!]CU/SG 98_LWS$'D$#.<8K;V<^Q/.N MYJ_\(YI_]VZ_\#)O_BJ;_P (U8>UU_X& M3?\ Q5'_ CFG_W;K_P,F_\ BJS8_'=C,',5AJKA/O;;7.WC//-0_P#"QM)# M8,&H [/,Y@_A_O=>GO1R3[!S+N;'_".:?_=NO_ R;_XJC_A'-/\ [MU_X&3? M_%5A_P#"SM#_ +E[_P!^1_C1_P +.T/^Y>_]^1_C1[.?8.>/1@"Z' MN+R;_P"*H_X1NPSG_2OI]LF_^*K$_P"%G:'_ '+W_OR/\:/^%G:'_!C%T?GD$ 70_[?)O_ (JL3_A9VA_W+W_O MR/\ &C_A9VA_W+W_ +\C_&CV<^P<\>YM+X9L%(R;P\8YO)OS^]2KX:T]?^?L M_6\F_P#BJQ/^%G:'_8DC1_\ 'XX!()!Y,F%Z?Q8SVI?^%G:'_QJS(NCP65W=7%OJ4,5K*(I"UW(3G(' $AXY%81\2>#6C M>-[*]=6 4AU)X&W&/F[;%_*K;>.?#+0RQ-!>E)9A.X\OJ^0<]?4"G[.?8.>/ MN%Y0/U: M0#H:R1K_ ()$;H-/NPKMNXCY7DG"G=\HY/ XYH_X2+P@A4P0ZG 48LIBRN"< MY_B]Z7LY]@YX]SM#X;L#@@78]OMDW_Q5,C\+V$;9,E\^>S7TQ'_H58__ LW M0_[M[_WY'^-'_"SM#_N7O_?D?XT>SGV#GCW-O_A&[#>3_I>,=/MDV/\ T*C_ M (1O3]P.+K'I]LF_^*K$_P"%G:'_ '+W_OR/\:YLKX;T]3?_%4#PWIX.3]K/\ V^3?_%5E_P#"P=,W MNGV34PT9 =3;/Y!QCR1_C2?\+.T/^[>_]^1_C1[.?8.> M/YM?\(YI_P#=NO\ P,F_^*H_X1S3 M_P"[=?\ @9-_\56'_P +.T/^[>_]^A_C1_PL[0_[MY_WZ'^-'LY]@YX]S<_X M1S3_ .[=?^!DW_Q5'_".:?\ W;K_ ,#)O_BJPS\3M#'5;S_OT/\ &GR_$G1X M)#'-#?(XQE6A /(R._I1[.?8.>/SGV#GCW-S_A'-/\ [MU_X&3?_%5D:W;:;H_V6..WO)'F?8L: M7,O]TG^__LFF#XEZ*RLPCOBJXW,(1@9Z=ZR]8\:>'M86 3-?1F%BZE8L')&. MH;T)_.IG2J.+LAJ<;ZLE&IZ*_G+&MX[PP+<.$NI?N'GC+CD#&1[TQK_2D>?= M8WJ3QC]XHNV+9XQTDR1R.>@J@^M>&8,QF"YC;:P(^S;25<<@G=T(Q4&Y MWE9I+]?.^^JQ$*3QSC?UX'-_P#?D?XT?\+.T/\ N7O_ M 'Y'^-/V<^PN>/[E/_ +-6'_PL M[1,_OE#_ !H/Q.T3'W+TG_KD/\:?LY]@YX]S<_X1O3L8V7.,8Q]KE_\ MBJ!XS MGV#GCW.MAB6")(DW;$ 4;F+''U/)I]86A>+].\0W8WF(%&,@>O MO6[4M-:,:=]@HHHI#"BBB@ KR3Q'<1#Q'K]I)=):27$D0$K@X*!1E3@$C/!] M\5ZW6#JJ7Z:O$EL%>WG4R-^Z!9#&,E0T; M5#'^^1O.E1CYL:K@ 8R1@YP#[=,5H)K^G2RM#<,_V2ZF+7/R@OA%41L?4Y4D M_P"\:ZVU\3S.P6;3[8E_+$;QQ,%9V90RG'UJ[JVLM875S;0V4+SK M@PJ8B0Z;"2Q('9N,5;JI]"/9ON>7S:E'/87:-)B:\NQ+)[( Q_FWZ5L+KNEF MY>"5Y/L$T[-)AU&.W:<:99O"K^6"D+ N,,?- [+\O3KBFZJ?0%3:ZG%1:I9L;.\ MFN );9YIFMP#NDE9RRD-T ^[UZ8IT.MVD,:Q>87B:*&UF'=HMK&0@GOO;/X" MNJ.L:E$BL8A,&D896WVK("7V[.,C[HQG/:K::]?2H[1Z?:G8K2/^X<8P,F+G M^,>O0\4O:I] ]F^YQ5SJ.GWTDZ?:DAA%R' D1L31*@1!\O((P>/]JJMMJEI; M:S>WH5I8V240QS.6+;OE 8YS]TDYS7:-KVJ7UPR6MB(E1CAEMN#\P #9!QC' MMUZ5LQZM))X9EU,V,$;B3:B>7O& P4L<=L[N_3%-54N@O9ON>[FD=?FM MS@@%L<<8S@ 9_4T>U78?LWW. DU."?3IOM-[YUPR2&,!"DB2NV6 8?*8SU(/ MTIUSJ-E]HN+R*[W^;:FWBM=A_=@IM(8GC Y(QG)]*[%O$-_;Q2M]CMY@LC%O M,MV5H5+':N,#<2,8Z<#N:==>(+]7+1Z=&4BD+/&MN=R ;AM?(YR &R/2CVJ[ M![-]SE;O7;"_CN(7G>/!_M4]M>TFZNM/DS-;1VMR7" M2'S B! % VC@;E&1[DUTMWXEOHKB9[:PMY(&/[G= P 4,XW$G'WL*/Q'K5S2 M]:F^V"WU*U@1"'F>9U"[$WLBJ1@<[MH''(I>U78/9ON>6AH+>^B=IDNHU=7D M*@KNYR1\PZ_XUL/J.FI(N Q#D#"\Y;:!GVJE+J^K?9)72PABP=HWV[,X)W-GT( 7!X MINM?H+V7F<4EYIL1$5S<_:HWNFN[@QJ1YF =D8SCJ2>\^P#-;TZ-EEC62,16W ME6T$!"M;N^?,8.V<].#_ +7M3_[;T[[7>H7/V/4;K-P OS"'9P?]X.Q/_ :[ MG2]2N;RYU!YK6)!!;ADM_)(V/N?Y6.,DD!>G8]*H6WB?4+J2"*+2+;S'&"6C M(5VY^Z>X'&>O7M1[1=@]F^YPUUJT,RZNZR'S+V9-@/\ SS!)_HE,FU<-H%M9 MJZ^:"RS-C!,8.43/=#G(_K5>V787LGW/,-P_O#\Z-R_WA^=>T:) MJ(OI98+NW@B>*3R5.P RN%W,M5]9\A>Q\SRC'YT;E_O#\Z]1M/$FHWM]%;1Z5;H9=N6>!L1 M=,[O7KQT_&BV\27]Y',\.FVI6%/,),##7;E_O# M\Z-R_P!X?G7I2>)]3B#1?V5!WM M[F25D?;#O! #X(^I Q]:/K/D'L?,\GW+_>'YT;E_O#\Z]6CUS48]:MM/GTNW M93(LY?[P_.CA:9/+':-<732!S+"><;B JJ,\X Y]14+>([^*VBFDTNVWRQF M1+86[F1OF8;?0,N 3Z@\4?6?(/8^9Y9N7^\/SHW+_>'YUZE-X@U"T*K=6>GH M'E\KSO(DV(1MR2.I^]@8[J:L0:U<#1=1O+FWM8I8)HPD2[E_O#\Z-R_WA^=>H_\)->>>J#3+=E6-F<^2RY"@MN!/8JO /53\N?89S^%=Y!XBU.X24KI5HC1LS;7B;A0"=IQT;C'X]*U=- MU$2:#.^?3TI1J^JVM](;B"TF23;Y<2V[ $[4.Q/]H[^I MR/E_*/:KL/V;[G#7-_8G39;:!(B1% B-Y8#%QS(Q;K[?2I(+K31I$$,TD2R> M:I?RX_GQORV[([+T*MSTQ7>#5M9;!33M/RR!PK0."N4=\$YZ_)CZL*:GB"^N M+N6"#3[5<,=KR6[$ ,2#@]3M7T^]TZ4_;+L'LWW.43[.=)FO3!#' T4[A7M MQAI'JK:II1FXB@\J*X+QJ(0"46,A'3;%QY''\9Z9;C&/7O6CJNLRV,VGK'80_Z2BM(C1$E5:^4LB$6L85(@)'(.96W=<_P /7D4NO01Q01QNUNEP M/,GD A\HD%PJ)MP", $\XKL+K7-2$,4;VEM#(XC;S$MV.[=L.Q1SA@&;)/I5 MOQ!JMU;ZNUM!!&B+\V1"6DE'EL=P.", C'KFG[;6]@]EYG"6DUC8:1:M<- S MS+/))$\09I 1L0!OX>03V]:DCU;2UC)/DR/"D4:B="1)&L?*#@XRY//'8YKK M6\3W;F>-K&WB,;.JO]G=PV,;47 YS?<\TTR[L4 M^UF9X87D=/++P^<8'/OS5VYU?3K@7,N8QYIFW0F'+.2<1$-_"%& MW\CUS7R?ZDTJ MV$$*&63$)!D4%00IS@,,G@YZ5J:GJ%U86^GM]AM1+.A,JF(M\^%Q&N.A.3@G MCBCVJ[#]F^YYY?ZSIUU;7;1I%YLSS$JZ?,#56PN].MM+F$ MDB23R12@QM&/OD83#8Z8YZ]:[.+6M4)ME^SI+L.)66W*9.<;'X/(P#D8'-$? MBVYEC3R+.UN&$RJS0VS8((4E1SU&X_EFCVR70/9N][G'Z5J=I;6"P7+HRF[$ MTL9CW;E5#M&?3<>:F36+#[+;17$C2Q);0PO$J[21YF^4$_@*ZVWUW4(XOGMH M9Y ,M;L!(X_Y9* /E8^O3BM2TU*]DTR]GGTV 3Q0)-%&L1'WL_*V>I&,G': MCVJ?0%3?<\PU:[M;N0-"T"F,8S&NWS,L3Z#&T8'3\ZS=R_WA^=>O:;=WVHR7 M\PBA\J.U_P!&VP;4E?+X<9Y_A'%9EOKNJPZ4MP]K;W2S,P6;[.5\K!4$L/3Y MCCZ=:I8BRM87LO,\TW+_ 'A^=&Y?[P_.O8+V[=[#2Y[E&L(+A"US)!'N:-MN M57[I(!.>W8#O5.;Q#OQ*_F6$)4R#RT^S,'<%4/ECT(#$Y/I[4Z36M6BM3/ M_95M(/E&T0,-FY%;<>>BY(-'UGR#V/F8'PL.?$%WCG_1>W^^M>IUA>'+ZZU+ MSI)[6"WB0*%,<; R'KN!/;V_6MVL)RYY7-81Y58****@H**** "N9U[Q#J6E MSW'V>UB>")XXPSJVQSD$8]1FHSXIUA+6>9+,!$ M9-S2(WR[SP1T^5<<_47N0L QSV(P<#DGMW +&DZW?ZCKL$-RBP((7+P*C<'Y- MK%B.AR<"H'\3ZK,_E6UFFY(G>9FC<[67>=GU(5?^^JK3^*-=E$T,5FJ;8SLF M$+YD^]^\53V^7[IYY^F9H_$VNW$\T,=C A#/M=HW(4*K$9&?XMHQ]: *\WBO M6%E>5+9<%55HFB;%N^7.UC_$QPHR..1[9V'U75'\/7%[Y:6\ZS[$0Q,=B"0* M2PZGC)R,<54?Q1J0Y2VC+.ZQB%H75HF8E4RQ.&YP2!V-6-:U_4;#49(;6T65 M4C#*OE.QDR&);<. %( (ZG- &=;QSO+AO,:-EZAL1D?WCC@_I6 MAJ]]?:?=6L>E6(]=>U-P;. A?E$2Q.6 MDX]2G7=9>:V, MD"6\4DX5P(F.Q1($()/KGKQ4]AXBO)=32VG6)X#&9C.D+QY0';]TDD98CGTS M6GKSWD&FM29X")!%C(E'0J<I/KEW;V=C#&6E$?VAX&/ )&6P>>!D=*OZ)KMYJH&<]^E9TOB?6H[O[*+.-I$9D+F!UC; .&#$\#@#^M7DU2]DT2WO MK&T@AFO7:4AHF(";692VWG<0JC/O0!BIXFU.XMYI8+6*WGE/RSK Q,I&W"#K MR 6Y/H>!S4G_ E>L+.\BPQNCL@"F-PL;8),>>I<],]/EZ51B-5?$#!"N_ M[V5Y[@+G'!]JIMK^OI&':VMV'E"0@0.#_JPY'WC_ +OU_*D_MW5X;82R6BE% MRJ[HF=PVT'<3D?+R1V^O6@!]WXIOK?5[JT\B)(8WQ]H:.1EC'7Y@.YZ#'KWJ MI)XIURRMT+VD4@D+N)'1E\L;W ##C^Z .GXFE'BK751939QMYA'R>4^%P#QG MK\Q!P><8[UHZWXBU#3;YHK>T64+&K+%L9FDSG+ C@!<#(ZGVH SK7Q#=0WS2 M7-I#;P)DS1+"W[ERS,Y M!ZUT&M:KJFFQI]G@BG98#)(PC8@G%(=0C@7[4\WDD&,[!R?F'/3ISG%0KXGU:JR>,;P")4MXED9<%7CDR90I)C ]<@#OC-/_X2'5H+J-9K48:< M12XBWMU9(]Y8)&Q13EEVN>Y7 ;C'I5A?$NNM;K,ME!L$98KY3DN0K-D'. M!G:!WY;O36\67\1ACMK!0H,89?(<#<0/,4'C&"3V/2G/XIUF*6-<8O$9"! M;R#;PQ'.3G&T9X[T ,@\5:U<+.4L(T:/U1W/B#6;._D5HH9E7;"(Q&R[W9W4 M.I)Z9V9'/!XJ_J^MZI8:I%:VVG?:(G53YH!P"25Y],-@_0T 93ZUK$-_=S-# M'>+:2E%C\A@W+NH"L.^T+D\\&A?%>M/9/.MG;E(@NZ7:^T[FQN'3A>_/Y4RV MUW7A<,_EEDBCWF"2%B6!,8 SQ\WS-S['BK<7BO4?*8RVB,S*/+98I OFDK^Z M(ZY7)R>AQVH K+XEU&5M]U:0DADECB:)C\VQ2$4XX8DL03TP:[!XX[NWPPW( MW(R/Q!Y[CK^%U\/6=REJ+VYD9HY5",I5LG''IP0?PJM=:WKDB13) L M*R$;4$3%D&$;Y^<'AL8[$&@!OFZM' 3<&:\B)N%EM[B($.BR*J ;5')4GD\& MKNA:]=WNHBRN+?8@MED#8;<#QPQ/3J>W;ZU0M_$^NC$;6<3L$4;C&XRQ."W' M8'C'MUK5N=7U2/2(9(H(FNS+*CYC@Z_=W>I/97< M)54@$@;8V[/&=Q.,=3CCG'&:AT[7;C4M.U>:73D9X4^1?+*^(M:@OW MC:%9#$K@1QQL [*9!N'?!PO'O6AJ^L:G8:L\< 3[,848,\+N$;Y^/EY)8@#V M_G-J7B"[L7AB6T)EFAC=%*.WSEL,I*CC YH H7'B74HS/:R6JBX638CJC@.H M+AG'7&-J^O6HKKQ9JEC$SW%O!&CJSQLZ/A<;P$//+'8.1C&[I6OH6NS7]A*; MM%6[B#-L1&4,HZ%0/J.@K%3Q!J6IVI-QI<$ZQGS-C0-^\Y0!5R2 WSGG M_9^M &CK^I74"V["6>"%[9I%:$@ /;J/K0 /XMU=;""Y-BBO-)M$)B?=@!2>OV?A^ MTO8K=?M%R&T1[J>%5FE,):4':.%QWR3Q[=.M56\2Z[9I M:V\ULLDS!"TGD, X95XZ_>!8YQZ=!6G<>(K\^%X]5MK:-7FD!2-U9B(R>"0. M_P"('-9Q\1ZU:V]Q)]F:17=FAWVS[D^=@%89'H,?UH T-.OM570YY9%,E[]H M2-/-0XPVP%L#' RQ_ U1N?$^L8V1PI%(I ?=;N2J@C,OIM/S #K5G2M4U9H- M7N)X9))(XQ);PNA R=YP. 3VJ%O%&K!W6&".<*I,9%K*GFC:3O&3P 1C'4]J M +.MZUJ6F:U(EI ;J/R$9;<1MES\^YE8<#&%R#Z\5-9ZSJ5UX?6Y\J(W37"P M@A&*%2P&_;UX!/?M6;/KFNQWTB^3O:-6"QB!PKD&1=W7H<*<9],5-<^)]5M/ M.A-B)[E&(CV0NHE50^YAU&,JO&>] $5MXHUR9)#_ &6CL9!$JX8&-VS@-[#' M)]Q21^)-9EO+8_9U>'GSS'$X$><94@\DITXZYZ<5:EUO5I/#4%ZEIF[,Y4(B MMAE&[!(ZXX''ZU+J-YK,N@L8OW=ZEX(BT4;8D4-U )R ?KTSS0!CW/B+6;VP MDBN;.&$.P*L(F>&SV/$8$*Q2(<$_/N8.. M!AVO-1A>#[5$\[ MB&)[=V$B="H(X &>>N30!I2:]=_\(Q!JZV@/G,"(&/S;&.$[]>5S]35"UUV MZTZ#5[4O$>H6EAILL5ENGN4WR1^6[ 'Y8HW8* T+&8HS-OVMG&.,C X/K0!0A\1:Y?/;B/RX6=CM5K=B'"[\MUZ'"]^I&# M6Y?ZK<2^&DO+%O+N"\0D^0OY1W*'! YXR<_2L"WUKQ)ID[0/;_;MS$J9%8%P M!C QD#&,\]!3&ZBV#V_^BO$DDF6R?F.>N : *#^+M7^UI%'8 MALC:3Y#@$]G'.=I&#C]:DCUW75O;J.2V^4NL,4AAO75N)$TZ2RQ(.61F(4@MDCV4<^YJ_8ZIJT6E7S2H)Y8H#-;,8F!.6WL: .DT74SJEE',ZB.21!*(LY M98V)V$^Y K1K!T"]N[K4+M;F,1)'&JK$L+((R&88R>&X /''-;U !1110 44 M44 %)-;U2UU":TL(9-A M@.UUA)(8JQ# ]^0!C'>@!^OZ_J-FUO%:V;^9/;[V41EF1CP<-TROI@TG]IW\ M'ABSEN LDLDCK/)-"SA0"Q7*K@\D*/QJA>^*M;&8K.U#[D;9*MN^&^]B0 GI MP.#_ %%20^)==F>6..TC)&=K>2YP &(R.,[MH(Y_BH NQW.KMHL]S=?:(97N MEWJJ9:&'C=M'.<#/.*B?7KNTM_+M5GN@P#6\MS$X+_,P;.T= N#@$YIEQKV MOP2Q(+**3@DL(G D. =HZX(!_'%6[#5]176$BU1EC@9-H*P,H=V\LJ,Y."-Q M7\* ,D>(M6N,32V\2* KQM):NRHPW@L,'/. N>V[\[O]N^( GF_VUMO-C6(-$5A9L'C+,<\@9/ ]*I0^(==5F M\Z%03AD06TC!OE&$!X(W$DY/3!H MZ5JVLZJ"9HT@CBC\W>D3_OB#]SGIZ$# M)J2VU[49O#B7DL2Q7'G^5(_D.4C7NX7.2.WU^E,\-3Z@M]+_ &QS,S6D<9 M.YMAA<^6%<#!YY)!XZ"KEKK6K2>'IKJX@1+A)ECWK$Y"H2NY]G!.W)Z=<5+I MNJ:M3QGCCM0!#K&OZC9O9"RLFD\Z$2LC0MG)Z MC(/!&>G-4;G7]V,K2+D;(7RQ,:MA1V )()SGCI4S^(=9C5O+@%P57* M$6DB>?P22,GY=N!]:=)KNLW)N'L[?;;AE6)C;N&DW9&1GIM//2@"&\\1:E;V MW^F1P1P3;U#2PLP0*6&",_,6VCTQGTJW?>(;VW_LV.U@A:2XM!/Y(C8ESE05 M4@_+@$G)]*HPZGKE^R6MUI]N\;-&NZ:W9B.!ER.!SSWXJ.3Q!K2%KE8"[" + MA;-PL;E@2AR$R7*>4S",G8"6 P3MW$[?;VH 9>ZOJOZ[<1*_P!FC&S ;="R^9EBH(.< M 8)/- #M7U_4K36)(XUVQ0AL((';<,)AV(.,9+# QTYJDWBG78XPXM(V:0I M^[>)P$^7H._S$''7&*VX=8U"\T.TO8($22ZG4*I4MLC)ZD9ZX'TY%8Q\6ZV( MT;[ =SN,((')'K&3QR/7T[4 :.O:QJEO<3VUE %/D9C/E,S,2K$LI' VD 8/ M7/YFHZQJ6ERV-M#"+DO;%F)C=G9PI].!R.>O6JL7B;5VD\MK4864J&%M)ME. M0!&#V."3DCC%:-KJNI#3+^>XM]SPQK)"J0L-V5SMVDY.#_D4 9M_XGU":VN3 M:QF,%7%N5MY&>7KR.RXXSGKFM7[=JOV#"QPF\%W]G+F)MA7KOVYSC\:RHO$> MO/:"<62R;,*T8A<-*27PP.> -JGC/WNM6UU?48?#MS=,&GN/M)CC86S*-F1@ M[#R!UZF@"H_B+5I5 $2V^W:T@%N[&,97J>X;<<8Y&.:B?Q3K$5DI6T3S> \< MD,G[I<<,S=#N_"KN@:IJUY>W4U[',D/V=72-HRJA\#(&1GKGBH?^$BUR-T6: MUC&Y(W0K;R'S&<*?* S\I&3R?3MS0!T]E.]YI\.DF"/RQ4D?B'6H8B&A,CHN0QMI#]HD"KF-0/ MN\D\\CBM"SUK4I= FNYX$6=)ECW)$Y"H2,L4ZG;D]/2@!D&K:C>Z%!=-:0-< M_:0D;-$S +S\^W@@]1UJM+XDUJ-K2)K1#+.5)Q;R;=K*A]>"-QS_ +O:K%AJ M.K&WU/4+I'81VZFWB$3*K'#<@=>< GN,X[57MO$&MW%GYOV:+:F V^)E$F2_ M.I7F@17L-M''-/<"-%92X5,[2QP>>03UZ8K.E\3:S;Q6W MFV2-),%SEN%L8D78K*K12':# MCYL]"""<<]J +8\3:Q->16Z6B1NZA6+P/A&R!NSGE>O^-0S>,-4A?RFMH#=! M2#;!'#M@$^8.>%X^[UX/-:VJ:U?VRV36UNV)XPY5XF+,Y*_N^/NG!)R?[M0: MG<7MKH\%^(+<:C.I5IUMF8Q J2JX&6ZX7/3)H BT[Q1>R:A;Q:A;QQ6TL1;S M%1^#G ))X /'KUZU:U+4]4MM7N([2$-#'&'S(C%3AG>L676_$-U T M1A,1A9"^V%F<8YPV.N[ /'K4Z^*-7ETZ0&T<7#KB%DMW.[YL$@22,K;*&%RJP2CRLLHP3_$RC/(]34/]OZS<3VY>%H2NTO;)$X+*=GS, MQXQ\S<#GCFM_P[>W-U;3K?,3<13%<&,J57C;GL>.?QJK+>:G'XM2'S!> M8R03Y;'&[MR* ,Z;Q+JEFL1NH;5)F6-BQA<;PVSY!SU&\\GC@<5=UC7=0LM2 MD@AB01H4 W02/^[/WI25XPO(QUXJ.._NI_$\5K=V*/ LLGE2/ 69,$X;<> . M!TSU^E+>ZSK%O>2)Y2):L[ 3FW=O("L0"0#\V[ Z8QF@"&+Q!KDRLXM(@B*S M;3!)E]J!N.>-V>/3WIMIXGU:]A:2WMX90%=R$BD^4@-B/.>3P.1Z]*N:?J>J MS:-=S2Q@7HN51(GC;]TK%>H'+ !B)=;,DRI;0E$C)1VAD7>H'$F.N">,?K3#XLU;#9M"NZ M)&4_9G^0Y );G&#DX.<<4 :*Z]J!T"&\DBCA=YS&\OE.ZHG.'VCGD@#\:2-B-O .X=3G)]JJVGB#6I8[62>TBC:[F%ND;(P9#M# M%SDY*XW_ $P*DUG4-5T_6II(&)M3$H0- SJ'^8XX/)8C&>W% &:/$NM2XBAL MA:H(T*D0-\H!7+ ?W3\PQZ8IUMXBUV*1!)"TP=U&6@9=Q&%*KCIW.?:MZ#4] M0311>W<&)&N K0B-LQ1^9M/N2!ELU5T36]1U#5#!>6YCA>'>H\AEV\_Q%CW! MZ8_K0!7N-;U^VC=VM89!L&-D#C82H8L>>0.1BH7US7YM.DF6!8L!0"EN[%NI MWC/;"CC'>K6C:KJ\EY;V]V/,1B5=C;LAQACOW=!A@%V_CWJ%=?UF>^DAM8DE M07$L980,!&$+87<3ABVT<]LT :VKZK=1:='=Z- MZ'8Q[0#UY /T##!K"DU; M7KF[A"K+9B=TVJ8&8#)0\^F%+9'UZ5+%XAUH;LVQ*(-T96RDS<-@$Q@9RA!) M&X\'\Z@7Q'XD\I&&GQ2,"3M$3CS3D?*..",GGI^M %[4]2UG^R].D@5H;B=G MCE"0D_,#@<=0.":6TUS6&UR&SN;1%A+&-G\IQY@#,"Z]<#"KP?7Z4BWVK7F@ M:DXDD%P9$2%XX&0A2$W84\Y&6&?:JW]LZ];6D+F$!1)'"R/ [2,-H);.>222 M.<=.N: )Y-0O;6[NYC)>RW<3O_HHC)A\G/RGIZ(]6DN)$MD$,& MUGCW%6KC6-6M?#5I.L;S7SLRO_ *.QP1NX*]N@&>^: MHR^+-5)NUMT1YXAEH5MV8P') !.?FR .1TSB@"9?$&NN'$%M&[*C2,?L\@", M 28NO)X'S>]%YXAUZWNS!%8K*R*P \EQYN"PWCG@#"\9[_2IH-7UMHWF^S!$ M#9"20R%CNW]\Y &T'&.].TG5=6OH;]Y@R.+4&!?(*@R#>"RD]>0O% &G?ZC/ M::'Y'+<8[&M&YO;Z;2M-FN_/MTD9OM;6J MOO7@[<#&X G';TH :-6U*UT"QF*+<7%S<-#B52A)9V$;8ZA1QD>E5E\3:O$' M:XL@ZE&^[!(-DV&VQ?[7('S#CFBYUG45MQ'#:,\\ W++E1KKVN1LS& L7(D2)K5]QR%_=9'"\%CD^E &EJ^K:O8W4$5GIWVE)4#%P# M\A/RD'_@14_0-6=%XAUJ2YE/V)W2"1CM6)EW Y7JHZS]AU*QA^R-'EXVB)X*A@IVKS_M=.E:FC:AJE]J.R2=JC/\ M4 :^AZG>:CUG6M2LK^2&V@4HH38# [F0'[SY7@;.I'4_B*Z&N7UK5M3L-3GBMR?)*(T; M?9FD"':W'R]=S #V_&@"A+KNNQ7#SA7:+[H_T=MC#H' ." >O6B+Q-X@/EM] MD3=,RMM>%P%&P948YR3G\L5H:UJFLQE8K:V97DMU(1(FI[5+9ZGK4L\+/;&. M(O%YD;0L2=Y(;!)X"X!J2?4=8^W3101$XD8(AMFVJBY(_>9P2^,>V: ,Q=8\ M0;TO9 (XS%L*?9Y&0'+D,%X.6VJ/;-6X]>\0&]M%>PC6*>0Y4HX*+OVE<\\@ M?-G@'-5%U?Q)/$HEMVA4NI5X[=BS_,NY#Q\N 6^;OBK<5WJS:%-)))<1W*W< M?/V9B8XSL)^7JPP3^N: %NM:US^WI[.&RC6$.J1RM$S%5)4>8>Q')XR.E5H] M8UV&Z>5XF?S2H6(V[[=P"@HN#A1GKUH LMK6M;56:)M[+&ZI': MN"P)RQW9P-O0@]?QJ*Y\4:I8QP"Z$4^4 \>M95WJNLQW4B7D$/EPO&D/RS^E5;?6/$=Q)%');>3)*RJX-L=L*DKB0-G!R"?E_AQ[5 M+H.I:T^IV]I?QRR0&)M\C6Y0AP3R6/&.@&/_ *] $%EJVHVO3SQQK9>69$3):V?$98ISUY&"Q[=*A@U'Q':I M*FV665B[*LELQP#N.[=G'RD !>,Y_&M76=0U>P<):1M.4@!&+4N)W)(;)!PF M ,_CWH I1:_KT[RI':8",Q#O;,-P57.W&>Y4#.?XJET76]4:_2UU!%P5DGD; MRR&C4,5"$9Y.2N#CD9]*BFU;Q'!J,D!A#6ZN$,RVKL5 Q^\"CALYZ \?A3]$ MN=4^V"6^CEWO9D[&@(+N-IP3^+8'N?>@#8U]KV&R6YTZ0B>)P/+*[E<,0IR! MSQG=^'O60=:U/3KUK9XWG@@D5)7,#EUCRN9"PX;.YN .,56M=<\2S12,++F( ME@K6[*9?F0!1S@?>;GG[M6[+4-8_L_4+B9)3-OBV![=@(P0N_:G5MN6Z=<4 M23Z_J26UE,EMM\Z)Y-I@=S(P8!4 '*$@YR?Z5076M?OK$^9%' 1EW(MG<% 4 MRN">N&;US@TRZUCQ!<1F.".52QQN6T96\L$8E&2>6.1LZ@(0QCN(#% M& JO*;=W>$8^\0!AMWL>,T .TK4]8M[V&*2/TU75O)NY[^!(D6VDF1#&0(V5F 4G/.0 >W6@"MH^MZMJ M&K0)>1&&W/F*0(&7<=JE02(M8-L?]$,YDC#6\GV9U$AR"PV]@ 3R>N,U&^OZW%.\/R2&,J)F6U; M]PI1&+G!^8J6(V]>,T 37U_K-WH^FW$?F02-*QF6%&^<+G;[@'%0W/B77;:) M6-HC-)B10ML^ #N^0\]?E'/OTIDOB+Q#&SC[&,&($-]G?"#<,R-]02=HS^AK M0T76=7N=2:&_ML1_9]_[N%UPWN6Q][GB@"'^WM/F!ZGKD<=!^E%IK_B*YCE9;(J8 MPT@#6S R8VXC'IR2,\]*LP7VL3Z?K$S-,DRP(85^SE!&_P VY5!^]CCD=>* M);W4]8M]1NXK:$-"C@@M&S[@2BX4YP,;BQZ]*HV&LZ_$EK9O&7F;8CR2V[DQ M@E?WC'.#G1+(IC"&+[.<$XD(D SD#A,_7M0!,->\010&::V1U"9VI:ON!*L0<;N0"O/ M^]5==#0!/I6K:M<7<*SVJ+;%_ M*RL+*6&TD2#)X'R@8Q_$.:JGQ)J[!REK%B*5XLK&T@E=" 5!'W=V>">FTYIE MKK?B"YN6B>U6#A%.;=VV9V?.>V.6XSQCV-6K._UF#1;J9K%#/"$E2)(3'O!Y M=0,]>O/J: (KG4K[5=$OXWM0L\,$9"F D+*6;(PW7 "]/6HSKNNPWJVB6<;; M-Z;A;LJM@L P.> =J\?[76JUWJGB26W65[>6V8 H1#&SJR^*-2FOY(HH8I9(69GA17!C W_ "L>C'"C'09-6(=;UFY\JW%J M8;EV7(;:X$4K75Q&DC?.R-\P#@#//3 )]\\TU/$'B%XA M.8&0X90OV9L$'8=Q'7Y 7X[XH T[;6=4N]/U'S[*8NM:M-HEQ,Z^3/ M:JMIJ>K_ &35;J1)))$AC:&+[.RJKX.]0#RVTXR>^*SAXJUE9%3[-&;PH0L! M@;=* KD-G/'W1\O?)H M-XEUD>9Y,"W 4'R\6<-I)<9/&",;>I[=:=-X@ MURT8)<) H=V19?LLAY!<<*#SNV ^V>],75?$LMI(WD;2OR*1;L&DSO ;G&,; M5XQWJ[X+4DW+&$:"7[.R9& MS,I^8@+@8.W QGKFM'2]>U:XGOA=6BB&"$O&1&P9F'3CH=W7 Y'2I_$(U=M0 M@ATR21([B(JTBC*PLIW9/^\/EK"2_P#$EQ(C,+JV%S.&5?)+>6I*?+[ -G\ M: +$.OZY<]:8VN>((AEK/S'5MIB^SM\Z#.9<^O&-GO5JVU35Y3J] MP;>0B--UE"T)7< S#//)) !Q]/6@"I%XEUB6)6>W\AR%#HUE*QB7 S+D'D9R M-O6I4\0:U1[9PH4LNUL$]U).,]J9%X@U@1E%MFF8L/(D^RNHE M4%@S$?PXPO!Q5G4]5U6QEL+>'%Q/) 975;=CYC!E&.OR##$Y/I0!EGQ+XA,? MG&T8 ;U5?LK@.?EZC)(V_-]<5HG4M7;3],EAMDBGN"WG 1,57+*-Q7CJ"3S5 M=-2\0P.IDC>1I$1^+9B&?:I\K&?D'+9;VJY/?:]#H=K>@Q@GOF@!M]KFL6^G:;)':9N)\^<]*;87NM'2Y"JR? M:7O$B5KF(L$C*KEL#''6JL]]XBGC:3;+ 6!*+';D[,J&Y.>2,[<8Z@TR#5O$ MRLL0A\TB+EI8&#$[CEN!C Z8S0!*WB+7D$"-9J9)"A.VV?:0P7*YSP5R?KCM M45OX@\1>?#;?9T8-&H\Z6!U.>,N0., DC'&<5J7NI:K;:7"S*1*)Y(I9EMFD MR 3L(0'.&PO/09K/36?$LS'9;%,H\CAK4_NG4,1$.?FS@?,/7Z4 12ZYKP8V MBV\H8JV7$#;LAC@@Y(P<5G&* MK3:YXE69XXK+CSOE=K=]H7GY.Y)/'.,>]68]3UE+^T>]5XK0NTDK);G"*/,& MQNI_A4Y]Z *A\4ZTDCQ7$,4,@E95 M9&W84D*.@R/6EA\4Z\US)'=6 M M(E.6D^SR2^4><(0N-V<#D?U%:NN:MJ%K?QP:=!'.7MWG7C++M'/&>^5 _$ M56L]9U=KB.":VD=&EC6.;[*Z;TW$.Q'\.!CK0!#I>OZLFHPP7\320.T@D<6K MJZX9L9[8 V^O6MGQ&]]#IZW.FR,L\3CY-NY7#':F-PQ@YSCY>/XJ739=8&F7+/Y_VEI(UC,R%MH+8)V^P.: &G6=4L M+UK9HGF@@=5=S"[.(P5'F%APQ8%N .,4^_U_5;>RTZ2&R$JL#QR @/LM6.U1@F0-T.>1MZU?U&\UJWUV=;3>]J(A*J_9 MRX.U#E0) M+57E0E OV9\. 6'FYS@#('R]>:2SU3Q%<1AY8-GEMR&M6S*"V!], Y_"J,FJ M>)BB720R;PGELK6[A 2S9?:.3T4ZMDB1<.K)"R#<>N2>IZ'CWYK>K'T2[U"_EGEO(S% N!% M&T)0G/.23^6*V* "BBB@ HHHH *Y;Q'?ZU'<7-OI\>G? ]:A'B#7=1LBUI',8F1B+B*V(W 9PR]>3@#%:6EZAJUQK M"VU]:N+.59"RO W')P2S<8Z#'Z55>75+*Y9[>WO9+I/.W@[O)" YCVKC:1C M&"#G- #SJ?B+:D<=JXE+ ;6MR0$)YDW$]1TV5E*-0\1OJC6: M"00A_+:X:U'R@?Q#L<_4_ATH D34_$%V!Y5L\!2+,A>V/,@#$J,GD$A1D>M4 MY]3\2)/)+%%*6P%>-K9ML39<@+@'?GY1N]#V[6M+U/6A?VMK>',EW(SLLD6T MPHH5CCGD'.T>AJ35-1\1I?7-M:V2M; '9,%))&W=V/7C;]30!+/-K,FA13$R M17+W7SQQ0\I'N(QCJ>QS[U2N+WQ%96382262)5 D,!._(0D;1GG)(SCMVIL- MSXEA665?/ED1MGD2P#!RTG(/L-G3KP*+G5?$3Z=<1P0W#O(-MO.MJ59AEMS, M/X#C;C/UH N:^^H%E:.*]*?9@84MRR_O\\ABN<'&,9^7KFJU_J^O"!UAL9/, MC1ENS*,V2-PP,X"CH>,^]=/>0?;]/DB622$R*"KKPR'J#]0>U &-J%[K5L MECY<.^1XP91%"7#R9&4//R#!)S[?G'JE]K5IHMG);1237DN6D M\[3C(4@9Q MSQ_4556[\06\=NRI*]SJS:34O'L+H6V*6.]E7J< YQ["K5A M=ZO/IU]/-&5>./%NKVY4R,!D,1G//'%44U#Q'-,L2JZ;Y A9[3 2/*@2=?O' M)RO;';%0S:MXH0A1;2'=&@9EM^(SD;F[Y/7 &?IQR ))K.NW.GF'[+<1W$J_ M)(MNP.T!]S>QR$P#@\].:;=ZQX@=9(X8;@*8W\N5+0JS8SA\'IT''7VYXFDU M'Q(]J)'C>,D@,L=NU6=8O]8M-5N?LAF-NR1F,BV,@!PW Q_> M;:#Z>W6@"JFK^)KBXN1':%(4WNK/;')VAR$P<=2%YYZU$=5\1V_G!+6XED,I M5"]N2OWG.WKTQMYQ^-:.JOK3ZQ:1VTLL$;QQLWEQ>8BMEM^3TX^7COGVI-(U M+7KNZN5O[40)Y!*+L(V/_" <LR:K-96]I<"U#JOF+ >1E2<-T((+#\.E5EU/Q,EQMCL3,(HE&) M8"&)(4'YOXHN<9(Y]"1+]D=/, /S,P_A MP,8SUQ2?VAK[!+F:W$2/A'/V4L\*_)E@.K9);CVSVJ==4O[*UT9;A97N&@+W M2%29,!D!.T>Q- $FK:CK-C!IZVL+7,\@!F98#@G*Y'!^7@M^76L_^W?$2+'_ M *&\K"9U91:LOF#C&,XP.H)./J<4XZEXDDM#H!/&?7KBJ']J>(#.KQ+ M<3@Q JC6AB&\9+#KSC@"RD>XE0-,H@8C.0,=CEMHIHHGDN2@7,6P@ ME=[<9Y"@,#[D4:K=:U=7=S9P":.(R*,I"?DCWIA@_,&'_J:ATW4M>FAU-KFU3S8HRT$6PK\_S83/ M\0P%.0>_7TI?VSX@,A^SQ2RJ%_="6R*>:,$LQY^4@X '&GQ:EK@R0?I5"TN M_$LNH^8T%Q"MW(#B1-RVJ':, 9P3PN,YI+K5M?T^Z+3?.BXB53!L65BP"L.>""PXSR%-2R:KXE2P6;R-K, KJ; M8YCX0E^,YZOQCMWQ4!UW7)"B7-JR I&YD6S9C;],MM/4]>!G&>G% &IJ^H:Y M97L,-C9)>1NB[W"X"')4]_5E/T#55T=]9?4+S[8+H1?9F\O=G;O^7IGG/6JT M&M>(5FA62WF+R3*SI]F.U4(3(!^A8^Q')[5>U?5==BUN6WTZV9X%B^4F$L"V M,[L_7CJ/ZT 9UKK7B1?L,7V1I(F*!YI+9U:0G;O4K_#C+?,< XJY>WNLPZQ= M16\)/+2&6.1"ZQ MN)8;5LEVVEH^"=H&6^8^E%QJFL6(2ZN88HH2_DM-+;DO"F$^?.U+ M_;/B9H+2XBA1EN#N"^0<8VJ0"1D@-EN3TQUJQ#>ZW?\ A[5?MD/EW"I^Y @. M0W.5 (^;&.#SU[T /.M:K)HNEWD$1=[B%G?9;E][\;5(S\@;GYCTQ4L6I:Q! MIEY<7D:*T, N$#Q[%4[FW1]>?E4<_P"U18:MJK1ZBUQ 0(8&DC#0E%1QG:H/ M\8*@'/;./89PUK7IS;1_9V>&5E)E>T(5E.W=D=@I+>F0,Y]0">76=?W1NEIN MWJLGE+;L1Y9&YFW]-R\#;W_&KMCJ&K72ZA,8-J1Q,UK$T)0RL6?;G//0+Q[U M'%K&J3^$WU!8L7$C[8EB3=A.?3X7>Z615D0 MH048#+ @'L>.XK(O;_Q"MO+#B(19230QL5CQL+6;!IAN;YMO53@#C'?/>G?;_$\D/G>6(WV, M_D_9\\J$PN<_Q%FY[;:BMM<\0HZ+=10"2:Y6!8VC92A.2<$XW!0O;/7K0!9U MG5=<@>R_LZRE?? ))4:'/S'JI()P1QQD?4U&UWK_ -IBM9O-V>;'B6.V_P!8 M-R%@3T0 %N>^#5[0+C4KQ+F341,DT3M''F/8K X(.T]2,8S[GDUA6]YXKL;, MQ)$\I2('=+&S-DX+-G!R068;?;I0!=U35=;@UB\2RLSY,:X65K9B /E((*YW M DM_AQ4)UK7V$C&SE_=HL@#0,BK@#(8YYSST)X]*OZ-J>MSZK%%J$6(&@W,5 M@**#V))]?3]!59[WQ)%;(T4+GYA&T;0;F12N3("3EBIXQWH CL=&[V^O+!O[3AD2X1R S1% PXY P.^1SZ=^M9 M0UC5XK8V]I8S!P?W(([^\-K]I:""0^5@Y$HE&./^N9YJ33K_P 0M9:DL]J? M-@3;;;HSDN"1SG[W !SGO3XI]7_L2\E"W-Q="[0Q"2(QDIA,X3/3.[Z\U9-W MK,.@WCLC2WB2*(6$(!*L$).W_9+,._W>AH H76H^([%)AY+W#;F6-TM>N&(7 M.">" #^-6]-U?4[J#4GFMP7M$VHL:9,DA&[&,]@5!&>N:I)K'B&*R^UW,058 MUP\XC=I6@@WLC$95=O;K@MVQ0!0C MU3Q#-'"LUHS;A)\K6A(R,E&/ X'R\<'V-13^(M9L[!9[E6@=E8;WMS^\90Q& M%)'!XYP#Q3O[7\0V,698Y5AVA=S6Y8H3(!N.3\Q(/ !]..]6+S4=>EL6@6VN M!.?F29;;G8 WS8Z!CA>.HS0!L:/ZU:S2MI MRCR5\MGVEH!'&8D59MC/ELC*':/X< M[J ,S_A)-:FGFMXU_P!*1?WL,5L6\@[EP0>^023D9%2W%YXFELE,BS1M+QM@ MM261@$(7.<@'+Y;MMQ1;ZSK;R74*VS23'9&'%J5*R'86#8[ %\'H<4ZUU37[ MBY^S0;\+,()7-OD0J OS;C]XDD@^G\P!T^IZUI\#W%PWE6@?RV+0Y,2_)\X) M/SU7$U34[GPM97D0.2U\T. M%:0FWX;(7*8&< 9?DXZ#GUNZ>VLKJMF+YG^SF([@D050Q13M;'H00#0!+8SZ MTVC7MU$K/)%]I.P-;_*Z%^07_A"I@@]^GM1K6H:];ZM-%I]N\MN8UVLL M.?+Z;FS_ !'K@#/TH @M)_$4*0VJB1B&"O))!]QI(-6\0KY+7-O-G>FY([0L&BR-SDG!#=1MQG MIQ23:CXH%MYJP,F^0@*;;)4;05R!DX))!/;':@!9[SQ/;Q,RKY_ R?LP!7Y4 M8L ,Y.6=<8/W?6DDO/$LEM#*XDBW%?,2.W!9<>62P[G.6X]JO:_%JTFIZ .!A@WJ3G(R?H* M)];N]62_$-BK^6T8V%8=X8DD-N;^':,$>M4M3CUB#PWI:6;W7VKR]LY5=SEC M&<;N_P!ZJ]SK.O-]H-G#-*HF= RVXQ&5=@ #SN! &3@X/IG(ECU3Q#?&>.!( MH_).UW2,,=WEL^W!. <[4(].JP2R*LZQEUMR?.0,W(&<+D8YX M^M7?$9O5N6>**]EC$'^CK;,P_?;N=VWGIC&>.M4FU#Q-#.J- SHH8;Q;Y\TX MSR!PN.,2/PH H7VL>((T=+>QN= MZ%@S+;;N=QV8/0_+MR0#U[4VZU3Q/#Y$D5M)(TK$^4+8%4 VC!;J,Y)YQTJ: MS.N:AJUH+PSQ6\,OF3 1^6-P#83/\2?=.>^:BU:YU^XU2YM+2&Y2U# "1$VE M<%3E6[@Y/KTZ#N 13ZGXAL@ESQ^^H/KQ6KJ][K5KH M5HUK$SWS@>;LBW!3MSC';G _PIFLWFJVMEIJV5K),\@!F5HM_("\-Z=_RZU7 MDNO$L"EP@ESCY5MP-H*L2>O)4@<=\B@"*ZU#Q"(23',L4P<[H[7+P8+!5 SS MGY>>U6-9&L&ST=+26YCD9%6=DCWD-\G+?^/?K41U/Q"R^3#;2>8QS',]MP4& M_P"9AGY6.$^7W_**YOO$EI=2;4EE"L%"K;9#J'<9&. 6&SKZ]1UH M6&I>(# MKD%O>6X%IA@SB$C< 6^?/1>B\9[TS5-0UJTU"[U".-AIZ*8%5N=N!GSMO<9R M.O/%7=8U'4K:_MK?3HHY#/"[[&'S*4&?UR![&JD&J:RSJCV\TL4CHD">#GZG'M5_4[S6;74Y(-.MMT*!3&@@.UD"DL=_0-D;0O MN*H'5?%86(O8)&6?80(RV3P><= 02,]BIYH 5]4\4QR1+]G5AG+,;8_-D*=O M'3&6Y)'3VJ[I=WK(U:+^TC*UN8>=MMM&YE0\X/&"6&?8U9UB^U.VO/(T^W9U M=$*.(2Z@[COW'/'RX^M,L]1U1_#?VF>WD%TDRAE,!W/'N&XJG!^[GL.G2@#6 MU*&6XTZ9()7AFV[HW3J&'(^HR.1WKFC=>(+:&+RDDEN)XA,5>$LID;.Y2<_( M$X '>GMJ'B)84N&A;:Y*F(6V61< [\=R.>#UQBJ=IJ/B92(Q!,\;)(R22VYW M'YFP2#T/W?E)Z?G0!L3:Q>Q^'[^^>,P&*7$9FB*D1_+EMIY)&6P.^!6-'K?B M*YL)+RU5IHR^R I:??'S?.1G(SA1^/;K6MXABU5GT^*SEF*O\D[1Q @GL16.ERVMJQFF M"M2>OYUF1:KXKD\X/:")U#'"P%@I"N0H)X8'"C(SU_"GW.I^ M*+>=8H[=9U4-^\%NV)3R>0/NXX[C/OTH 2TU?Q*[?Z7;O'&&W9BM"[;O^>># MCY?]KVZTZ;4O$=ZKK%;20*D"L^;<@O*-NY%.>F2>?:M#29M7.M&+4&D:W$) M;R=JL?E.^VH=.O-=NKZ..>-HH_-)E8VVT(!N^0$GY@<+\P]?R '^' MM1U.:]6QO'$GDPB661H]KY8X",.Q!#'/<8JG=77B+R[M84DC56D5-L)9SDR$ M,"3V"IQ_M?2IM1O]0>-U1 M'5?%#VJJ\#AF61.].U2^\12^:D*7,861LB&W/R_>"@-_ M&",$D=*6?4O%-IM/UF[U>RT2T:T5 MY[UR!(RV^[!VD\J.G.!65:Z]K>H:C):0-&)4;][&( 1#RW&[/.<+D]LT 3/K MFOVMFM[<0(%9>8&AV$'2VXG_@-:.O7VKV-I:?8H3->_\501!DA\XL%#+]GP M4RN688)R5/&.?Z4 -O+_ ,2?874I*/-A+;X;3OM:LW@?2[,74+)N<;#N!!Z?CN'TVF@"/1EU:V\-7 E:5KU6Q$)5SM&U0, M#N!R:R+O6-:CFDTT2,+EQ*(E6'YG'SD2 Y^7E5P.F#4L/_"2)=E7EN%:,,V! M#F-L++SU[D)QGN/05L:K?ZA +:2UL6:6:WQ\L)PP7Z\<4 -TF]U& M/6KB#57D*'$5NPA*I*0S_-D< X XJIJLNL1ZI>F&2Z$*,C1E("PV_N]V,=?X M^/8U-;ZAJ\OAS5)+B%DNXMXA?RRFX;>J@\Y'/_U^M1WEI/:LK+,Q#8^63A3D# MH6.1TP:NZ!>:[=WL:ZBIC@",S$V^S+?+\F3C@$M@@*=\=OY9V>7@R26Y+$YP2>V0??D 'O4VHWN MMV.HW>H;)$T^1A @)W>4 P'F[.G/S]^I:?X6DO9 MM[7<$S%HIT"EE\P@(/P(P15-;_Q3+),OV?RBI)&V#(3 1GK3+B^ M\5Q3(@MQ,HW;28.)#U&<9VXXQTS[T 6%U/Q#:WR+<6[2Q*X6?9;':$X^9"/O M$\Y7M^'-J[;5KW2=*FC#V]Z6,DV(MVS]V_!4^IP/QK.N+OQ)"TIWSMLA&PBU MR'8[&;@ X(R5'X^E7HY)--O+"2:>\(N1)-<0RG?Y0(7@*.@#X Z]30!3@UCQ M/+)*_P#9S_*HQ%)#L^8_+P>X!(;J> >E:6AWFN2ZA>Q:G"BQ1@^41&5!;.!@ M]"".>_7\*37KS6;?5;6/3X"UHR8D98MYW9.?R'(Z9]^E9\FI>)DM@SVC"[*' M9"EN&1VR2 M<;2 HP,#)[5J:S?ZO;Z=8'389I9I%#2DPY.=H.&';.3^744 4(M<\0>>L4L M0SSK#$)H=CQ'EV):8[V#20E0"..6R ..H-7K6[U>Y\+M+<0G[ M:)E"@1E"R;UYV\$<9].E9=Y=^);6]N=AGD"E43%MD2*"V6& 0"G6MK6 MM0U.VDB6QM'D\V'C$>[;)N7ACV&TM^5 "6$VKG3KPW2"6<0+) K0A/G*D[", M\X('YTFB7.JW5SB\,@MD0D-);>4TI..H_AQS]>M9D]SXD*I%(DJK(L;"2*#Y MBY"DH<'Y0/F^;V_.QH]YK]UJ2)>QF&W)=I#Y&,$=$R<<>XS]30 EI=ZVFH"" M5)Y(_M+ ;[?Y3'YC9)?^':NTCU]^SM4_MI-:E:QDN/)2,R(@B#(V(_N^^6'X M?C1J,&HMJMQY7VS[2TT9M'C)\E(N-^X=,_>SD9/RXJA;OXI@TYI(_M$LC\%9 MXUW1@(F6 ZDYW\="1TYH V/#][K5UJ%X-5MQ# O^K&PC!W'@'^(8QR,_TK?K M%\/RZK!ALX^4X^GI=TJYURXEU**[A$$?E,T(2':4?M@XPV>O?^E5;*X\1106.G MJ+A65@L]S) &PAV$')X)Y<'K[T %U>^*H$*IN<%SB4VPRH#. ,#.=P"$G QG MJ.SKJY\3>9$X$RAF=MB6X94(+A5/.2"-IZ^E0/<^)I[NWDEM[@.@.8EBVQC[ MF&)!YRIZ_S% #([CQ$]ZDV+K;'&K21O;A49C(H9!R<@#)#=<=S5F]OM>;7)K: MUAF2U8JBRF ,%!9,N#WX+=3VZ>K?M'B)1)+(TNT8)1+925!D8$J.I(55..?O M56>[\4?9?M#PLLWSJ$6 '8HV;3@=2WS'H<8XH M:?>^(9(-3-U'MDCC/D P' MB3+8 Z;AC:>_]!274_%I.%..W'-6XKKQ(\Z2,)$CW MKF)H4Z9C!Y^C.?\ @-27UYX@;7)X+.&1;0;5$AC4CDI\P)Z\%_RZ>H!#_:6O MY:!(+EB9<),]J%_=%<;B,XSNR<<''857EN_%$8NXRC!,L \=MEE/S;=HQAMV M%R><9[=KFGS:W/KEJNH"X6.)I P6$+&Z;2%9F_O$X^7\:B:X\4H@D0&1F4'R MS"H"D^9D9]@J?BU #KI]:MY[(6S7(_T.-6,B;HRY/SM(2?E*CGWZ4YK[6;WP M_9:C#&_GR2--Y42YVIY;[ ?49VG\:B6[\4/'+)#&[JAVQ)/ J&92'^9AV((4 M8X_6I-(U36Y-3M;.]V@2!I7S%M9(U. "/]HD8.!]TT 0PW_B@V@F6%G9&VB- MX0IE!+?,>F,87H!UJ3[9K4/AV6:,7DEW)=D([V^'$?&&V8.!QCIW_&HKB[\1 MVUPT=E;SR+OF8%U#*07?')YX&S R.O0]K$E_XCE>2>U@98U?$<$L(4NI+ MHQ@?G0 "]\0E$>1)464?,$M@QAP5Y SR3D]<]/:L^VN_$L$44ABNC)(BJ(Y( MMV]DV@AO[@.6;/L/QEBO?$D5R##%<212R,Y-Q!M+<*,8'W.,XY'/KTJ9)O$M MO+,^YI40(XWP@"8MLW _W0N6Z>F: )KZ;7(K'2YHVN7N6B=YQ' &&\J"J,O0 M#.1GVJM=W_B&Z>%(;29?+8><50IEMQR%.<%=H7GWJ;3->U"^\.WUS"TMU<1R MHJ%8 #R%W 9SC+>OXU ;WQ)-;#SA=PR@H=D5H"-@89;=G[QY^4?E0 RSN/$ M,^IB0QW"K*%1I9+?:(3D;L+G! Y&>^,U#)XCUW[1]E!(O1%NDA6VW[ %0[N. M
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image_002.jpg GRAPHIC begin 644 image_002.jpg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end GRAPHIC 8 image_003.jpg GRAPHIC begin 644 image_003.jpg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end EX-101.SCH 9 ecia-20220630.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Condensed Balance Sheets (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Condensed Balance Sheets (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Condensed Statements of Operations (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Condensed Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Disclosure - ORGANIZATION AND NATURE OF BUSINESS link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Basic and Diluted Income and Loss per Common Share link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - SHARE-BASED COMPENSATION link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - RELATED PARTY TRANSACTION link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Basic and Diluted Income and Loss per Common Share (Tables) link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - SHARE-BASED COMPENSATION (Tables) link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - ORGANIZATION AND NATURE OF BUSINESS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - BASIC AND DILUTED INCOME AND LOSS PER COMMON SHARE (Details) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details 2) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - SHARE-BASED COMPENSATION (Details) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - SHARE-BASED COMPENSATION (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - RELATED PARTY TRANSACTION (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 10 ecia-20220630_cal.xml XBRL CALCULATION FILE EX-101.DEF 11 ecia-20220630_def.xml XBRL DEFINITION FILE EX-101.LAB 12 ecia-20220630_lab.xml XBRL LABEL FILE Product and Service [Axis] Product [Member] Service [Member] Related Party [Axis] Lease Payment [Member] E I D L Payment [Member] U S Bank Payment [Member] Long-Term Debt, Type [Axis] SBA [Member] EIDL [Member] PPPLoan [Member] Income Statement Location [Axis] Cost of Sales [Member] Selling and Marketing Expense [Member] General and Administrative Expense [Member] Research and Development Expense [Member] Director [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Statement of Financial Position [Abstract] ASSETS Current assets: Cash Accounts receivable Inventories, net of reserve for obsolescence of $34,948 at June 30, 2022 and $36,000 at March 31, 2022 Prepaid expenses and other assets Total current assets Equipment: Furniture, fixtures and equipment, at cost Accumulated depreciation Equipment, net Right of use asset Patents, net of accumulated amortization of $290,077 at June 30, 2022 and $282,081 at March 31, 2022 Other assets TOTAL ASSETS LIABILITIES AND SHAREHOLDERS’ EQUITY Current liabilities: Accounts payable Secured notes Accrued compensation Other accrued liabilities Accrued lease liability Total current liabilities Long-term liability: Secured notes Accrued lease liability Total liabilities Commitments and contingencies (Note 4) Shareholders’ equity: Preferred stock, no par value: 10,000,000 shares authorized; none issued and outstanding Common stock and additional paid-in capital, no par value: 100,000,000 shares authorized; 11,719,543 issued and outstanding at June 30, 2022 and March 31, 2022 Accumulated (deficit) Total shareholders’ equity TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY Inventories, reserve for obsolescence Accumulated amortization Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par value Common stock and additional paid-in capital, shares authorized Common stock and additional paid-in capital, shares issued Common stock and additional paid-in capital, shares outstanding Statement [Table] Statement [Line Items] NET REVENUE: Total revenue COST OF REVENUE: Total cost of revenue GROSS PROFIT OPERATING EXPENSES: Sales and marketing General and administrative Research and development Total operating expenses OPERATING (LOSS) INCOME Interest expense, net Other income (expense), net Interest expense, extinguishment of debt income and other income (expense), net (LOSS) INCOME BEFORE PROVISION FOR INCOME TAXES Provision for income taxes NET (LOSS) INCOME Net (loss) income per share—basic and diluted Weighted average shares—basic Weighted average shares—diluted Statement of Cash Flows [Abstract] Cash flows (used in) operating activities: Net income Adjustments to reconcile net income to net cash (used in) operating activities: Depreciation and amortization Stock-based compensation expense related to stock options (Recovery from) doubtful accounts, net change (Recovery from) provision for inventory obsolescence, net change Change in operating assets and liabilities: Right of use asset, net Accounts receivable Inventories Prepaid expenses and other assets Accounts payable Accrued compensation and other accrued liabilities Net cash (used in) generated by operating activities Cash flows (used in) investing activities: Acquisition of property and equipment Patent costs Net cash (used in) generated by investing activities Cash flows from financing activities: (Paydown of) secured notes Net cash (used in) generated by financing activities Net (decrease) increase in cash Cash, beginning of fiscal year Cash, end of fiscal quarter Supplemental disclosures of cash flow information: Cash paid during the three months for interest Organization, Consolidation and Presentation of Financial Statements [Abstract] ORGANIZATION AND NATURE OF BUSINESS Accounting Policies [Abstract] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Earnings Per Share [Abstract] Basic and Diluted Income and Loss per Common Share Commitments and Contingencies Disclosure [Abstract] COMMITMENTS AND CONTINGENCIES Equity [Abstract] SHARE-BASED COMPENSATION Related Party Transactions [Abstract] RELATED PARTY TRANSACTION Subsequent Events [Abstract] SUBSEQUENT EVENTS Basis of Presentation Use of Estimates in the Preparation of Financial Statements Cash and Cash Equivalents Fair Value of Financial Instruments Concentration of Credit Risk Inventories Property and Equipment Long-Lived Assets Patents Income Taxes Revenue Recognition Research and Development Expenses Stock-Based Compensation Segment Reporting Recently Issued Accounting Pronouncements Schedule of inventory Schedule of service performs electrical engineering activities for external entities Schedule of basic and diluted net loss per share Schedule of Defined Benefit Plans Disclosures [Table] Defined Benefit Plan Disclosure [Line Items] Schedule of principal U.S. Bank payment Schedule of summarizes stock-based compensation Accumulated deficit Stock options exercised Raw materials Finished goods Total gross inventories Less reserve for obsolescence Total net inventories Schedule of Product Information [Table] Product Information [Line Items] Net revenue Cost of revenue Gross profit Operating income (loss) Depreciation and amortization Patent and capital expenditures Equipment and patents, net Federally insured limit Depreciation expense Unrecognized tax benefits Uncertain tax positions Stock based compensation Net (loss) income Weighted-average basic shares outstanding Effect of dilutive securities Weighted-average diluted shares Basic net income (loss) per share Diluted net income (loss) per share  Antidilutive employee stock options 2023 2024 2025 Total 2026 Thereafter Schedule of Long-Term Debt Instruments [Table] Debt Instrument [Line Items] Proceed from loan Principal amount Interest rate Debt Instrument, Maturity Date Debt Forgiveness Extinguishment of debt income Stock-based compensation expense related to grants of employee stock options Stock options granted Number of shares exercised Stock options forfeited Unrecognized compensation costs Schedule of Related Party Transactions, by Related Party [Table] Related Party Transaction [Line Items] Consulting fees paid Assets, Current Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Property, Plant and Equipment, Net Assets Liabilities, Current Secured Debt Operating Lease, Liability Liabilities Stockholders' Equity Attributable to Parent Liabilities and Equity Operating Expenses Interest Expense Nonoperating Income (Expense) Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest Increase (Decrease) in Operating Assets Increase (Decrease) in Accounts Receivable Increase (Decrease) in Inventories Increase (Decrease) in Prepaid Expense and Other Assets Increase (Decrease) in Accounts Payable Net Cash Provided by (Used in) Operating Activities Payments to Acquire Property, Plant, and Equipment Payments to Acquire Intangible Assets Net Cash Provided by (Used in) Investing Activities Repayments of Secured Debt Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Inventory, Gross Depreciation, Depletion and Amortization, Nonproduction EX-101.PRE 13 ecia-20220630_pre.xml XBRL PRESENTATION FILE XML 14 R1.htm IDEA: XBRL DOCUMENT v3.22.2
Cover - shares
3 Months Ended
Jun. 30, 2022
Jul. 31, 2022
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Jun. 30, 2022  
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2023  
Current Fiscal Year End Date --03-31  
Entity File Number 001-11789  
Entity Registrant Name ENCISION INC.  
Entity Central Index Key 0000930775  
Entity Tax Identification Number 84-1162056  
Entity Incorporation, State or Country Code CO  
Entity Address, Address Line One 6797 Winchester Circle  
Entity Address, City or Town Boulder  
Entity Address, State or Province CO  
Entity Address, Postal Zip Code 80301  
City Area Code (303)  
Local Phone Number 444-2600  
Title of 12(b) Security Common Stock, no par value  
Trading Symbol ECIA  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   11,719,543

XML 15 R2.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Balance Sheets (Unaudited) - USD ($)
Jun. 30, 2022
Mar. 31, 2022
Current assets:    
Cash $ 827,944 $ 949,645
Accounts receivable 921,123 947,623
Inventories, net of reserve for obsolescence of $34,948 at June 30, 2022 and $36,000 at March 31, 2022 1,798,655 1,584,321
Prepaid expenses and other assets 101,287 120,133
Total current assets 3,649,009 3,601,722
Equipment:    
Furniture, fixtures and equipment, at cost 2,499,871 2,468,949
Accumulated depreciation (2,265,202) (2,279,652)
Equipment, net 234,669 189,297
Right of use asset 715,349 786,407
Patents, net of accumulated amortization of $290,077 at June 30, 2022 and $282,081 at March 31, 2022 177,589 180,719
Other assets 42,198 34,240
TOTAL ASSETS 4,818,814 4,792,385
Current liabilities:    
Accounts payable 388,077 576,381
Secured notes 23,154 21,491
Accrued compensation 221,678 190,853
Other accrued liabilities 114,835 125,179
Accrued lease liability 370,677 362,487
Total current liabilities 1,118,421 1,276,391
Long-term liability:    
Secured notes 200,806 205,809
Accrued lease liability 476,761 564,321
Total liabilities 1,795,988 2,046,521
Shareholders’ equity:    
Preferred stock, no par value: 10,000,000 shares authorized; none issued and outstanding
Common stock and additional paid-in capital, no par value: 100,000,000 shares authorized; 11,719,543 issued and outstanding at June 30, 2022 and March 31, 2022 24,287,544 24,275,183
Accumulated (deficit) (21,264,718) (21,529,319)
Total shareholders’ equity 3,022,826 2,745,864
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY $ 4,818,814 $ 4,792,385
XML 16 R3.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Balance Sheets (Unaudited) (Parenthetical) - USD ($)
Jun. 30, 2022
Mar. 31, 2022
Statement of Financial Position [Abstract]    
Inventories, reserve for obsolescence $ 34,948 $ 36,000
Accumulated amortization $ 290,077 $ 282,081
Preferred stock, shares authorized 10,000,000 10,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock, par value $ 0 $ 0
Common stock and additional paid-in capital, shares authorized 100,000,000 100,000,000
Common stock and additional paid-in capital, shares issued 11,719,543 11,719,543
Common stock and additional paid-in capital, shares outstanding 11,719,543 11,719,543
XML 17 R4.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Jun. 30, 2022
Jun. 30, 2021
NET REVENUE:    
Total revenue $ 2,154,362 $ 2,008,444
COST OF REVENUE:    
Total cost of revenue 869,905 981,476
GROSS PROFIT 1,284,457 1,026,968
OPERATING EXPENSES:    
Sales and marketing 502,967 528,474
General and administrative 344,119 326,721
Research and development 170,469 176,875
Total operating expenses 1,017,555 1,032,070
OPERATING (LOSS) INCOME 266,902 (5,102)
Interest expense, net (2,363) (1,806)
Other income (expense), net 61 66
Interest expense, extinguishment of debt income and other income (expense), net (2,302) (1,740)
(LOSS) INCOME BEFORE PROVISION FOR INCOME TAXES 264,601 (6,842)
Provision for income taxes
NET (LOSS) INCOME $ 264,601 $ (6,842)
Net (loss) income per share—basic and diluted $ 0.02 $ 0.00
Weighted average shares—basic 11,719,543 11,582,641
Weighted average shares—diluted 12,021,280 11,582,641
Product [Member]    
NET REVENUE:    
Total revenue $ 1,696,029 $ 1,718,404
COST OF REVENUE:    
Total cost of revenue 869,905 838,426
GROSS PROFIT 826,124 879,978
OPERATING EXPENSES:    
OPERATING (LOSS) INCOME (191,431) (152,092)
Service [Member]    
NET REVENUE:    
Total revenue 458,333 290,040
COST OF REVENUE:    
Total cost of revenue 143,050
GROSS PROFIT 458,333 146,990
OPERATING EXPENSES:    
OPERATING (LOSS) INCOME $ 458,333 $ 146,990
XML 18 R5.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Cash flows (used in) operating activities:    
Net income $ 264,601 $ (6,842)
Adjustments to reconcile net income to net cash (used in) operating activities:    
Depreciation and amortization 20,087 26,783
Stock-based compensation expense related to stock options 12,361 8,340
(Recovery from) doubtful accounts, net change (25,000)
(Recovery from) provision for inventory obsolescence, net change (1,052) (49,000)
Change in operating assets and liabilities:    
Right of use asset, net (8,312) (4,687)
Accounts receivable 26,500 (91,601)
Inventories (213,282) (96,813)
Prepaid expenses and other assets 10,888 44,049
Accounts payable (188,304) 131,938
Accrued compensation and other accrued liabilities 20,481 (65,216)
Net cash (used in) generated by operating activities (56,032) (128,049)
Cash flows (used in) investing activities:    
Acquisition of property and equipment (57,463) (6,720)
Patent costs (4,866) (7,561)
Net cash (used in) generated by investing activities (62,329) (14,281)
Cash flows from financing activities:    
(Paydown of) secured notes (3,340) (3,340)
Net cash (used in) generated by financing activities (3,340) (3,340)
Net (decrease) increase in cash (121,701) (145,670)
Cash, beginning of fiscal year 949,645 1,474,339
Cash, end of fiscal quarter 827,944 1,328,669
Supplemental disclosures of cash flow information:    
Cash paid during the three months for interest $ 2,363 $ 1,806
XML 19 R6.htm IDEA: XBRL DOCUMENT v3.22.2
ORGANIZATION AND NATURE OF BUSINESS
3 Months Ended
Jun. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
ORGANIZATION AND NATURE OF BUSINESS

Note 1. ORGANIZATION AND NATURE OF BUSINESS

 

Encision Inc. is a medical device company that designs, develops, manufactures and markets patented surgical instruments that provide greater safety to, and saves lives of, patients undergoing minimally-invasive surgery. We believe that our patented AEM® (Active Electrode Monitoring) surgical instrument technology is changing the marketplace for electrosurgical devices and instruments by providing a solution to a patient safety risk in laparoscopic surgery. Our sales to date have been made principally in the United States.

 

We have an accumulated deficit of $21,264,718 at June 30, 2022. A significant portion of our operating funds have been provided by issuances of our common stock and warrants, the exercise of stock options to purchase our common stock, loans, and (in some periods) by operating profits. Shareholders’ equity increased by $276,962 since March 31, 2022 as a result of our net income of $264,601 and share-based compensation of $12,361. Should our liquidity be diminished in the future because of operating losses, we may be required to seek additional capital.

 

Our strategic marketing and sales plan is designed to expand the use of our products in surgically active hospitals and surgery centers in the United States.

 

We have been actively monitoring the coronavirus (“COVID”) situation and its impact globally. Our production facilities continued to operate during the year as they had prior to the COVID pandemic with minimal change, other than for enhanced safety measures intended to prevent the spread of the virus. The remote working arrangements and travel restrictions imposed by various governments had limited impact on our ability to maintain operations during the year, as our manufacturing operations have generally been exempted from stay-at-home orders. However, we cannot predict the impact of the progression of the COVID pandemic on future results due to a variety of factors, including the continued good health of our employees, the ability of suppliers to continue to operate and deliver, our ability and our customers to maintain operations, continued access to transportation resources, the changing needs and priorities of customers, any further government and/or public actions taken in response to the pandemic and ultimately the length of the pandemic. We will continue to closely monitor the COVID pandemic in order to ensure the safety of our people and our ability to serve our customers and patients worldwide.

 

XML 20 R7.htm IDEA: XBRL DOCUMENT v3.22.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
3 Months Ended
Jun. 30, 2022
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Note 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation. The condensed interim financial statements included herein have been prepared by us, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles accepted in the United States (“GAAP”) have been condensed or omitted pursuant to such rules and regulations, although we believe that the disclosures made are adequate to make the information presented not misleading. The condensed interim financial statements and notes thereto should be read in conjunction with the financial statements and the notes thereto included in our Annual Report on Form 10-K for the fiscal year ended March 31, 2022 filed on July 13, 2022.

 

The accompanying condensed interim financial statements have been prepared, in all material respects, in conformity with the standards of accounting measurements and reflect, in the opinion of management, all adjustments necessary to summarize fairly the financial position and results of operations for such periods in accordance with GAAP. All adjustments are of a normal recurring nature. The results of operations for the most recent interim period are not necessarily indicative of the results to be expected for the full year.

 

Use of Estimates in the Preparation of Financial Statements. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions. Such estimates and assumptions affect the reported amounts of assets and liabilities as well as disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of sales and expense during the reporting period. Actual results could differ from those estimates.

 

Cash and Cash Equivalents. For purposes of reporting cash flows, we consider all cash and highly liquid investments with an original maturity of three months or less to be cash equivalents.

 

Fair Value of Financial Instruments. Our financial instruments consist of cash, trade receivables, payables and Economic Injury Disaster Loan (“EIDL”) loan. The carrying values of cash and trade receivables approximate their fair value due to their short maturities.The fair values of the EIDL Loan approximates the carrying value based on estimated discounted future cash flows using the current rates at which similar loans would be made.

 

Concentration of Credit Risk. Financial instruments, which potentially subject us to concentrations of credit risk, consist of cash and accounts receivable. From time to time, the amount of cash on deposit with financial institutions may exceed the $250,000 federally insured limit at June 30, 2022. We believe that our cash on deposit that exceeds $250,000 with financial institutions is financially sound and the risk of loss is minimal.

 

We have no significant off-balance sheet concentrations of credit risk such as foreign exchange contracts, options contracts or other foreign hedging arrangements. We maintain the majority of our cash balances with one financial institution in the form of demand deposits.

 

Accounts receivable are typically unsecured and are derived from transactions with and from entities in the healthcare industry primarily located in the United States. Accordingly, we may be exposed to credit risk generally associated with the healthcare industry. We maintain allowances for doubtful accounts for estimated losses resulting from the inability of our customers to make required payments. The net accounts receivable balance at June 30, 2022 of $921,123 and at March 31, 2022 of $947,623 included no more than 12% from any one customer.

 

Inventories. Inventories are stated at the lower of cost (first-in, first-out basis) or net realizable value. We reduce inventory for estimated obsolete or unmarketable inventory equal to the difference between the cost of inventory and the net realizable value based upon assumptions about future demand and market conditions. If actual market conditions are less favorable than those projected by management, additional inventory write-downs may be required. At June 30, 2022 and March 31, 2022 inventory consisted of the following:

 

          
   June 30, 2022   March 31, 2022 
Raw materials  $1,318,891   $1,083,387 
Finished goods   514,712    536,934 
Total gross inventories   1,833,603    1,620,321 
Less reserve for obsolescence   (34,948)   (36,000)
Total net inventories  $1,798,655   $1,584,321 

 

Property and Equipment. Property and equipment are stated at cost, with depreciation computed over the estimated useful lives of the assets, generally five to seven years. Depreciation expense for the three months ended June 30, 2022 and 2021 was $12,091 and $14,877, respectively. We use the straight-line method of depreciation for property and equipment. Leasehold improvements are depreciated over the shorter of the remaining lease term or the estimated useful life of the asset. Maintenance and repairs are expense as incurred and major additions, replacements and improvements are capitalized.

 

Long-Lived Assets. Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. A long-lived asset is considered impaired when estimated future cash flows related to the asset, undiscounted and without interest, are insufficient to recover the carrying amount of the asset. If deemed impaired, the long-lived asset is reduced to its estimated fair value. Long-lived assets to be disposed of are reported at the lower of their carrying amount or estimated fair value less cost to sell.

 

Patents. The costs of applying for patents are capitalized and amortized on a straight-line basis over the lesser of the patent’s economic or legal life (20 years from the date of application in the United States). Capitalized costs are expensed if patents are not issued. We review the carrying value of our patents periodically to determine whether the patents have continuing value and such reviews could result in the conclusion that the recorded amounts have been impaired.

 

Income Taxes. We account for income taxes under the provisions of FASB Accounting Standards Codification (“ASC”) Topic 740, “Accounting for Income Taxes” (“ASC 740”). ASC 740 requires recognition of deferred income tax assets and liabilities for the expected future income tax consequences, based on enacted tax laws, of temporary differences between the financial reporting and tax bases of assets and liabilities. ASC 740 also requires recognition of deferred tax assets for the expected future tax effects of all deductible temporary differences, loss carryforwards and tax credit carryforwards. Deferred tax assets are then reduced, if deemed necessary, by a valuation allowance for the amount of any tax benefits, which, more likely than not based on current circumstances, are not expected to be realized. As a result, no provision for income tax is reflected in the accompanying statements of operations. Should we achieve sufficient, sustained income in the future, we may conclude that some or all of the valuation allowance should be reversed. We are required to make many subjective assumptions and judgments regarding our income tax exposures. At June 30, 2022, we had no unrecognized tax benefits, which would affect the effective tax rate if recognized and had no accrued interest, or penalties related to uncertain tax positions.

 

Revenue Recognition. We record revenue at a single point in time, when control is transferred to the customer. We will continue to apply our current business processes, policies, systems and controls to support recognition and disclosure. Our shipping policy is FOB Shipping Point. We recognize revenue from sales to stocking distributors when there is no right of return, other than for normal warranty claims. We have no ongoing obligations related to product sales, except for normal warranty obligations. As presented on the Statement of Operations our revenue is disaggregated between product revenue and service revenue. As it relates specifically to product revenue, we do not believe further disaggregation is necessary as substantially all of our product revenue comes from multiple products within a line of medical devices. Our engineering service contracts are billed on a time and materials basis and revenue is recognized over time as the services are performed.

 

Research and Development Expenses. We expense research and development costs for products and processes as incurred.

 

Stock-Based Compensation. Stock-based compensation is presented in accordance with the guidance of ASC Topic 718, “Compensation – Stock Compensation” (“ASC 718”). Under the provisions of ASC 718, we are required to estimate the fair value of share-based payment awards on the date of grant using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods in our statements of operations.

 

Stock-based compensation expense recognized under ASC 718 for the three months ended June 30, 2022 and 2021 was $12,361 and $8,340, respectively, which consisted of stock-based compensation expense related to grants of employee stock options.

 

Segment Reporting. We have concluded that we have two operating segments, product and service. Product designs, develops, manufactures and markets patented surgical instruments. Service performs electrical engineering activities for external entities.

 

                              
  

Three Months Ended

June 30, 2022

  

Three Months Ended

June 30, 2021

 
  

 

Product

  

 

Service

  

 

Total

  

 

Product

  

 

Service

  

 

Total

 
Net revenue  $1,696,029   $458,333   $2,154,362   $1,718,404   $290,040   $2,008,444 
Cost of revenue   869,905          869,905    838,426    143,050    981,476 
Gross profit   826,124    458,333    1,284,457    879,978    146,990    1,026,968 
Operating income (loss)   (191,431)   458,333    266,902    (152,092)   146,990    (5,102)
Depreciation and amortization   20,087          20,087    26,783          26,783 
Patent and capital expenditures   62,329          62,329    14,281          14,281 
Equipment and patents, net  $412,258   $     $412,258   $370,016   $     $370,016 

 

Recently Issued Accounting Pronouncements. In June 2016, the FASB issued ASU 2016-13, “Measurement of Credit Losses on Financial Instruments”. ASU 2016-13 adds a current expected credit loss (“CECL”) impairment model to U.S. GAAP that is based on expected losses rather than incurred losses. Modified retrospective adoption is required with any cumulative-effect adjustment recorded to retained earnings as of the beginning of the period of adoption. ASU 2016-13 is effective for fiscal years beginning after December 15, 2019, excluding smaller reporting entities, which will be effective for fiscal years beginning after December 15, 2022. We will adopt ASU 2016-13 beginning April 1, 2023 and do not expect the application of the CECL impairment model to have a significant impact on our allowance for uncollectible amounts for accounts receivable.

 

XML 21 R8.htm IDEA: XBRL DOCUMENT v3.22.2
Basic and Diluted Income and Loss per Common Share
3 Months Ended
Jun. 30, 2022
Earnings Per Share [Abstract]  
Basic and Diluted Income and Loss per Common Share

Note 3. Basic and Diluted Income and Loss per Common Share

 

We report both basic and diluted net income (loss) per share. Basic net income or loss per common share is computed by dividing net income or loss for the period by the weighted average number of common shares outstanding for the period. Diluted net income or loss per common share is computed by dividing the net income or loss for the period by the weighted average number of common and potential common shares outstanding during the period if the effect of the potential common shares is dilutive. The shares used in the calculation of dilutive potential common shares exclude options to purchase shares where the exercise price was greater than the average market price of common shares for the period.

 

The following table presents the calculation of basic and diluted net income (loss) per share:

 

          
   Three Months Ended 
    June 30, 2022   June 30, 2021 
Net (loss) income  $264,601   $(6,842)
Weighted-average basic shares outstanding   11,719,543    11,582,641 
Effect of dilutive securities   301,737       
Weighted-average diluted shares   12,021,280    11,582,641 
Basic net income (loss) per share  $0.02   $0.00 
Diluted net income (loss) per share  $0.02   $0.00 
 Antidilutive employee stock options   756,263    1,036,000 

 

XML 22 R9.htm IDEA: XBRL DOCUMENT v3.22.2
COMMITMENTS AND CONTINGENCIES
3 Months Ended
Jun. 30, 2022
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES

Note 4. COMMITMENTS AND CONTINGENCIES

 

We have a noncancelable lease agreement for our facilities at 6797 Winchester Circle, Boulder, Colorado. The lease expires October 31, 2024.

 

In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) ("ASU 2016-02"), which modified lease accounting for both lessees and lessors to increase transparency and comparability by recognizing lease assets and lease liabilities by lessees for those leases classified as either finance or operating leases under previous accounting standards and disclosing key information about leasing arrangements. We adopted Topic 842 on April 1, 2019, using the alternative modified transition method, which requires a cumulative effect adjustment, if any, to the opening balance of retained earnings to be recognized on the date of adoption with prior periods not restated. There was no cumulative effect adjustment recorded on April 1, 2019. The primary impact for us was the balance sheet recognition of right-of-use (“ROU”) assets and lease liabilities for operating leases as a lessee.

 

We determine if an arrangement contains a lease at inception. We currently do not have any finance leases. Operating lease ROU assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. ROU assets also include any initial direct costs incurred and any lease payments made at or before the lease commencement date, less lease incentives received. We use our incremental borrowing rate based on the information available at the commencement date in determining the lease liabilities as our leases do not provide an implicit rate. Lease expense is recognized on a straight-line basis over the lease term.

 

The minimum future lease payment, by fiscal year, as of June 30, 2022 is as follows:

 

       
Fiscal Year   Amount 
 2023   $281,542 
 2024    386,667 
 2025    232,139 
 Total   $900,348 

 

During January 2021, we canceled our relationship with Crestmark Bank. We had no borrowings and incurred a $20,000 exit fee.

 

On August 4, 2020, we received $150,000 principal in loan funding from the U.S. Small Business Administration (“SBA”) under the Economic Injury Disaster Loan (“EIDL”) program administered by the SBA, which program was expanded pursuant to the CARES Act. The EIDL is evidenced by a promissory note, dated August 1, 2020 in the original principal amount of $150,000 with the SBA, the lender. Under the terms of the Note, interest accrues on the outstanding principal at the rate of 3.75% per annum. The term of the Note is thirty years, though it may be payable sooner upon an event of default under the Note. Under the Note, we will be obligated to make equal monthly payments of principal and interest of $774 beginning on August 1, 2023 through the maturity date of August 1, 2050. The Note may be prepaid in part or in full, at any time, without penalty.

 

During January 2021, we entered into a note agreement with U.S. Bank for $92,000. The note is for five years at a 5% interest rate and the proceeds were used to purchase equipment. The note is secured by the equipment.

 

On April 17, 2020, we entered into an unsecured promissory note under the PPP for a principal amount of $598,567. The PPP was established under the Consolidated Appropriations Act of 2020, enacted December 27, 2020. Under the terms of the CARES Act, a PPP loan recipient may apply for, and be granted, forgiveness for all or a portion of loans granted under the PPP. Such forgiveness will be determined based upon the use of loan proceeds for payroll costs, rent and utility costs, and the maintenance of employee and compensation levels. In the quarter that ended December 31, 2020, we achieved the requirements for forgiveness, and all of the $598,567 was forgiven. We recognized the forgiveness as extinguishment of debt income of $598,567.On February 8, 2021, we entered into a second unsecured promissory note under the PPP for a principal amount of $533,118. This was our second PPP loan. During the quarter that ended September 30, 2021, we achieved the requirements for forgiveness of the second note and recognized the forgiveness as extinguishment of debt income of $533,118.

 

The minimum future EIDL payment, by fiscal year, as of June 30, 2022 is as follows:

 

       
Fiscal Year   Amount 
 2023   $1,546 
 2024    3,208 
 2025    3,331 
 2026    3,457 
 Thereafter    148,018 
 Total   $159,560 

 


During January 2021, we entered into a note agreement with U.S. Bank for $92,000. The note is for five years at a 5% interest rate and the proceeds were used to purchase equipment. The note is secured by the equipment.

 

The minimum future principal U.S. Bank payment, by fiscal year, as of June 30, 2022 is as follows:

 

       
Fiscal Year   Amount 
 2023   $13,800 
 2024    18,400 
 2025    18,400 
 2026    13,800 
 Total   $64,400 

 

 

Aside from the operating lease, EIDL loan and U.S. Bank loan, we do not have any material contractual commitments requiring settlement in the future.

 

We are subject to regulation by the United States Food and Drug Administration (“FDA”). The FDA provides regulations governing the manufacture and sale of our products and regularly inspects us and other manufacturers to determine compliance with these regulations. We believe that we were in substantial compliance with all known regulations at June 30, 2022. FDA inspections are conducted periodically at the discretion of the FDA. Our latest inspection by the FDA occurred in October 2019.

 

XML 23 R10.htm IDEA: XBRL DOCUMENT v3.22.2
SHARE-BASED COMPENSATION
3 Months Ended
Jun. 30, 2022
Equity [Abstract]  
SHARE-BASED COMPENSATION

Note 5. SHARE-BASED COMPENSATION

 

The provisions of ASC 718-10-55 requires the measurement and recognition of compensation expense for all share-based payment awards made to our employees and directors, including employee stock options and RSUs, based on estimated fair values. The following table summarizes stock-based compensation expense related to employee stock options for the three months ended June 30, 2022 and 2021, which was allocated as follows:

 

          
   Three Months Ended 
   June 30, 2022   June 30, 2021 
Cost of sales  $158   $918 
Sales and marketing   1,656    1,218 
General and administrative   9,429    5,658 
Research and development   1,118    546 
Stock-based compensation expense  $12,361   $8,340 

 

Share-based compensation cost for stock options is measured at the grant date, based on the fair value as calculated by the Black-Scholes-Merton ("BSM") option-pricing model. The BSM option-pricing model requires the use of actual employee exercise behavior data and the application of a number of assumptions, including expected volatility, risk-free interest rate and expected dividends. There were no stock options granted, exercised or forfeited during the three months ended June 30, 2022 and 2021.

 

As of June 30, 2022, approximately $182,000 of total unrecognized compensation costs related to nonvested stock options is expected to be recognized over a period of five years.

 

XML 24 R11.htm IDEA: XBRL DOCUMENT v3.22.2
RELATED PARTY TRANSACTION
3 Months Ended
Jun. 30, 2022
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTION

Note 6. RELATED PARTY TRANSACTION

 

We paid consulting fees of $13,728 and $28,816 to an entity owned by one of our directors during the three months ended June 30, 2022 and 2021 respectively.

 

XML 25 R12.htm IDEA: XBRL DOCUMENT v3.22.2
SUBSEQUENT EVENTS
3 Months Ended
Jun. 30, 2022
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

Note 7. SUBSEQUENT EVENTS

We evaluated all of our activity as of the date the condensed interim financial statements were issued and concluded that no subsequent events have occurred that would require recognition in our financial statements or disclosed in the notes to our condensed interim financial statements.

XML 26 R13.htm IDEA: XBRL DOCUMENT v3.22.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
3 Months Ended
Jun. 30, 2022
Accounting Policies [Abstract]  
Basis of Presentation

Basis of Presentation. The condensed interim financial statements included herein have been prepared by us, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles accepted in the United States (“GAAP”) have been condensed or omitted pursuant to such rules and regulations, although we believe that the disclosures made are adequate to make the information presented not misleading. The condensed interim financial statements and notes thereto should be read in conjunction with the financial statements and the notes thereto included in our Annual Report on Form 10-K for the fiscal year ended March 31, 2022 filed on July 13, 2022.

 

The accompanying condensed interim financial statements have been prepared, in all material respects, in conformity with the standards of accounting measurements and reflect, in the opinion of management, all adjustments necessary to summarize fairly the financial position and results of operations for such periods in accordance with GAAP. All adjustments are of a normal recurring nature. The results of operations for the most recent interim period are not necessarily indicative of the results to be expected for the full year.

 

Use of Estimates in the Preparation of Financial Statements

Use of Estimates in the Preparation of Financial Statements. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions. Such estimates and assumptions affect the reported amounts of assets and liabilities as well as disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of sales and expense during the reporting period. Actual results could differ from those estimates.

 

Cash and Cash Equivalents

Cash and Cash Equivalents. For purposes of reporting cash flows, we consider all cash and highly liquid investments with an original maturity of three months or less to be cash equivalents.

 

Fair Value of Financial Instruments

Fair Value of Financial Instruments. Our financial instruments consist of cash, trade receivables, payables and Economic Injury Disaster Loan (“EIDL”) loan. The carrying values of cash and trade receivables approximate their fair value due to their short maturities.The fair values of the EIDL Loan approximates the carrying value based on estimated discounted future cash flows using the current rates at which similar loans would be made.

 

Concentration of Credit Risk

Concentration of Credit Risk. Financial instruments, which potentially subject us to concentrations of credit risk, consist of cash and accounts receivable. From time to time, the amount of cash on deposit with financial institutions may exceed the $250,000 federally insured limit at June 30, 2022. We believe that our cash on deposit that exceeds $250,000 with financial institutions is financially sound and the risk of loss is minimal.

 

We have no significant off-balance sheet concentrations of credit risk such as foreign exchange contracts, options contracts or other foreign hedging arrangements. We maintain the majority of our cash balances with one financial institution in the form of demand deposits.

 

Accounts receivable are typically unsecured and are derived from transactions with and from entities in the healthcare industry primarily located in the United States. Accordingly, we may be exposed to credit risk generally associated with the healthcare industry. We maintain allowances for doubtful accounts for estimated losses resulting from the inability of our customers to make required payments. The net accounts receivable balance at June 30, 2022 of $921,123 and at March 31, 2022 of $947,623 included no more than 12% from any one customer.

 

Inventories

Inventories. Inventories are stated at the lower of cost (first-in, first-out basis) or net realizable value. We reduce inventory for estimated obsolete or unmarketable inventory equal to the difference between the cost of inventory and the net realizable value based upon assumptions about future demand and market conditions. If actual market conditions are less favorable than those projected by management, additional inventory write-downs may be required. At June 30, 2022 and March 31, 2022 inventory consisted of the following:

 

          
   June 30, 2022   March 31, 2022 
Raw materials  $1,318,891   $1,083,387 
Finished goods   514,712    536,934 
Total gross inventories   1,833,603    1,620,321 
Less reserve for obsolescence   (34,948)   (36,000)
Total net inventories  $1,798,655   $1,584,321 

 

Property and Equipment

Property and Equipment. Property and equipment are stated at cost, with depreciation computed over the estimated useful lives of the assets, generally five to seven years. Depreciation expense for the three months ended June 30, 2022 and 2021 was $12,091 and $14,877, respectively. We use the straight-line method of depreciation for property and equipment. Leasehold improvements are depreciated over the shorter of the remaining lease term or the estimated useful life of the asset. Maintenance and repairs are expense as incurred and major additions, replacements and improvements are capitalized.

 

Long-Lived Assets

Long-Lived Assets. Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. A long-lived asset is considered impaired when estimated future cash flows related to the asset, undiscounted and without interest, are insufficient to recover the carrying amount of the asset. If deemed impaired, the long-lived asset is reduced to its estimated fair value. Long-lived assets to be disposed of are reported at the lower of their carrying amount or estimated fair value less cost to sell.

 

Patents

Patents. The costs of applying for patents are capitalized and amortized on a straight-line basis over the lesser of the patent’s economic or legal life (20 years from the date of application in the United States). Capitalized costs are expensed if patents are not issued. We review the carrying value of our patents periodically to determine whether the patents have continuing value and such reviews could result in the conclusion that the recorded amounts have been impaired.

 

Income Taxes

Income Taxes. We account for income taxes under the provisions of FASB Accounting Standards Codification (“ASC”) Topic 740, “Accounting for Income Taxes” (“ASC 740”). ASC 740 requires recognition of deferred income tax assets and liabilities for the expected future income tax consequences, based on enacted tax laws, of temporary differences between the financial reporting and tax bases of assets and liabilities. ASC 740 also requires recognition of deferred tax assets for the expected future tax effects of all deductible temporary differences, loss carryforwards and tax credit carryforwards. Deferred tax assets are then reduced, if deemed necessary, by a valuation allowance for the amount of any tax benefits, which, more likely than not based on current circumstances, are not expected to be realized. As a result, no provision for income tax is reflected in the accompanying statements of operations. Should we achieve sufficient, sustained income in the future, we may conclude that some or all of the valuation allowance should be reversed. We are required to make many subjective assumptions and judgments regarding our income tax exposures. At June 30, 2022, we had no unrecognized tax benefits, which would affect the effective tax rate if recognized and had no accrued interest, or penalties related to uncertain tax positions.

 

Revenue Recognition

Revenue Recognition. We record revenue at a single point in time, when control is transferred to the customer. We will continue to apply our current business processes, policies, systems and controls to support recognition and disclosure. Our shipping policy is FOB Shipping Point. We recognize revenue from sales to stocking distributors when there is no right of return, other than for normal warranty claims. We have no ongoing obligations related to product sales, except for normal warranty obligations. As presented on the Statement of Operations our revenue is disaggregated between product revenue and service revenue. As it relates specifically to product revenue, we do not believe further disaggregation is necessary as substantially all of our product revenue comes from multiple products within a line of medical devices. Our engineering service contracts are billed on a time and materials basis and revenue is recognized over time as the services are performed.

 

Research and Development Expenses

Research and Development Expenses. We expense research and development costs for products and processes as incurred.

 

Stock-Based Compensation

Stock-Based Compensation. Stock-based compensation is presented in accordance with the guidance of ASC Topic 718, “Compensation – Stock Compensation” (“ASC 718”). Under the provisions of ASC 718, we are required to estimate the fair value of share-based payment awards on the date of grant using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods in our statements of operations.

 

Stock-based compensation expense recognized under ASC 718 for the three months ended June 30, 2022 and 2021 was $12,361 and $8,340, respectively, which consisted of stock-based compensation expense related to grants of employee stock options.

 

Segment Reporting

Segment Reporting. We have concluded that we have two operating segments, product and service. Product designs, develops, manufactures and markets patented surgical instruments. Service performs electrical engineering activities for external entities.

 

                              
  

Three Months Ended

June 30, 2022

  

Three Months Ended

June 30, 2021

 
  

 

Product

  

 

Service

  

 

Total

  

 

Product

  

 

Service

  

 

Total

 
Net revenue  $1,696,029   $458,333   $2,154,362   $1,718,404   $290,040   $2,008,444 
Cost of revenue   869,905          869,905    838,426    143,050    981,476 
Gross profit   826,124    458,333    1,284,457    879,978    146,990    1,026,968 
Operating income (loss)   (191,431)   458,333    266,902    (152,092)   146,990    (5,102)
Depreciation and amortization   20,087          20,087    26,783          26,783 
Patent and capital expenditures   62,329          62,329    14,281          14,281 
Equipment and patents, net  $412,258   $     $412,258   $370,016   $     $370,016 

 

Recently Issued Accounting Pronouncements

Recently Issued Accounting Pronouncements. In June 2016, the FASB issued ASU 2016-13, “Measurement of Credit Losses on Financial Instruments”. ASU 2016-13 adds a current expected credit loss (“CECL”) impairment model to U.S. GAAP that is based on expected losses rather than incurred losses. Modified retrospective adoption is required with any cumulative-effect adjustment recorded to retained earnings as of the beginning of the period of adoption. ASU 2016-13 is effective for fiscal years beginning after December 15, 2019, excluding smaller reporting entities, which will be effective for fiscal years beginning after December 15, 2022. We will adopt ASU 2016-13 beginning April 1, 2023 and do not expect the application of the CECL impairment model to have a significant impact on our allowance for uncollectible amounts for accounts receivable.

 

XML 27 R14.htm IDEA: XBRL DOCUMENT v3.22.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
3 Months Ended
Jun. 30, 2022
Accounting Policies [Abstract]  
Schedule of inventory
          
   June 30, 2022   March 31, 2022 
Raw materials  $1,318,891   $1,083,387 
Finished goods   514,712    536,934 
Total gross inventories   1,833,603    1,620,321 
Less reserve for obsolescence   (34,948)   (36,000)
Total net inventories  $1,798,655   $1,584,321 
Schedule of service performs electrical engineering activities for external entities
                              
  

Three Months Ended

June 30, 2022

  

Three Months Ended

June 30, 2021

 
  

 

Product

  

 

Service

  

 

Total

  

 

Product

  

 

Service

  

 

Total

 
Net revenue  $1,696,029   $458,333   $2,154,362   $1,718,404   $290,040   $2,008,444 
Cost of revenue   869,905          869,905    838,426    143,050    981,476 
Gross profit   826,124    458,333    1,284,457    879,978    146,990    1,026,968 
Operating income (loss)   (191,431)   458,333    266,902    (152,092)   146,990    (5,102)
Depreciation and amortization   20,087          20,087    26,783          26,783 
Patent and capital expenditures   62,329          62,329    14,281          14,281 
Equipment and patents, net  $412,258   $     $412,258   $370,016   $     $370,016 
XML 28 R15.htm IDEA: XBRL DOCUMENT v3.22.2
Basic and Diluted Income and Loss per Common Share (Tables)
3 Months Ended
Jun. 30, 2022
Earnings Per Share [Abstract]  
Schedule of basic and diluted net loss per share
          
   Three Months Ended 
    June 30, 2022   June 30, 2021 
Net (loss) income  $264,601   $(6,842)
Weighted-average basic shares outstanding   11,719,543    11,582,641 
Effect of dilutive securities   301,737       
Weighted-average diluted shares   12,021,280    11,582,641 
Basic net income (loss) per share  $0.02   $0.00 
Diluted net income (loss) per share  $0.02   $0.00 
 Antidilutive employee stock options   756,263    1,036,000 
XML 29 R16.htm IDEA: XBRL DOCUMENT v3.22.2
COMMITMENTS AND CONTINGENCIES (Tables)
3 Months Ended
Jun. 30, 2022
Lease Payment [Member]  
Defined Benefit Plan Disclosure [Line Items]  
Schedule of principal U.S. Bank payment
       
Fiscal Year   Amount 
 2023   $281,542 
 2024    386,667 
 2025    232,139 
 Total   $900,348 
E I D L Payment [Member]  
Defined Benefit Plan Disclosure [Line Items]  
Schedule of principal U.S. Bank payment
       
Fiscal Year   Amount 
 2023   $1,546 
 2024    3,208 
 2025    3,331 
 2026    3,457 
 Thereafter    148,018 
 Total   $159,560 
U S Bank Payment [Member]  
Defined Benefit Plan Disclosure [Line Items]  
Schedule of principal U.S. Bank payment
       
Fiscal Year   Amount 
 2023   $13,800 
 2024    18,400 
 2025    18,400 
 2026    13,800 
 Total   $64,400 
XML 30 R17.htm IDEA: XBRL DOCUMENT v3.22.2
SHARE-BASED COMPENSATION (Tables)
3 Months Ended
Jun. 30, 2022
Equity [Abstract]  
Schedule of summarizes stock-based compensation
          
   Three Months Ended 
   June 30, 2022   June 30, 2021 
Cost of sales  $158   $918 
Sales and marketing   1,656    1,218 
General and administrative   9,429    5,658 
Research and development   1,118    546 
Stock-based compensation expense  $12,361   $8,340 
XML 31 R18.htm IDEA: XBRL DOCUMENT v3.22.2
ORGANIZATION AND NATURE OF BUSINESS (Details Narrative) - USD ($)
3 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]      
Accumulated deficit $ 21,264,718   $ 21,529,319
Net income 264,601 $ (6,842)  
Stock options exercised $ 12,361    
XML 32 R19.htm IDEA: XBRL DOCUMENT v3.22.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)
Jun. 30, 2022
Mar. 31, 2022
Accounting Policies [Abstract]    
Raw materials $ 1,318,891 $ 1,083,387
Finished goods 514,712 536,934
Total gross inventories 1,833,603 1,620,321
Less reserve for obsolescence (34,948) (36,000)
Total net inventories $ 1,798,655 $ 1,584,321
XML 33 R20.htm IDEA: XBRL DOCUMENT v3.22.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1) - USD ($)
3 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Product Information [Line Items]    
Net revenue $ 2,154,362 $ 2,008,444
Cost of revenue 869,905 981,476
Gross profit 1,284,457 1,026,968
Operating income (loss) 266,902 (5,102)
Depreciation and amortization 20,087 26,783
Patent and capital expenditures 62,329 14,281
Equipment and patents, net 412,258 370,016
Product [Member]    
Product Information [Line Items]    
Net revenue 1,696,029 1,718,404
Cost of revenue 869,905 838,426
Gross profit 826,124 879,978
Operating income (loss) (191,431) (152,092)
Depreciation and amortization 20,087 26,783
Patent and capital expenditures 62,329 14,281
Equipment and patents, net 412,258 370,016
Service [Member]    
Product Information [Line Items]    
Net revenue 458,333 290,040
Cost of revenue 143,050
Gross profit 458,333 146,990
Operating income (loss) 458,333 146,990
Depreciation and amortization
Patent and capital expenditures
Equipment and patents, net
XML 34 R21.htm IDEA: XBRL DOCUMENT v3.22.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
3 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Mar. 31, 2022
Accounting Policies [Abstract]      
Federally insured limit $ 250,000    
Accounts receivable 921,123   $ 947,623
Depreciation expense 12,091 $ 14,877  
Unrecognized tax benefits 0    
Uncertain tax positions 0    
Stock based compensation $ 12,361 $ 8,340  
XML 35 R22.htm IDEA: XBRL DOCUMENT v3.22.2
BASIC AND DILUTED INCOME AND LOSS PER COMMON SHARE (Details) - USD ($)
3 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Earnings Per Share [Abstract]    
Net (loss) income $ 264,601 $ (6,842)
Weighted-average basic shares outstanding 11,719,543 11,582,641
Effect of dilutive securities 301,737
Weighted-average diluted shares 12,021,280 11,582,641
Basic net income (loss) per share $ 0.02 $ 0.00
Diluted net income (loss) per share 0.02 0.00
 Antidilutive employee stock options $ 756,263 $ 1,036,000
XML 36 R23.htm IDEA: XBRL DOCUMENT v3.22.2
COMMITMENTS AND CONTINGENCIES (Details) - Lease Payment [Member]
Jun. 30, 2022
USD ($)
Defined Benefit Plan Disclosure [Line Items]  
2023 $ 281,542
2024 386,667
2025 232,139
Total $ 900,348
XML 37 R24.htm IDEA: XBRL DOCUMENT v3.22.2
COMMITMENTS AND CONTINGENCIES (Details 1) - E I D L Payment [Member]
Jun. 30, 2022
USD ($)
Defined Benefit Plan Disclosure [Line Items]  
2023 $ 1,546
2024 3,208
2025 3,331
2026 3,457
Thereafter 148,018
Total $ 159,560
XML 38 R25.htm IDEA: XBRL DOCUMENT v3.22.2
COMMITMENTS AND CONTINGENCIES (Details 2) - U S Bank Payment [Member]
Jun. 30, 2022
USD ($)
Defined Benefit Plan Disclosure [Line Items]  
2023 $ 13,800
2024 18,400
2025 18,400
2026 13,800
Total $ 64,400
XML 39 R26.htm IDEA: XBRL DOCUMENT v3.22.2
COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended
Aug. 04, 2021
Aug. 01, 2020
Dec. 31, 2020
Sep. 30, 2021
Dec. 31, 2020
Feb. 08, 2021
Apr. 17, 2020
SBA [Member]              
Debt Instrument [Line Items]              
Proceed from loan $ 150,000            
EIDL [Member]              
Debt Instrument [Line Items]              
Principal amount   $ 150,000          
Interest rate   3.75%          
Debt Instrument, Maturity Date   Aug. 01, 2050          
PPPLoan [Member]              
Debt Instrument [Line Items]              
Principal amount           $ 533,118 $ 598,567
Debt Forgiveness         $ 598,567    
Extinguishment of debt income     $ 598,567 $ 533,118      
XML 40 R27.htm IDEA: XBRL DOCUMENT v3.22.2
SHARE-BASED COMPENSATION (Details) - USD ($)
3 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Stock-based compensation expense related to grants of employee stock options $ 12,361 $ 8,340
Cost of Sales [Member]    
Stock-based compensation expense related to grants of employee stock options 158 918
Selling and Marketing Expense [Member]    
Stock-based compensation expense related to grants of employee stock options 1,656 1,218
General and Administrative Expense [Member]    
Stock-based compensation expense related to grants of employee stock options 9,429 5,658
Research and Development Expense [Member]    
Stock-based compensation expense related to grants of employee stock options $ 1,118 $ 546
XML 41 R28.htm IDEA: XBRL DOCUMENT v3.22.2
SHARE-BASED COMPENSATION (Details Narrative) - USD ($)
3 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Equity [Abstract]    
Stock options granted 0 0
Number of shares exercised 0 0
Stock options forfeited 0 0
Unrecognized compensation costs $ 182,000  
XML 42 R29.htm IDEA: XBRL DOCUMENT v3.22.2
RELATED PARTY TRANSACTION (Details Narrative) - USD ($)
3 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Director [Member]    
Related Party Transaction [Line Items]    
Consulting fees paid $ 13,728 $ 28,816
XML 43 ecia_10q-063022_htm.xml IDEA: XBRL DOCUMENT 0000930775 2022-04-01 2022-06-30 0000930775 2022-07-31 0000930775 2022-06-30 0000930775 2022-03-31 0000930775 2021-04-01 2021-06-30 0000930775 us-gaap:ProductMember 2022-04-01 2022-06-30 0000930775 us-gaap:ProductMember 2021-04-01 2021-06-30 0000930775 us-gaap:ServiceMember 2022-04-01 2022-06-30 0000930775 us-gaap:ServiceMember 2021-04-01 2021-06-30 0000930775 2021-03-31 0000930775 2021-06-30 0000930775 ecia:LeasePaymentMember 2022-04-01 2022-06-30 0000930775 ecia:EIDLPaymentMember 2022-04-01 2022-06-30 0000930775 ecia:USBankPaymentMember 2022-04-01 2022-06-30 0000930775 ecia:LeasePaymentMember 2022-06-30 0000930775 ecia:SBAMember 2021-08-01 2021-08-04 0000930775 ecia:EIDLMember 2020-08-01 0000930775 ecia:EIDLMember 2020-07-30 2020-08-01 0000930775 ecia:PPPLoanMember 2020-04-17 0000930775 ecia:PPPLoanMember 2020-10-01 2020-12-31 0000930775 ecia:PPPLoanMember 2020-12-01 2020-12-31 0000930775 ecia:PPPLoanMember 2021-02-08 0000930775 ecia:PPPLoanMember 2021-07-01 2021-09-30 0000930775 ecia:EIDLPaymentMember 2022-06-30 0000930775 ecia:USBankPaymentMember 2022-06-30 0000930775 us-gaap:CostOfSalesMember 2022-04-01 2022-06-30 0000930775 us-gaap:CostOfSalesMember 2021-04-01 2021-06-30 0000930775 us-gaap:SellingAndMarketingExpenseMember 2022-04-01 2022-06-30 0000930775 us-gaap:SellingAndMarketingExpenseMember 2021-04-01 2021-06-30 0000930775 us-gaap:GeneralAndAdministrativeExpenseMember 2022-04-01 2022-06-30 0000930775 us-gaap:GeneralAndAdministrativeExpenseMember 2021-04-01 2021-06-30 0000930775 us-gaap:ResearchAndDevelopmentExpenseMember 2022-04-01 2022-06-30 0000930775 us-gaap:ResearchAndDevelopmentExpenseMember 2021-04-01 2021-06-30 0000930775 srt:DirectorMember 2022-04-01 2022-06-30 0000930775 srt:DirectorMember 2021-04-01 2021-06-30 iso4217:USD shares iso4217:USD shares pure 0000930775 false --03-31 2023 Q1 10-Q true 2022-06-30 false 001-11789 ENCISION INC. CO 84-1162056 6797 Winchester Circle Boulder CO 80301 (303) 444-2600 Common Stock, no par value ECIA Yes Yes Non-accelerated Filer true false false 11719543 827944 949645 921123 947623 34948 36000 1798655 1584321 101287 120133 3649009 3601722 2499871 2468949 2265202 2279652 234669 189297 715349 786407 290077 282081 177589 180719 42198 34240 4818814 4792385 388077 576381 23154 21491 221678 190853 114835 125179 370677 362487 1118421 1276391 200806 205809 476761 564321 1795988 2046521 10000000 10000000 0 0 0 0 0 0 100000000 100000000 11719543 11719543 11719543 11719543 24287544 24275183 -21264718 -21529319 3022826 2745864 4818814 4792385 1696029 1718404 458333 290040 2154362 2008444 869905 838426 143050 869905 981476 1284457 1026968 502967 528474 344119 326721 170469 176875 1017555 1032070 266902 -5102 2363 1806 61 66 -2302 -1740 264601 -6842 264601 -6842 0.02 0.00 11719543 11582641 12021280 11582641 264601 -6842 20087 26783 12361 8340 -25000 -1052 -49000 8312 4687 -26500 91601 213282 96813 -10888 -44049 -188304 131938 20481 -65216 -56032 -128049 57463 6720 4866 7561 -62329 -14281 3340 3340 -3340 -3340 -121701 -145670 949645 1474339 827944 1328669 2363 1806 <p id="xdx_80A_eus-gaap--NatureOfOperations_zF8OdFJCSSMg" style="font: 10pt Times New Roman, Times, Serif; margin: 0">Note 1. <span style="text-decoration: underline"><span id="xdx_82C_zWBrWZ0kMAgi">ORGANIZATION AND NATURE OF BUSINESS</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Encision Inc. is a medical device company that designs, develops, manufactures and markets patented surgical instruments that provide greater safety to, and saves lives of, patients undergoing minimally-invasive surgery. We believe that our patented AEM<sup>®</sup> (Active Electrode Monitoring) surgical instrument technology is changing the marketplace for electrosurgical devices and instruments by providing a solution to a patient safety risk in laparoscopic surgery. Our sales to date have been made principally in the United States.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have an accumulated deficit of $<span id="xdx_90F_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pp0p0_di_c20220630_zbZdX694XxR9" title="Accumulated deficit">21,264,718</span> at June 30, 2022. A significant portion of our operating funds have been provided by issuances of our common stock and warrants, the exercise of stock options to purchase our common stock, loans, and (in some periods) by operating profits. Shareholders’ equity increased by $276,962 since March 31, 2022 as a result of our net income of $<span id="xdx_902_eus-gaap--NetIncomeLoss_c20220401__20220630_pp0p0" title="Net income">264,601</span> and share-based compensation of $<span id="xdx_909_eus-gaap--ProceedsFromStockOptionsExercised_c20220401__20220630_pp0p0" title="Stock options exercised">12,361</span>. Should our liquidity be diminished in the future because of operating losses, we may be required to seek additional capital.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our strategic marketing and sales plan is designed to expand the use of our products in surgically active hospitals and surgery centers in the United States.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have been actively monitoring the coronavirus (“COVID”) situation and its impact globally. Our production facilities continued to operate during the year as they had prior to the COVID pandemic with minimal change, other than for enhanced safety measures intended to prevent the spread of the virus. The remote working arrangements and travel restrictions imposed by various governments had limited impact on our ability to maintain operations during the year, as our manufacturing operations have generally been exempted from stay-at-home orders. However, we cannot predict the impact of the progression of the COVID pandemic on future results due to a variety of factors, including the continued good health of our employees, the ability of suppliers to continue to operate and deliver, our ability and our customers to maintain operations, continued access to transportation resources, the changing needs and priorities of customers, any further government and/or public actions taken in response to the pandemic and ultimately the length of the pandemic. We will continue to closely monitor the COVID pandemic in order to ensure the safety of our people and our ability to serve our customers and patients worldwide.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> -21264718 264601 12361 <p id="xdx_80B_eus-gaap--BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_zR4RZfK0kohi" style="font: 10pt Times New Roman, Times, Serif; margin: 0">Note 2. <span style="text-decoration: underline"><span id="xdx_820_zyklv0fslVxl">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p id="xdx_84E_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zbupX9jDBMc8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_86B_zPgPi9EEoqyf">Basis of Presentation</span>.</span> The condensed interim financial statements included herein have been prepared by us, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles accepted in the United States (“GAAP”) have been condensed or omitted pursuant to such rules and regulations, although we believe that the disclosures made are adequate to make the information presented not misleading. The condensed interim financial statements and notes thereto should be read in conjunction with the financial statements and the notes thereto included in our Annual Report on Form 10-K for the fiscal year ended March 31, 2022 filed on July 13, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying condensed interim financial statements have been prepared, in all material respects, in conformity with the standards of accounting measurements and reflect, in the opinion of management, all adjustments necessary to summarize fairly the financial position and results of operations for such periods in accordance with GAAP. All adjustments are of a normal recurring nature. The results of operations for the most recent interim period are not necessarily indicative of the results to be expected for the full year.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_84E_eus-gaap--UseOfEstimates_zPxxRbhjIznb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_866_zYH8KJcgyaGa">Use of Estimates in the Preparation of Financial Statements</span>.</span> The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions. Such estimates and assumptions affect the reported amounts of assets and liabilities as well as disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of sales and expense during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_84D_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_zwauvFmfodcc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_864_zWDEbrVn6WJ6">Cash and Cash Equivalents</span>.</span> For purposes of reporting cash flows, we consider all cash and highly liquid investments with an original maturity of three months or less to be cash equivalents.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_849_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zWgI8AYibvTj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_86D_za8F4R1nPFji">Fair Value of Financial Instruments</span>.</span> Our financial instruments consist of cash, trade receivables, payables and Economic Injury Disaster Loan (“EIDL”) loan. The carrying values of cash and trade receivables approximate their fair value due to their short maturities.The fair values of the EIDL Loan approximates the carrying value based on estimated discounted future cash flows using the current rates at which similar loans would be made.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_846_eus-gaap--ConcentrationRiskCreditRisk_ztKhFpQBwU0k" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_86B_z0v2PTXly4tf">Concentration of Credit Risk</span>.</span> Financial instruments, which potentially subject us to concentrations of credit risk, consist of cash and accounts receivable. From time to time, the amount of cash on deposit with financial institutions may exceed the $<span id="xdx_900_eus-gaap--CashFDICInsuredAmount_c20220630_pp0p0" title="Federally insured limit">250,000</span> federally insured limit at June 30, 2022. We believe that our cash on deposit that exceeds $250,000 with financial institutions is financially sound and the risk of loss is minimal.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have no significant off-balance sheet concentrations of credit risk such as foreign exchange contracts, options contracts or other foreign hedging arrangements. We maintain the majority of our cash balances with one financial institution in the form of demand deposits.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Accounts receivable are typically unsecured and are derived from transactions with and from entities in the healthcare industry primarily located in the United States. Accordingly, we may be exposed to credit risk generally associated with the healthcare industry. We maintain allowances for doubtful accounts for estimated losses resulting from the inability of our customers to make required payments. The net accounts receivable balance at June 30, 2022 of $<span id="xdx_905_eus-gaap--AccountsReceivableNetCurrent_c20220630_pp0p0" title="Accounts receivable">921,123</span> and at March 31, 2022 of $<span id="xdx_90E_eus-gaap--AccountsReceivableNetCurrent_iI_pp0p0_c20220331_zu5mhwwCtXFf" title="Accounts receivable">947,623</span> included no more than 12% from any one customer.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_843_eus-gaap--InventoryPolicyTextBlock_zwMNIhDke1Ii" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_867_zACsnBGTbzUj">Inventories</span></span>. Inventories are stated at the lower of cost (first-in, first-out basis) or net realizable value. We reduce inventory for estimated obsolete or unmarketable inventory equal to the difference between the cost of inventory and the net realizable value based upon assumptions about future demand and market conditions. If actual market conditions are less favorable than those projected by management, additional inventory write-downs may be required. At June 30, 2022 and March 31, 2022 inventory consisted of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="text-underline-style: double"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_ztjlb4lybL93" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 5.4pt"><span id="xdx_8B2_zr5AKL0cABN6" style="display: none">Schedule of inventory</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_494_20220630_z9a5hXQ92hPi" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_493_20220331_z38cMw1t70Gh" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">June 30, 2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">March 31, 2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr id="xdx_402_eus-gaap--InventoryRawMaterials_iI_pp0p0_maIGz5Xl_z2GnnMmJJus5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%; text-align: left; padding-left: 5.4pt">Raw materials</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">1,318,891</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">1,083,387</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--InventoryFinishedGoods_iI_pp0p0_maIGz5Xl_zQiqGxg8kUKf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Finished goods</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">514,712</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">536,934</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--InventoryGross_iTI_pp0p0_mtIGz5Xl_maINz837_zN4tQiM5Nszc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 5.4pt">Total gross inventories</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,833,603</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,620,321</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--InventoryValuationReserves_iNI_pp0p0_di_msINz837_zCuajOzbUfK1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Less reserve for obsolescence</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(34,948</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(36,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_407_eus-gaap--InventoryNet_iTI_pp0p0_mtINz837_zh3PHTXooZza" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Total net inventories</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1,798,655</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1,584,321</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> </table> <p id="xdx_8A9_zJnfvSBE2iNc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_84E_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zlhcbUCbGM75" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_86D_zn3ewwHgpwM3">Property and Equipment</span></span>. Property and equipment are stated at cost, with depreciation computed over the estimated useful lives of the assets, generally five to seven years. Depreciation expense for the three months ended June 30, 2022 and 2021 was $<span id="xdx_908_eus-gaap--Depreciation_c20220401__20220630_pp0p0" title="Depreciation expense">12,091</span> and $<span id="xdx_90A_eus-gaap--Depreciation_c20210401__20210630_pp0p0" title="Depreciation expense">14,877</span>, respectively. We use the straight-line method of depreciation for property and equipment. Leasehold improvements are depreciated over the shorter of the remaining lease term or the estimated useful life of the asset. Maintenance and repairs are expense as incurred and major additions, replacements and improvements are capitalized.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_842_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zTA9ENv6UTUl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_863_zZIweOUbiQI7">Long-Lived Assets</span>.</span> Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. A long-lived asset is considered impaired when estimated future cash flows related to the asset, undiscounted and without interest, are insufficient to recover the carrying amount of the asset. If deemed impaired, the long-lived asset is reduced to its estimated fair value. Long-lived assets to be disposed of are reported at the lower of their carrying amount or estimated fair value less cost to sell.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_84E_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zngBodClZkL3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_868_zyK56FutvT8d">Patents</span>.</span> The costs of applying for patents are capitalized and amortized on a straight-line basis over the lesser of the patent’s economic or legal life (20 years from the date of application in the United States). Capitalized costs are expensed if patents are not issued. We review the carrying value of our patents periodically to determine whether the patents have continuing value and such reviews could result in the conclusion that the recorded amounts have been impaired.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_84A_eus-gaap--IncomeTaxPolicyTextBlock_zr845kKVRIw2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_867_zwj2Vcl9A0m7">Income Taxes</span>.</span> We account for income taxes under the provisions of FASB Accounting Standards Codification (“ASC”) Topic 740, “Accounting for Income Taxes” (“ASC 740”). ASC 740 requires recognition of deferred income tax assets and liabilities for the expected future income tax consequences, based on enacted tax laws, of temporary differences between the financial reporting and tax bases of assets and liabilities. ASC 740 also requires recognition of deferred tax assets for the expected future tax effects of all deductible temporary differences, loss carryforwards and tax credit carryforwards. Deferred tax assets are then reduced, if deemed necessary, by a valuation allowance for the amount of any tax benefits, which, more likely than not based on current circumstances, are not expected to be realized. As a result, no provision for income tax is reflected in the accompanying statements of operations. Should we achieve sufficient, sustained income in the future, we may conclude that some or all of the valuation allowance should be reversed. We are required to make many subjective assumptions and judgments regarding our income tax exposures. At June 30, 2022, we had <span id="xdx_90D_eus-gaap--UnrecognizedTaxBenefits_iI_pp0p0_do_c20220630_z2dFMpRlFgv5" title="Unrecognized tax benefits">no</span> unrecognized tax benefits, which would affect the effective tax rate if recognized and had <span id="xdx_906_eus-gaap--LiabilityForUncertainTaxPositionsCurrent_iI_pp0p0_do_c20220630_zClokvZSWVx7" title="Uncertain tax positions">no</span> accrued interest, or penalties related to uncertain tax positions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_845_eus-gaap--RevenueRecognitionPolicyTextBlock_zyw84ngkRVlj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_864_zU9Y1orlq8d7">Revenue Recognition</span>.</span> We record revenue at a single point in time, when control is transferred to the customer. We will continue to apply our current business processes, policies, systems and controls to support recognition and disclosure. Our shipping policy is FOB Shipping Point. We recognize revenue from sales to stocking distributors when there is no right of return, other than for normal warranty claims. We have no ongoing obligations related to product sales, except for normal warranty obligations. As presented on the Statement of Operations our revenue is disaggregated between product revenue and service revenue. As it relates specifically to product revenue, we do not believe further disaggregation is necessary as substantially all of our product revenue comes from multiple products within a line of medical devices. Our engineering service contracts are billed on a time and materials basis and revenue is recognized over time as the services are performed.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_840_eus-gaap--ResearchAndDevelopmentExpensePolicy_zU0VbF8x0noi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_861_zYvTdYSqOypi">Research and Development Expenses</span></span>. We expense research and development costs for products and processes as incurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_846_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zEPUp4SVJfi7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_868_zvrK6omlu9h9">Stock-Based Compensation</span></span>. Stock-based compensation is presented in accordance with the guidance of ASC Topic 718, “Compensation – Stock Compensation” (“ASC 718”). Under the provisions of ASC 718, we are required to estimate the fair value of share-based payment awards on the date of grant using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods in our statements of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Stock-based compensation expense recognized under ASC 718 for the three months ended June 30, 2022 and 2021 was $<span id="xdx_908_eus-gaap--ShareBasedCompensation_c20220401__20220630_pp0p0" title="Stock based compensation">12,361</span> and $<span id="xdx_907_eus-gaap--ShareBasedCompensation_c20210401__20210630_pp0p0" title="Stock based compensation">8,340</span>, respectively, which consisted of stock-based compensation expense related to grants of employee stock options.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_846_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zImriJyxsSnh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_861_zFy3mD5FKO1j">Segment Reporting</span>.</span> We have concluded that we have two operating segments, product and service. Product designs, develops, manufactures and markets patented surgical instruments. Service performs electrical engineering activities for external entities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_881_ecustom--ScheduleOfServicePerformsElectricalEngineeringActivitiesForExternalEntitiesTableTextBlock_z8e2JsVjvFPi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 5.4pt"><span id="xdx_8B3_z4VwKr2iCo38" style="display: none">Schedule of service performs electrical engineering activities for external entities</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="10" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold; vertical-align: bottom"><p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt">Three Months Ended</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt">June 30, 2022</span></p></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="10" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt">Three Months Ended</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt">June 30, 2021</span></p></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt"><span style="font-size: 8pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 8pt"><b> </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 8pt"><b>Product</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 8pt"><b> </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 8pt"><b>Service</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 8pt"><b> </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt"><b>Total</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 8pt"><b> </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 8pt"><b>Product</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 8pt"><b> </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 8pt"><b>Service</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 8pt"><b> </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 8pt"><b>Total</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left; padding-left: 5.4pt">Net revenue</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--Revenues_pp0p0_c20220401__20220630__srt--ProductOrServiceAxis__us-gaap--ProductMember_zYRTuDcYA4Jh" style="width: 7%; text-align: right" title="Net revenue">1,696,029</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--Revenues_c20220401__20220630__srt--ProductOrServiceAxis__us-gaap--ServiceMember_pp0p0" style="width: 7%; text-align: right" title="Net revenue">458,333</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--Revenues_pp0p0_c20220401__20220630_zolF7xavln93" style="width: 7%; text-align: right" title="Net revenue">2,154,362</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--Revenues_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__us-gaap--ProductMember_zPHY6TLuNE2c" style="width: 7%; text-align: right" title="Net revenue">1,718,404</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--Revenues_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__us-gaap--ServiceMember_zpoNoH1jKCQk" style="width: 7%; text-align: right" title="Net revenue">290,040</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--Revenues_pp0p0_c20210401__20210630_zDjJxIww58vg" style="width: 7%; text-align: right" title="Net revenue">2,008,444</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 5.4pt">Cost of revenue</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--CostOfRevenue_c20220401__20220630__srt--ProductOrServiceAxis__us-gaap--ProductMember_pp0p0" style="text-align: right" title="Cost of revenue">869,905</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--CostOfRevenue_pp0p0_c20220401__20220630__srt--ProductOrServiceAxis__us-gaap--ServiceMember_zANqoP6Xaqvi" style="text-align: right" title="Cost of revenue"><span style="-sec-ix-hidden: xdx2ixbrl0428">—</span>  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--CostOfRevenue_pp0p0_c20220401__20220630_zyjlgf0gHKXg" style="text-align: right" title="Cost of revenue">869,905</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--CostOfRevenue_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__us-gaap--ProductMember_zEua8EoJ0pFd" style="text-align: right" title="Cost of revenue">838,426</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--CostOfRevenue_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__us-gaap--ServiceMember_zJnzXGR4XIib" style="text-align: right" title="Cost of revenue">143,050</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--CostOfRevenue_pp0p0_c20210401__20210630_zwitqMteNbi5" style="text-align: right" title="Cost of revenue">981,476</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 5.4pt">Gross profit</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--GrossProfit_c20220401__20220630__srt--ProductOrServiceAxis__us-gaap--ProductMember_pp0p0" style="text-align: right" title="Gross profit">826,124</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--GrossProfit_c20220401__20220630__srt--ProductOrServiceAxis__us-gaap--ServiceMember_pp0p0" style="text-align: right" title="Gross profit">458,333</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--GrossProfit_c20220401__20220630_pp0p0" style="text-align: right" title="Gross profit">1,284,457</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--GrossProfit_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__us-gaap--ProductMember_zJZvTli9yyQ6" style="text-align: right" title="Gross profit">879,978</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--GrossProfit_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__us-gaap--ServiceMember_zmpizZJoCbdf" style="text-align: right" title="Gross profit">146,990</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--GrossProfit_pp0p0_c20210401__20210630_zPdcmjOA6mx8" style="text-align: right" title="Gross profit">1,026,968</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 5.4pt">Operating income (loss)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--OperatingIncomeLoss_c20220401__20220630__srt--ProductOrServiceAxis__us-gaap--ProductMember_pp0p0" style="text-align: right" title="Operating income (loss)">(191,431</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--OperatingIncomeLoss_c20220401__20220630__srt--ProductOrServiceAxis__us-gaap--ServiceMember_pp0p0" style="text-align: right" title="Operating income (loss)">458,333</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--OperatingIncomeLoss_c20220401__20220630_pp0p0" style="text-align: right" title="Operating income (loss)">266,902</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--OperatingIncomeLoss_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__us-gaap--ProductMember_zQPJ1hu6zURa" style="text-align: right" title="Operating income (loss)">(152,092</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--OperatingIncomeLoss_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__us-gaap--ServiceMember_zafjBXJNoJ75" style="text-align: right" title="Operating income (loss)">146,990</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--OperatingIncomeLoss_pp0p0_c20210401__20210630_zDCVEvqxmfda" style="text-align: right" title="Operating income (loss)">(5,102</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 5.4pt">Depreciation and amortization</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--DepreciationAndAmortization_c20220401__20220630__srt--ProductOrServiceAxis__us-gaap--ProductMember_pp0p0" style="text-align: right" title="Depreciation and amortization">20,087</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--DepreciationAndAmortization_c20220401__20220630__srt--ProductOrServiceAxis__us-gaap--ServiceMember_pdp0" style="text-align: right" title="Depreciation and amortization"><span style="-sec-ix-hidden: xdx2ixbrl0464">—</span>  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--DepreciationAndAmortization_c20220401__20220630_pp0p0" style="text-align: right" title="Depreciation and amortization">20,087</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--DepreciationAndAmortization_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__us-gaap--ProductMember_zb6NgEDTfC9c" style="text-align: right" title="Depreciation and amortization">26,783</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--DepreciationAndAmortization_pdp0_c20210401__20210630__srt--ProductOrServiceAxis__us-gaap--ServiceMember_zeoIcMBTv6J5" style="text-align: right" title="Depreciation and amortization"><span style="-sec-ix-hidden: xdx2ixbrl0470">—</span>  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--DepreciationAndAmortization_pp0p0_c20210401__20210630_z6uJj05lTLq3" style="text-align: right" title="Depreciation and amortization">26,783</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 5.4pt">Patent and capital expenditures</td><td style="font-size: 12pt"> </td> <td style="font-size: 12pt; text-align: left"> </td><td id="xdx_98A_eus-gaap--CapitalExpenditureDiscontinuedOperations_c20220401__20220630__srt--ProductOrServiceAxis__us-gaap--ProductMember_pp0p0" style="font-size: 10pt; text-align: right" title="Patent and capital expenditures">62,329</td><td style="font-size: 12pt; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--CapitalExpenditureDiscontinuedOperations_c20220401__20220630__srt--ProductOrServiceAxis__us-gaap--ServiceMember_pdp0" style="text-align: right" title="Patent and capital expenditures"><span style="-sec-ix-hidden: xdx2ixbrl0476">—</span>  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--CapitalExpenditureDiscontinuedOperations_c20220401__20220630_pp0p0" style="text-align: right" title="Patent and capital expenditures">62,329</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--CapitalExpenditureDiscontinuedOperations_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__us-gaap--ProductMember_zGR2vAoDiahb" style="text-align: right" title="Patent and capital expenditures">14,281</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--CapitalExpenditureDiscontinuedOperations_pdp0_c20210401__20210630__srt--ProductOrServiceAxis__us-gaap--ServiceMember_z1P5nNOtq4eb" style="text-align: right" title="Patent and capital expenditures"><span style="-sec-ix-hidden: xdx2ixbrl0482">—</span>  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--CapitalExpenditureDiscontinuedOperations_pp0p0_c20210401__20210630_zxNFMJG4GTT2" style="text-align: right" title="Patent and capital expenditures">14,281</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 5.4pt">Equipment and patents, net</td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_ecustom--EquipmentAndPatentsNet_pp0p0_c20220401__20220630__srt--ProductOrServiceAxis__us-gaap--ProductMember_z86XRG9RRJMc" style="text-align: right" title="Equipment and patents, net">412,258</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_ecustom--EquipmentAndPatentsNet_pdp0_c20220401__20220630__srt--ProductOrServiceAxis__us-gaap--ServiceMember_z3tu9BPefu95" style="text-align: right" title="Equipment and patents, net"><span style="-sec-ix-hidden: xdx2ixbrl0488">—</span>  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_ecustom--EquipmentAndPatentsNet_pp0p0_c20220401__20220630_zaUiXnrKV4V9" style="text-align: right" title="Equipment and patents, net">412,258</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_ecustom--EquipmentAndPatentsNet_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__us-gaap--ProductMember_zCVlWuY9vUnj" style="text-align: right" title="Equipment and patents, net">370,016</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_ecustom--EquipmentAndPatentsNet_pdp0_c20210401__20210630__srt--ProductOrServiceAxis__us-gaap--ServiceMember_zUrCAGaVxtqg" style="text-align: right" title="Equipment and patents, net"><span style="-sec-ix-hidden: xdx2ixbrl0494">—</span>  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_ecustom--EquipmentAndPatentsNet_pp0p0_c20210401__20210630_zIBhtJW8QHtc" style="text-align: right" title="Equipment and patents, net">370,016</td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_84C_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zgZ9znj6wv1h" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_864_zZuivL9PE4m1">Recently Issued Accounting Pronouncements</span>.</span> In June 2016, the FASB issued ASU 2016-13, “Measurement of Credit Losses on Financial Instruments”. ASU 2016-13 adds a current expected credit loss (“CECL”) impairment model to U.S. GAAP that is based on expected losses rather than incurred losses. Modified retrospective adoption is required with any cumulative-effect adjustment recorded to retained earnings as of the beginning of the period of adoption. ASU 2016-13 is effective for fiscal years beginning after December 15, 2019, excluding smaller reporting entities, which will be effective for fiscal years beginning after December 15, 2022. We will adopt ASU 2016-13 beginning April 1, 2023 and do not expect the application of the CECL impairment model to have a significant impact on our allowance for uncollectible amounts for accounts receivable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-transform: uppercase"> </span></p> <p id="xdx_84E_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zbupX9jDBMc8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_86B_zPgPi9EEoqyf">Basis of Presentation</span>.</span> The condensed interim financial statements included herein have been prepared by us, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles accepted in the United States (“GAAP”) have been condensed or omitted pursuant to such rules and regulations, although we believe that the disclosures made are adequate to make the information presented not misleading. The condensed interim financial statements and notes thereto should be read in conjunction with the financial statements and the notes thereto included in our Annual Report on Form 10-K for the fiscal year ended March 31, 2022 filed on July 13, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying condensed interim financial statements have been prepared, in all material respects, in conformity with the standards of accounting measurements and reflect, in the opinion of management, all adjustments necessary to summarize fairly the financial position and results of operations for such periods in accordance with GAAP. All adjustments are of a normal recurring nature. The results of operations for the most recent interim period are not necessarily indicative of the results to be expected for the full year.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_84E_eus-gaap--UseOfEstimates_zPxxRbhjIznb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_866_zYH8KJcgyaGa">Use of Estimates in the Preparation of Financial Statements</span>.</span> The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions. Such estimates and assumptions affect the reported amounts of assets and liabilities as well as disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of sales and expense during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_84D_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_zwauvFmfodcc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_864_zWDEbrVn6WJ6">Cash and Cash Equivalents</span>.</span> For purposes of reporting cash flows, we consider all cash and highly liquid investments with an original maturity of three months or less to be cash equivalents.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_849_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zWgI8AYibvTj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_86D_za8F4R1nPFji">Fair Value of Financial Instruments</span>.</span> Our financial instruments consist of cash, trade receivables, payables and Economic Injury Disaster Loan (“EIDL”) loan. The carrying values of cash and trade receivables approximate their fair value due to their short maturities.The fair values of the EIDL Loan approximates the carrying value based on estimated discounted future cash flows using the current rates at which similar loans would be made.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_846_eus-gaap--ConcentrationRiskCreditRisk_ztKhFpQBwU0k" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_86B_z0v2PTXly4tf">Concentration of Credit Risk</span>.</span> Financial instruments, which potentially subject us to concentrations of credit risk, consist of cash and accounts receivable. From time to time, the amount of cash on deposit with financial institutions may exceed the $<span id="xdx_900_eus-gaap--CashFDICInsuredAmount_c20220630_pp0p0" title="Federally insured limit">250,000</span> federally insured limit at June 30, 2022. We believe that our cash on deposit that exceeds $250,000 with financial institutions is financially sound and the risk of loss is minimal.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have no significant off-balance sheet concentrations of credit risk such as foreign exchange contracts, options contracts or other foreign hedging arrangements. We maintain the majority of our cash balances with one financial institution in the form of demand deposits.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Accounts receivable are typically unsecured and are derived from transactions with and from entities in the healthcare industry primarily located in the United States. Accordingly, we may be exposed to credit risk generally associated with the healthcare industry. We maintain allowances for doubtful accounts for estimated losses resulting from the inability of our customers to make required payments. The net accounts receivable balance at June 30, 2022 of $<span id="xdx_905_eus-gaap--AccountsReceivableNetCurrent_c20220630_pp0p0" title="Accounts receivable">921,123</span> and at March 31, 2022 of $<span id="xdx_90E_eus-gaap--AccountsReceivableNetCurrent_iI_pp0p0_c20220331_zu5mhwwCtXFf" title="Accounts receivable">947,623</span> included no more than 12% from any one customer.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> 250000 921123 947623 <p id="xdx_843_eus-gaap--InventoryPolicyTextBlock_zwMNIhDke1Ii" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_867_zACsnBGTbzUj">Inventories</span></span>. Inventories are stated at the lower of cost (first-in, first-out basis) or net realizable value. We reduce inventory for estimated obsolete or unmarketable inventory equal to the difference between the cost of inventory and the net realizable value based upon assumptions about future demand and market conditions. If actual market conditions are less favorable than those projected by management, additional inventory write-downs may be required. At June 30, 2022 and March 31, 2022 inventory consisted of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="text-underline-style: double"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_ztjlb4lybL93" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 5.4pt"><span id="xdx_8B2_zr5AKL0cABN6" style="display: none">Schedule of inventory</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_494_20220630_z9a5hXQ92hPi" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_493_20220331_z38cMw1t70Gh" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">June 30, 2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">March 31, 2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr id="xdx_402_eus-gaap--InventoryRawMaterials_iI_pp0p0_maIGz5Xl_z2GnnMmJJus5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%; text-align: left; padding-left: 5.4pt">Raw materials</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">1,318,891</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">1,083,387</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--InventoryFinishedGoods_iI_pp0p0_maIGz5Xl_zQiqGxg8kUKf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Finished goods</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">514,712</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">536,934</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--InventoryGross_iTI_pp0p0_mtIGz5Xl_maINz837_zN4tQiM5Nszc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 5.4pt">Total gross inventories</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,833,603</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,620,321</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--InventoryValuationReserves_iNI_pp0p0_di_msINz837_zCuajOzbUfK1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Less reserve for obsolescence</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(34,948</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(36,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_407_eus-gaap--InventoryNet_iTI_pp0p0_mtINz837_zh3PHTXooZza" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Total net inventories</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1,798,655</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1,584,321</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> </table> <p id="xdx_8A9_zJnfvSBE2iNc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_ztjlb4lybL93" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 5.4pt"><span id="xdx_8B2_zr5AKL0cABN6" style="display: none">Schedule of inventory</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_494_20220630_z9a5hXQ92hPi" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_493_20220331_z38cMw1t70Gh" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">June 30, 2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">March 31, 2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr id="xdx_402_eus-gaap--InventoryRawMaterials_iI_pp0p0_maIGz5Xl_z2GnnMmJJus5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%; text-align: left; padding-left: 5.4pt">Raw materials</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">1,318,891</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">1,083,387</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--InventoryFinishedGoods_iI_pp0p0_maIGz5Xl_zQiqGxg8kUKf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Finished goods</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">514,712</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">536,934</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--InventoryGross_iTI_pp0p0_mtIGz5Xl_maINz837_zN4tQiM5Nszc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 5.4pt">Total gross inventories</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,833,603</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,620,321</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--InventoryValuationReserves_iNI_pp0p0_di_msINz837_zCuajOzbUfK1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Less reserve for obsolescence</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(34,948</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(36,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_407_eus-gaap--InventoryNet_iTI_pp0p0_mtINz837_zh3PHTXooZza" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Total net inventories</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1,798,655</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1,584,321</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> </table> 1318891 1083387 514712 536934 1833603 1620321 34948 36000 1798655 1584321 <p id="xdx_84E_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zlhcbUCbGM75" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_86D_zn3ewwHgpwM3">Property and Equipment</span></span>. Property and equipment are stated at cost, with depreciation computed over the estimated useful lives of the assets, generally five to seven years. Depreciation expense for the three months ended June 30, 2022 and 2021 was $<span id="xdx_908_eus-gaap--Depreciation_c20220401__20220630_pp0p0" title="Depreciation expense">12,091</span> and $<span id="xdx_90A_eus-gaap--Depreciation_c20210401__20210630_pp0p0" title="Depreciation expense">14,877</span>, respectively. We use the straight-line method of depreciation for property and equipment. Leasehold improvements are depreciated over the shorter of the remaining lease term or the estimated useful life of the asset. Maintenance and repairs are expense as incurred and major additions, replacements and improvements are capitalized.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> 12091 14877 <p id="xdx_842_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zTA9ENv6UTUl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_863_zZIweOUbiQI7">Long-Lived Assets</span>.</span> Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. A long-lived asset is considered impaired when estimated future cash flows related to the asset, undiscounted and without interest, are insufficient to recover the carrying amount of the asset. If deemed impaired, the long-lived asset is reduced to its estimated fair value. Long-lived assets to be disposed of are reported at the lower of their carrying amount or estimated fair value less cost to sell.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_84E_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zngBodClZkL3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_868_zyK56FutvT8d">Patents</span>.</span> The costs of applying for patents are capitalized and amortized on a straight-line basis over the lesser of the patent’s economic or legal life (20 years from the date of application in the United States). Capitalized costs are expensed if patents are not issued. We review the carrying value of our patents periodically to determine whether the patents have continuing value and such reviews could result in the conclusion that the recorded amounts have been impaired.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_84A_eus-gaap--IncomeTaxPolicyTextBlock_zr845kKVRIw2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_867_zwj2Vcl9A0m7">Income Taxes</span>.</span> We account for income taxes under the provisions of FASB Accounting Standards Codification (“ASC”) Topic 740, “Accounting for Income Taxes” (“ASC 740”). ASC 740 requires recognition of deferred income tax assets and liabilities for the expected future income tax consequences, based on enacted tax laws, of temporary differences between the financial reporting and tax bases of assets and liabilities. ASC 740 also requires recognition of deferred tax assets for the expected future tax effects of all deductible temporary differences, loss carryforwards and tax credit carryforwards. Deferred tax assets are then reduced, if deemed necessary, by a valuation allowance for the amount of any tax benefits, which, more likely than not based on current circumstances, are not expected to be realized. As a result, no provision for income tax is reflected in the accompanying statements of operations. Should we achieve sufficient, sustained income in the future, we may conclude that some or all of the valuation allowance should be reversed. We are required to make many subjective assumptions and judgments regarding our income tax exposures. At June 30, 2022, we had <span id="xdx_90D_eus-gaap--UnrecognizedTaxBenefits_iI_pp0p0_do_c20220630_z2dFMpRlFgv5" title="Unrecognized tax benefits">no</span> unrecognized tax benefits, which would affect the effective tax rate if recognized and had <span id="xdx_906_eus-gaap--LiabilityForUncertainTaxPositionsCurrent_iI_pp0p0_do_c20220630_zClokvZSWVx7" title="Uncertain tax positions">no</span> accrued interest, or penalties related to uncertain tax positions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> 0 0 <p id="xdx_845_eus-gaap--RevenueRecognitionPolicyTextBlock_zyw84ngkRVlj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_864_zU9Y1orlq8d7">Revenue Recognition</span>.</span> We record revenue at a single point in time, when control is transferred to the customer. We will continue to apply our current business processes, policies, systems and controls to support recognition and disclosure. Our shipping policy is FOB Shipping Point. We recognize revenue from sales to stocking distributors when there is no right of return, other than for normal warranty claims. We have no ongoing obligations related to product sales, except for normal warranty obligations. As presented on the Statement of Operations our revenue is disaggregated between product revenue and service revenue. As it relates specifically to product revenue, we do not believe further disaggregation is necessary as substantially all of our product revenue comes from multiple products within a line of medical devices. Our engineering service contracts are billed on a time and materials basis and revenue is recognized over time as the services are performed.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_840_eus-gaap--ResearchAndDevelopmentExpensePolicy_zU0VbF8x0noi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_861_zYvTdYSqOypi">Research and Development Expenses</span></span>. We expense research and development costs for products and processes as incurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_846_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zEPUp4SVJfi7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_868_zvrK6omlu9h9">Stock-Based Compensation</span></span>. Stock-based compensation is presented in accordance with the guidance of ASC Topic 718, “Compensation – Stock Compensation” (“ASC 718”). Under the provisions of ASC 718, we are required to estimate the fair value of share-based payment awards on the date of grant using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods in our statements of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Stock-based compensation expense recognized under ASC 718 for the three months ended June 30, 2022 and 2021 was $<span id="xdx_908_eus-gaap--ShareBasedCompensation_c20220401__20220630_pp0p0" title="Stock based compensation">12,361</span> and $<span id="xdx_907_eus-gaap--ShareBasedCompensation_c20210401__20210630_pp0p0" title="Stock based compensation">8,340</span>, respectively, which consisted of stock-based compensation expense related to grants of employee stock options.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> 12361 8340 <p id="xdx_846_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zImriJyxsSnh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_861_zFy3mD5FKO1j">Segment Reporting</span>.</span> We have concluded that we have two operating segments, product and service. Product designs, develops, manufactures and markets patented surgical instruments. Service performs electrical engineering activities for external entities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_881_ecustom--ScheduleOfServicePerformsElectricalEngineeringActivitiesForExternalEntitiesTableTextBlock_z8e2JsVjvFPi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 5.4pt"><span id="xdx_8B3_z4VwKr2iCo38" style="display: none">Schedule of service performs electrical engineering activities for external entities</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="10" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold; vertical-align: bottom"><p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt">Three Months Ended</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt">June 30, 2022</span></p></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="10" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt">Three Months Ended</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt">June 30, 2021</span></p></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt"><span style="font-size: 8pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 8pt"><b> </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 8pt"><b>Product</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 8pt"><b> </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 8pt"><b>Service</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 8pt"><b> </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt"><b>Total</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 8pt"><b> </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 8pt"><b>Product</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 8pt"><b> </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 8pt"><b>Service</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 8pt"><b> </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 8pt"><b>Total</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left; padding-left: 5.4pt">Net revenue</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--Revenues_pp0p0_c20220401__20220630__srt--ProductOrServiceAxis__us-gaap--ProductMember_zYRTuDcYA4Jh" style="width: 7%; text-align: right" title="Net revenue">1,696,029</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--Revenues_c20220401__20220630__srt--ProductOrServiceAxis__us-gaap--ServiceMember_pp0p0" style="width: 7%; text-align: right" title="Net revenue">458,333</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--Revenues_pp0p0_c20220401__20220630_zolF7xavln93" style="width: 7%; text-align: right" title="Net revenue">2,154,362</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--Revenues_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__us-gaap--ProductMember_zPHY6TLuNE2c" style="width: 7%; text-align: right" title="Net revenue">1,718,404</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--Revenues_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__us-gaap--ServiceMember_zpoNoH1jKCQk" style="width: 7%; text-align: right" title="Net revenue">290,040</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--Revenues_pp0p0_c20210401__20210630_zDjJxIww58vg" style="width: 7%; text-align: right" title="Net revenue">2,008,444</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 5.4pt">Cost of revenue</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--CostOfRevenue_c20220401__20220630__srt--ProductOrServiceAxis__us-gaap--ProductMember_pp0p0" style="text-align: right" title="Cost of revenue">869,905</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--CostOfRevenue_pp0p0_c20220401__20220630__srt--ProductOrServiceAxis__us-gaap--ServiceMember_zANqoP6Xaqvi" style="text-align: right" title="Cost of revenue"><span style="-sec-ix-hidden: xdx2ixbrl0428">—</span>  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--CostOfRevenue_pp0p0_c20220401__20220630_zyjlgf0gHKXg" style="text-align: right" title="Cost of revenue">869,905</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--CostOfRevenue_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__us-gaap--ProductMember_zEua8EoJ0pFd" style="text-align: right" title="Cost of revenue">838,426</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--CostOfRevenue_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__us-gaap--ServiceMember_zJnzXGR4XIib" style="text-align: right" title="Cost of revenue">143,050</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--CostOfRevenue_pp0p0_c20210401__20210630_zwitqMteNbi5" style="text-align: right" title="Cost of revenue">981,476</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 5.4pt">Gross profit</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--GrossProfit_c20220401__20220630__srt--ProductOrServiceAxis__us-gaap--ProductMember_pp0p0" style="text-align: right" title="Gross profit">826,124</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--GrossProfit_c20220401__20220630__srt--ProductOrServiceAxis__us-gaap--ServiceMember_pp0p0" style="text-align: right" title="Gross profit">458,333</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--GrossProfit_c20220401__20220630_pp0p0" style="text-align: right" title="Gross profit">1,284,457</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--GrossProfit_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__us-gaap--ProductMember_zJZvTli9yyQ6" style="text-align: right" title="Gross profit">879,978</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--GrossProfit_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__us-gaap--ServiceMember_zmpizZJoCbdf" style="text-align: right" title="Gross profit">146,990</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--GrossProfit_pp0p0_c20210401__20210630_zPdcmjOA6mx8" style="text-align: right" title="Gross profit">1,026,968</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 5.4pt">Operating income (loss)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--OperatingIncomeLoss_c20220401__20220630__srt--ProductOrServiceAxis__us-gaap--ProductMember_pp0p0" style="text-align: right" title="Operating income (loss)">(191,431</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--OperatingIncomeLoss_c20220401__20220630__srt--ProductOrServiceAxis__us-gaap--ServiceMember_pp0p0" style="text-align: right" title="Operating income (loss)">458,333</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--OperatingIncomeLoss_c20220401__20220630_pp0p0" style="text-align: right" title="Operating income (loss)">266,902</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--OperatingIncomeLoss_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__us-gaap--ProductMember_zQPJ1hu6zURa" style="text-align: right" title="Operating income (loss)">(152,092</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--OperatingIncomeLoss_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__us-gaap--ServiceMember_zafjBXJNoJ75" style="text-align: right" title="Operating income (loss)">146,990</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--OperatingIncomeLoss_pp0p0_c20210401__20210630_zDCVEvqxmfda" style="text-align: right" title="Operating income (loss)">(5,102</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 5.4pt">Depreciation and amortization</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--DepreciationAndAmortization_c20220401__20220630__srt--ProductOrServiceAxis__us-gaap--ProductMember_pp0p0" style="text-align: right" title="Depreciation and amortization">20,087</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--DepreciationAndAmortization_c20220401__20220630__srt--ProductOrServiceAxis__us-gaap--ServiceMember_pdp0" style="text-align: right" title="Depreciation and amortization"><span style="-sec-ix-hidden: xdx2ixbrl0464">—</span>  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--DepreciationAndAmortization_c20220401__20220630_pp0p0" style="text-align: right" title="Depreciation and amortization">20,087</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--DepreciationAndAmortization_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__us-gaap--ProductMember_zb6NgEDTfC9c" style="text-align: right" title="Depreciation and amortization">26,783</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--DepreciationAndAmortization_pdp0_c20210401__20210630__srt--ProductOrServiceAxis__us-gaap--ServiceMember_zeoIcMBTv6J5" style="text-align: right" title="Depreciation and amortization"><span style="-sec-ix-hidden: xdx2ixbrl0470">—</span>  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--DepreciationAndAmortization_pp0p0_c20210401__20210630_z6uJj05lTLq3" style="text-align: right" title="Depreciation and amortization">26,783</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 5.4pt">Patent and capital expenditures</td><td style="font-size: 12pt"> </td> <td style="font-size: 12pt; text-align: left"> </td><td id="xdx_98A_eus-gaap--CapitalExpenditureDiscontinuedOperations_c20220401__20220630__srt--ProductOrServiceAxis__us-gaap--ProductMember_pp0p0" style="font-size: 10pt; text-align: right" title="Patent and capital expenditures">62,329</td><td style="font-size: 12pt; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--CapitalExpenditureDiscontinuedOperations_c20220401__20220630__srt--ProductOrServiceAxis__us-gaap--ServiceMember_pdp0" style="text-align: right" title="Patent and capital expenditures"><span style="-sec-ix-hidden: xdx2ixbrl0476">—</span>  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--CapitalExpenditureDiscontinuedOperations_c20220401__20220630_pp0p0" style="text-align: right" title="Patent and capital expenditures">62,329</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--CapitalExpenditureDiscontinuedOperations_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__us-gaap--ProductMember_zGR2vAoDiahb" style="text-align: right" title="Patent and capital expenditures">14,281</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--CapitalExpenditureDiscontinuedOperations_pdp0_c20210401__20210630__srt--ProductOrServiceAxis__us-gaap--ServiceMember_z1P5nNOtq4eb" style="text-align: right" title="Patent and capital expenditures"><span style="-sec-ix-hidden: xdx2ixbrl0482">—</span>  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--CapitalExpenditureDiscontinuedOperations_pp0p0_c20210401__20210630_zxNFMJG4GTT2" style="text-align: right" title="Patent and capital expenditures">14,281</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 5.4pt">Equipment and patents, net</td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_ecustom--EquipmentAndPatentsNet_pp0p0_c20220401__20220630__srt--ProductOrServiceAxis__us-gaap--ProductMember_z86XRG9RRJMc" style="text-align: right" title="Equipment and patents, net">412,258</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_ecustom--EquipmentAndPatentsNet_pdp0_c20220401__20220630__srt--ProductOrServiceAxis__us-gaap--ServiceMember_z3tu9BPefu95" style="text-align: right" title="Equipment and patents, net"><span style="-sec-ix-hidden: xdx2ixbrl0488">—</span>  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_ecustom--EquipmentAndPatentsNet_pp0p0_c20220401__20220630_zaUiXnrKV4V9" style="text-align: right" title="Equipment and patents, net">412,258</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_ecustom--EquipmentAndPatentsNet_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__us-gaap--ProductMember_zCVlWuY9vUnj" style="text-align: right" title="Equipment and patents, net">370,016</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_ecustom--EquipmentAndPatentsNet_pdp0_c20210401__20210630__srt--ProductOrServiceAxis__us-gaap--ServiceMember_zUrCAGaVxtqg" style="text-align: right" title="Equipment and patents, net"><span style="-sec-ix-hidden: xdx2ixbrl0494">—</span>  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_ecustom--EquipmentAndPatentsNet_pp0p0_c20210401__20210630_zIBhtJW8QHtc" style="text-align: right" title="Equipment and patents, net">370,016</td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_881_ecustom--ScheduleOfServicePerformsElectricalEngineeringActivitiesForExternalEntitiesTableTextBlock_z8e2JsVjvFPi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 5.4pt"><span id="xdx_8B3_z4VwKr2iCo38" style="display: none">Schedule of service performs electrical engineering activities for external entities</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="10" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold; vertical-align: bottom"><p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt">Three Months Ended</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt">June 30, 2022</span></p></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="10" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt">Three Months Ended</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt">June 30, 2021</span></p></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt"><span style="font-size: 8pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 8pt"><b> </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 8pt"><b>Product</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 8pt"><b> </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 8pt"><b>Service</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 8pt"><b> </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt"><b>Total</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 8pt"><b> </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 8pt"><b>Product</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 8pt"><b> </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 8pt"><b>Service</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 8pt"><b> </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 8pt"><b>Total</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left; padding-left: 5.4pt">Net revenue</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--Revenues_pp0p0_c20220401__20220630__srt--ProductOrServiceAxis__us-gaap--ProductMember_zYRTuDcYA4Jh" style="width: 7%; text-align: right" title="Net revenue">1,696,029</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--Revenues_c20220401__20220630__srt--ProductOrServiceAxis__us-gaap--ServiceMember_pp0p0" style="width: 7%; text-align: right" title="Net revenue">458,333</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--Revenues_pp0p0_c20220401__20220630_zolF7xavln93" style="width: 7%; text-align: right" title="Net revenue">2,154,362</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--Revenues_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__us-gaap--ProductMember_zPHY6TLuNE2c" style="width: 7%; text-align: right" title="Net revenue">1,718,404</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--Revenues_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__us-gaap--ServiceMember_zpoNoH1jKCQk" style="width: 7%; text-align: right" title="Net revenue">290,040</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--Revenues_pp0p0_c20210401__20210630_zDjJxIww58vg" style="width: 7%; text-align: right" title="Net revenue">2,008,444</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 5.4pt">Cost of revenue</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--CostOfRevenue_c20220401__20220630__srt--ProductOrServiceAxis__us-gaap--ProductMember_pp0p0" style="text-align: right" title="Cost of revenue">869,905</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--CostOfRevenue_pp0p0_c20220401__20220630__srt--ProductOrServiceAxis__us-gaap--ServiceMember_zANqoP6Xaqvi" style="text-align: right" title="Cost of revenue"><span style="-sec-ix-hidden: xdx2ixbrl0428">—</span>  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--CostOfRevenue_pp0p0_c20220401__20220630_zyjlgf0gHKXg" style="text-align: right" title="Cost of revenue">869,905</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--CostOfRevenue_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__us-gaap--ProductMember_zEua8EoJ0pFd" style="text-align: right" title="Cost of revenue">838,426</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--CostOfRevenue_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__us-gaap--ServiceMember_zJnzXGR4XIib" style="text-align: right" title="Cost of revenue">143,050</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--CostOfRevenue_pp0p0_c20210401__20210630_zwitqMteNbi5" style="text-align: right" title="Cost of revenue">981,476</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 5.4pt">Gross profit</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--GrossProfit_c20220401__20220630__srt--ProductOrServiceAxis__us-gaap--ProductMember_pp0p0" style="text-align: right" title="Gross profit">826,124</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--GrossProfit_c20220401__20220630__srt--ProductOrServiceAxis__us-gaap--ServiceMember_pp0p0" style="text-align: right" title="Gross profit">458,333</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--GrossProfit_c20220401__20220630_pp0p0" style="text-align: right" title="Gross profit">1,284,457</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--GrossProfit_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__us-gaap--ProductMember_zJZvTli9yyQ6" style="text-align: right" title="Gross profit">879,978</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--GrossProfit_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__us-gaap--ServiceMember_zmpizZJoCbdf" style="text-align: right" title="Gross profit">146,990</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--GrossProfit_pp0p0_c20210401__20210630_zPdcmjOA6mx8" style="text-align: right" title="Gross profit">1,026,968</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 5.4pt">Operating income (loss)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--OperatingIncomeLoss_c20220401__20220630__srt--ProductOrServiceAxis__us-gaap--ProductMember_pp0p0" style="text-align: right" title="Operating income (loss)">(191,431</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--OperatingIncomeLoss_c20220401__20220630__srt--ProductOrServiceAxis__us-gaap--ServiceMember_pp0p0" style="text-align: right" title="Operating income (loss)">458,333</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--OperatingIncomeLoss_c20220401__20220630_pp0p0" style="text-align: right" title="Operating income (loss)">266,902</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--OperatingIncomeLoss_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__us-gaap--ProductMember_zQPJ1hu6zURa" style="text-align: right" title="Operating income (loss)">(152,092</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--OperatingIncomeLoss_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__us-gaap--ServiceMember_zafjBXJNoJ75" style="text-align: right" title="Operating income (loss)">146,990</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--OperatingIncomeLoss_pp0p0_c20210401__20210630_zDCVEvqxmfda" style="text-align: right" title="Operating income (loss)">(5,102</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 5.4pt">Depreciation and amortization</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--DepreciationAndAmortization_c20220401__20220630__srt--ProductOrServiceAxis__us-gaap--ProductMember_pp0p0" style="text-align: right" title="Depreciation and amortization">20,087</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--DepreciationAndAmortization_c20220401__20220630__srt--ProductOrServiceAxis__us-gaap--ServiceMember_pdp0" style="text-align: right" title="Depreciation and amortization"><span style="-sec-ix-hidden: xdx2ixbrl0464">—</span>  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--DepreciationAndAmortization_c20220401__20220630_pp0p0" style="text-align: right" title="Depreciation and amortization">20,087</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--DepreciationAndAmortization_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__us-gaap--ProductMember_zb6NgEDTfC9c" style="text-align: right" title="Depreciation and amortization">26,783</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--DepreciationAndAmortization_pdp0_c20210401__20210630__srt--ProductOrServiceAxis__us-gaap--ServiceMember_zeoIcMBTv6J5" style="text-align: right" title="Depreciation and amortization"><span style="-sec-ix-hidden: xdx2ixbrl0470">—</span>  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--DepreciationAndAmortization_pp0p0_c20210401__20210630_z6uJj05lTLq3" style="text-align: right" title="Depreciation and amortization">26,783</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 5.4pt">Patent and capital expenditures</td><td style="font-size: 12pt"> </td> <td style="font-size: 12pt; text-align: left"> </td><td id="xdx_98A_eus-gaap--CapitalExpenditureDiscontinuedOperations_c20220401__20220630__srt--ProductOrServiceAxis__us-gaap--ProductMember_pp0p0" style="font-size: 10pt; text-align: right" title="Patent and capital expenditures">62,329</td><td style="font-size: 12pt; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--CapitalExpenditureDiscontinuedOperations_c20220401__20220630__srt--ProductOrServiceAxis__us-gaap--ServiceMember_pdp0" style="text-align: right" title="Patent and capital expenditures"><span style="-sec-ix-hidden: xdx2ixbrl0476">—</span>  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--CapitalExpenditureDiscontinuedOperations_c20220401__20220630_pp0p0" style="text-align: right" title="Patent and capital expenditures">62,329</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--CapitalExpenditureDiscontinuedOperations_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__us-gaap--ProductMember_zGR2vAoDiahb" style="text-align: right" title="Patent and capital expenditures">14,281</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--CapitalExpenditureDiscontinuedOperations_pdp0_c20210401__20210630__srt--ProductOrServiceAxis__us-gaap--ServiceMember_z1P5nNOtq4eb" style="text-align: right" title="Patent and capital expenditures"><span style="-sec-ix-hidden: xdx2ixbrl0482">—</span>  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--CapitalExpenditureDiscontinuedOperations_pp0p0_c20210401__20210630_zxNFMJG4GTT2" style="text-align: right" title="Patent and capital expenditures">14,281</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 5.4pt">Equipment and patents, net</td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_ecustom--EquipmentAndPatentsNet_pp0p0_c20220401__20220630__srt--ProductOrServiceAxis__us-gaap--ProductMember_z86XRG9RRJMc" style="text-align: right" title="Equipment and patents, net">412,258</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_ecustom--EquipmentAndPatentsNet_pdp0_c20220401__20220630__srt--ProductOrServiceAxis__us-gaap--ServiceMember_z3tu9BPefu95" style="text-align: right" title="Equipment and patents, net"><span style="-sec-ix-hidden: xdx2ixbrl0488">—</span>  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_ecustom--EquipmentAndPatentsNet_pp0p0_c20220401__20220630_zaUiXnrKV4V9" style="text-align: right" title="Equipment and patents, net">412,258</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_ecustom--EquipmentAndPatentsNet_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__us-gaap--ProductMember_zCVlWuY9vUnj" style="text-align: right" title="Equipment and patents, net">370,016</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_ecustom--EquipmentAndPatentsNet_pdp0_c20210401__20210630__srt--ProductOrServiceAxis__us-gaap--ServiceMember_zUrCAGaVxtqg" style="text-align: right" title="Equipment and patents, net"><span style="-sec-ix-hidden: xdx2ixbrl0494">—</span>  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_ecustom--EquipmentAndPatentsNet_pp0p0_c20210401__20210630_zIBhtJW8QHtc" style="text-align: right" title="Equipment and patents, net">370,016</td><td style="text-align: left"> </td></tr> </table> 1696029 458333 2154362 1718404 290040 2008444 869905 869905 838426 143050 981476 826124 458333 1284457 879978 146990 1026968 -191431 458333 266902 -152092 146990 -5102 20087 20087 26783 26783 62329 62329 14281 14281 412258 412258 370016 370016 <p id="xdx_84C_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zgZ9znj6wv1h" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_864_zZuivL9PE4m1">Recently Issued Accounting Pronouncements</span>.</span> In June 2016, the FASB issued ASU 2016-13, “Measurement of Credit Losses on Financial Instruments”. ASU 2016-13 adds a current expected credit loss (“CECL”) impairment model to U.S. GAAP that is based on expected losses rather than incurred losses. Modified retrospective adoption is required with any cumulative-effect adjustment recorded to retained earnings as of the beginning of the period of adoption. ASU 2016-13 is effective for fiscal years beginning after December 15, 2019, excluding smaller reporting entities, which will be effective for fiscal years beginning after December 15, 2022. We will adopt ASU 2016-13 beginning April 1, 2023 and do not expect the application of the CECL impairment model to have a significant impact on our allowance for uncollectible amounts for accounts receivable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-transform: uppercase"> </span></p> <p id="xdx_80A_eus-gaap--EarningsPerShareTextBlock_z9GUcgSAtZP5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Note 3.<span style="text-transform: uppercase"> <span style="text-decoration: underline"><span id="xdx_822_zbMWP8HlsbS6">Basic and Diluted Income and Loss per Common Share</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We report both basic and diluted net income (loss) per share. Basic net income or loss per common share is computed by dividing net income or loss for the period by the weighted average number of common shares outstanding for the period. Diluted net income or loss per common share is computed by dividing the net income or loss for the period by the weighted average number of common and potential common shares outstanding during the period if the effect of the potential common shares is dilutive. The shares used in the calculation of dilutive potential common shares exclude options to purchase shares where the exercise price was greater than the average market price of common shares for the period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table presents the calculation of basic and diluted net income (loss) per share:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zAWH1AZvPr21" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - BASIC AND DILUTED INCOME AND LOSS PER COMMON SHARE (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-left: 5.4pt"><span id="xdx_8B6_zXyoxx58sUaa" style="display: none">Schedule of basic and diluted net loss per share</span></td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_49C_20220401__20220630_zHdYgSK3tju2" style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_497_20210401__20210630_zTr9kHZFhtFd" style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-size: 8pt"><b> </b></span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt"><b> </b></span></td> <td colspan="6" style="vertical-align: bottom; text-align: center"><span style="font-size: 8pt"><b>Three Months Ended</b></span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt"><b> </b></span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; text-align: justify"><span style="font-size: 8pt"><b> </b></span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt"><b> </b></span></td> <td colspan="2" style="text-align: center"><span style="font-size: 8pt"><b> June 30, 2022</b></span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt"><b> </b></span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"><b> </b></span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt"><b>June 30, 2021</b></span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt"><b> </b></span></td></tr> <tr id="xdx_408_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%; font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Net (loss) income</td><td style="width: 1%; font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 14%; font-size: 10pt; text-align: right">264,601</td><td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 14%; font-size: 10pt; text-align: right">(6,842</td><td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td></tr> <tr id="xdx_403_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i_pdd" style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-left: 5.4pt">Weighted-average basic shares outstanding</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">11,719,543</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">11,582,641</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_i_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Effect of dilutive securities</td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">301,737</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0514">—</span>  </td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_zUw1cFlhYfmf" style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 1pt; padding-left: 5.4pt">Weighted-average diluted shares</td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">12,021,280</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">11,582,641</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--EarningsPerShareBasic_i_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Basic net income (loss) per share</td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">0.02</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">0.00</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--EarningsPerShareDiluted_i_pdd" style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Diluted net income (loss) per share</td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">0.02</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">0.00</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_40C_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfNetIncomePerOutstandingUnit_zKG2LoHmhMW2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"> Antidilutive employee stock options</td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">756,263</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">1,036,000</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zAWH1AZvPr21" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - BASIC AND DILUTED INCOME AND LOSS PER COMMON SHARE (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-left: 5.4pt"><span id="xdx_8B6_zXyoxx58sUaa" style="display: none">Schedule of basic and diluted net loss per share</span></td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_49C_20220401__20220630_zHdYgSK3tju2" style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_497_20210401__20210630_zTr9kHZFhtFd" style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-size: 8pt"><b> </b></span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt"><b> </b></span></td> <td colspan="6" style="vertical-align: bottom; text-align: center"><span style="font-size: 8pt"><b>Three Months Ended</b></span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt"><b> </b></span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; text-align: justify"><span style="font-size: 8pt"><b> </b></span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt"><b> </b></span></td> <td colspan="2" style="text-align: center"><span style="font-size: 8pt"><b> June 30, 2022</b></span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt"><b> </b></span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"><b> </b></span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt"><b>June 30, 2021</b></span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt"><b> </b></span></td></tr> <tr id="xdx_408_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%; font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Net (loss) income</td><td style="width: 1%; font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 14%; font-size: 10pt; text-align: right">264,601</td><td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 14%; font-size: 10pt; text-align: right">(6,842</td><td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td></tr> <tr id="xdx_403_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i_pdd" style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-left: 5.4pt">Weighted-average basic shares outstanding</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">11,719,543</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">11,582,641</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_i_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Effect of dilutive securities</td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">301,737</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0514">—</span>  </td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_zUw1cFlhYfmf" style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 1pt; padding-left: 5.4pt">Weighted-average diluted shares</td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">12,021,280</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">11,582,641</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--EarningsPerShareBasic_i_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Basic net income (loss) per share</td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">0.02</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">0.00</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--EarningsPerShareDiluted_i_pdd" style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Diluted net income (loss) per share</td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">0.02</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">0.00</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_40C_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfNetIncomePerOutstandingUnit_zKG2LoHmhMW2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"> Antidilutive employee stock options</td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">756,263</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">1,036,000</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td></tr> </table> 264601 -6842 11719543 11582641 301737 12021280 11582641 0.02 0.00 0.02 0.00 756263 1036000 <p id="xdx_80C_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zXyswT6fJcT8" style="font: 10pt Times New Roman, Times, Serif; margin: 0">Note 4. <span style="text-decoration: underline"><span id="xdx_82D_zH1RnTeM1kG1">COMMITMENTS AND CONTINGENCIES</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have a noncancelable lease agreement for our facilities at 6797 Winchester Circle, Boulder, Colorado. The lease expires October 31, 2024.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) ("ASU 2016-02"), which modified lease accounting for both lessees and lessors to increase transparency and comparability by recognizing lease assets and lease liabilities by lessees for those leases classified as either finance or operating leases under previous accounting standards and disclosing key information about leasing arrangements. We adopted Topic 842 on April 1, 2019, using the alternative modified transition method, which requires a cumulative effect adjustment, if any, to the opening balance of retained earnings to be recognized on the date of adoption with prior periods not restated. There was no cumulative effect adjustment recorded on April 1, 2019. The primary impact for us was the balance sheet recognition of right-of-use (“ROU”) assets and lease liabilities for operating leases as a lessee.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We determine if an arrangement contains a lease at inception. We currently do not have any finance leases. Operating lease ROU assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. ROU assets also include any initial direct costs incurred and any lease payments made at or before the lease commencement date, less lease incentives received. We use our incremental borrowing rate based on the information available at the commencement date in determining the lease liabilities as our leases do not provide an implicit rate. Lease expense is recognized on a straight-line basis over the lease term.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The minimum future lease payment, by fiscal year, as of June 30, 2022 is as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LeasePaymentMember_zmKCIKdFJro5" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto" summary="xdx: Disclosure - COMMITMENTS AND CONTINGENCIES (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-align: left"> </td><td style="vertical-align: top; text-align: left"><span id="xdx_8B0_zxShm2MEFcek" style="display: none">Schedule of Lease payment</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: left; font-weight: bold; vertical-align: top"><span style="font-size: 8pt">Fiscal Year</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold; vertical-align: bottom"><span style="font-size: 8pt">Amount</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; width: 1%; text-align: left"> </td><td style="vertical-align: top; width: 69%; text-align: left">2023</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInThreeYears_c20220630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LeasePaymentMember_pp0p0" style="width: 25%; text-align: right" title="2023">281,542</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-align: left"> </td><td style="vertical-align: top; text-align: left">2024</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInFourYears_c20220630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LeasePaymentMember_pp0p0" style="text-align: right" title="2024">386,667</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt; vertical-align: top; text-align: left"> </td><td style="padding-bottom: 1pt; vertical-align: top; text-align: left">2025</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInFiveYears_c20220630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LeasePaymentMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="2025">232,139</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; vertical-align: top; text-align: left"> </td><td style="padding-bottom: 2.5pt; vertical-align: top; text-align: left"><span style="font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--OperatingLeasesFutureMinimumPaymentsDue_c20220630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LeasePaymentMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">900,348</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A9_zfP1Ts7tkmqa" style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0; margin-bottom: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> During January 2021, we canceled our relationship with Crestmark Bank. We had no borrowings and incurred a $20,000 exit fee. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> On August 4, 2020, we received $<span id="xdx_90C_eus-gaap--ProceedsFromLoans_c20210801__20210804__us-gaap--LongtermDebtTypeAxis__custom--SBAMember_pp0p0" title="Proceed from loan">150,000</span> principal in loan funding from the U.S. Small Business Administration (“SBA”) under the Economic Injury Disaster Loan (“EIDL”) program administered by the SBA, which program was expanded pursuant to the CARES Act. The EIDL is evidenced by a promissory note, dated August 1, 2020 in the original principal amount of $<span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_c20200801__us-gaap--LongtermDebtTypeAxis__custom--EIDLMember_pp0p0" title="Principal amount">150,000</span> with the SBA, the lender. Under the terms of the Note, interest accrues on the outstanding principal at the rate of <span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20200730__20200801__us-gaap--LongtermDebtTypeAxis__custom--EIDLMember_zbLgR4nZxR3f" title="Interest rate">3.75</span>% per annum. The term of the Note is thirty years, though it may be payable sooner upon an event of default under the Note. Under the Note, we will be obligated to make equal monthly payments of principal and interest of $774 beginning on August 1, 2023 through the maturity date of <span id="xdx_901_eus-gaap--DebtInstrumentMaturityDate_dd_c20200730__20200801__us-gaap--LongtermDebtTypeAxis__custom--EIDLMember_zTY3SaaNtMTc" title="Debt Instrument, Maturity Date">August 1, 2050</span>. The Note may be prepaid in part or in full, at any time, without penalty. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">   </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> During January 2021, we entered into a note agreement with U.S. Bank for $92,000. The note is for five years at a 5% interest rate and the proceeds were used to purchase equipment. The note is secured by the equipment. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">   </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> On April 17, 2020, we entered into an unsecured promissory note under the PPP for a principal amount of $<span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20200417__us-gaap--LongtermDebtTypeAxis__custom--PPPLoanMember_zyyM1qZeHRc4" title="Principal amount">598,567</span>. The PPP was established under the Consolidated Appropriations Act of 2020, enacted December 27, 2020. Under the terms of the CARES Act, a PPP loan recipient may apply for, and be granted, forgiveness for all or a portion of loans granted under the PPP. Such forgiveness will be determined based upon the use of loan proceeds for payroll costs, rent and utility costs, and the maintenance of employee and compensation levels. In the quarter that ended December 31, 2020, we achieved the requirements for forgiveness, and all of the $<span id="xdx_90F_eus-gaap--DebtInstrumentDecreaseForgiveness_pp0p0_c20201001__20201231__us-gaap--LongtermDebtTypeAxis__custom--PPPLoanMember_zVtmYDkPWuSa" title="Debt Forgiveness">598,567</span> was forgiven. We recognized the forgiveness as extinguishment of debt income of $<span id="xdx_90C_ecustom--ExtinguishmentOfDebtIncome_pp0p0_c20201201__20201231__us-gaap--LongtermDebtTypeAxis__custom--PPPLoanMember_zXL7WNf0PWnb" title="Extinguishment of debt income">598,567</span>.On February 8, 2021, we entered into a second unsecured promissory note under the PPP for a principal amount of $<span id="xdx_90A_eus-gaap--DebtInstrumentFaceAmount_c20210208__us-gaap--LongtermDebtTypeAxis__custom--PPPLoanMember_pp0p0" title="Principal amount">533,118</span>. This was our second PPP loan. During the quarter that ended September 30, 2021, we achieved the requirements for forgiveness of the second note and recognized the forgiveness as extinguishment of debt income of $<span id="xdx_902_ecustom--ExtinguishmentOfDebtIncome_pp0p0_c20210701__20210930__us-gaap--LongtermDebtTypeAxis__custom--PPPLoanMember_zgcmu2iyE7je" title="Extinguishment of debt income">533,118</span>. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The minimum future EIDL payment, by fiscal year, as of June 30, 2022 is as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EIDLPaymentMember_zmdrAG2mimgk" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto" summary="xdx: Disclosure - COMMITMENTS AND CONTINGENCIES (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: bottom; text-align: left"> </td><td style="vertical-align: bottom; text-align: left"><span id="xdx_8B5_zXLUwNMz7nth" style="display: none">Schedule of EIDL payment</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: left; font-weight: bold; vertical-align: bottom"><span style="font-size: 8pt">Fiscal Year</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold; vertical-align: bottom"><span style="font-size: 8pt">Amount</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: bottom; width: 1%; text-align: left"> </td><td style="vertical-align: bottom; width: 69%; text-align: left">2023</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInThreeYears_c20220630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EIDLPaymentMember_pp0p0" style="width: 25%; text-align: right" title="2023">1,546</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: bottom; text-align: left"> </td><td style="vertical-align: bottom; text-align: left">2024</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInFourYears_c20220630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EIDLPaymentMember_pp0p0" style="text-align: right" title="2024">3,208</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: bottom; text-align: left"> </td><td style="vertical-align: bottom; text-align: left">2025</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInFiveYears_c20220630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EIDLPaymentMember_pp0p0" style="text-align: right" title="2025">3,331</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: bottom; text-align: left"> </td><td style="vertical-align: bottom; text-align: left">2026</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInFourAndFiveYears_c20220630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EIDLPaymentMember_pp0p0" style="text-align: right" title="2026">3,457</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: bottom; padding-bottom: 1pt; text-align: left"> </td><td style="vertical-align: bottom; padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt">Thereafter</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueThereafter_c20220630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EIDLPaymentMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Thereafter">148,018</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: bottom; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; vertical-align: bottom; text-align: left"><span style="font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--OperatingLeasesFutureMinimumPaymentsDue_c20220630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EIDLPaymentMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">159,560</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A1_zJ4nhPA1aUjk" style="margin-top: 0; margin-bottom: 0"> </p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><br/> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During January 2021, we entered into a note agreement with U.S. Bank for $92,000. The note is for five years at a 5% interest rate and the proceeds were used to purchase equipment. The note is secured by the equipment.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The minimum future principal U.S. Bank payment, by fiscal year, as of June 30, 2022 is as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--USBankPaymentMember_zpZZs1mKqml4" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto" summary="xdx: Disclosure - COMMITMENTS AND CONTINGENCIES (Details 2)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: bottom; text-align: left"> </td><td style="vertical-align: bottom; text-align: left"><span id="xdx_8BF_zfLMUFpbAVH9" style="display: none">Schedule of principal U.S. Bank payment</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: left; font-weight: bold; vertical-align: bottom"><span style="font-size: 8pt">Fiscal Year</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold; vertical-align: bottom"><span style="font-size: 8pt">Amount</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: bottom; width: 1%; text-align: left"> </td><td style="vertical-align: bottom; width: 69%; text-align: left">2023</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInThreeYears_c20220630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--USBankPaymentMember_pp0p0" style="width: 25%; text-align: right" title="2023">13,800</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: bottom; text-align: left"> </td><td style="vertical-align: bottom; text-align: left">2024</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInFourYears_c20220630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--USBankPaymentMember_pp0p0" style="text-align: right" title="2024">18,400</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: bottom; text-align: left"> </td><td style="vertical-align: bottom; text-align: left">2025</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInFiveYears_c20220630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--USBankPaymentMember_pp0p0" style="text-align: right" title="2025">18,400</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: bottom; padding-bottom: 1pt; text-align: left"> </td><td style="vertical-align: bottom; padding-bottom: 1pt; text-align: left">2026</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInFourAndFiveYears_c20220630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--USBankPaymentMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="2026">13,800</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: bottom; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; vertical-align: bottom; text-align: left"><span style="font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--OperatingLeasesFutureMinimumPaymentsDue_c20220630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--USBankPaymentMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">64,400</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A4_z3sb29Fg9w4e" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Aside from the operating lease, EIDL loan and U.S. Bank loan, we do not have any material contractual commitments requiring settlement in the future.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We are subject to regulation by the United States Food and Drug Administration (“FDA”). The FDA provides regulations governing the manufacture and sale of our products and regularly inspects us and other manufacturers to determine compliance with these regulations. We believe that we were in substantial compliance with all known regulations at June 30, 2022. FDA inspections are conducted periodically at the discretion of the FDA. Our latest inspection by the FDA occurred in October 2019.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LeasePaymentMember_zmKCIKdFJro5" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto" summary="xdx: Disclosure - COMMITMENTS AND CONTINGENCIES (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-align: left"> </td><td style="vertical-align: top; text-align: left"><span id="xdx_8B0_zxShm2MEFcek" style="display: none">Schedule of Lease payment</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: left; font-weight: bold; vertical-align: top"><span style="font-size: 8pt">Fiscal Year</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold; vertical-align: bottom"><span style="font-size: 8pt">Amount</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; width: 1%; text-align: left"> </td><td style="vertical-align: top; width: 69%; text-align: left">2023</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInThreeYears_c20220630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LeasePaymentMember_pp0p0" style="width: 25%; text-align: right" title="2023">281,542</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-align: left"> </td><td style="vertical-align: top; text-align: left">2024</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInFourYears_c20220630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LeasePaymentMember_pp0p0" style="text-align: right" title="2024">386,667</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt; vertical-align: top; text-align: left"> </td><td style="padding-bottom: 1pt; vertical-align: top; text-align: left">2025</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInFiveYears_c20220630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LeasePaymentMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="2025">232,139</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; vertical-align: top; text-align: left"> </td><td style="padding-bottom: 2.5pt; vertical-align: top; text-align: left"><span style="font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--OperatingLeasesFutureMinimumPaymentsDue_c20220630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LeasePaymentMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">900,348</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 281542 386667 232139 900348 150000 150000 0.0375 2050-08-01 598567 598567 598567 533118 533118 <table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EIDLPaymentMember_zmdrAG2mimgk" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto" summary="xdx: Disclosure - COMMITMENTS AND CONTINGENCIES (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: bottom; text-align: left"> </td><td style="vertical-align: bottom; text-align: left"><span id="xdx_8B5_zXLUwNMz7nth" style="display: none">Schedule of EIDL payment</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: left; font-weight: bold; vertical-align: bottom"><span style="font-size: 8pt">Fiscal Year</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold; vertical-align: bottom"><span style="font-size: 8pt">Amount</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: bottom; width: 1%; text-align: left"> </td><td style="vertical-align: bottom; width: 69%; text-align: left">2023</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInThreeYears_c20220630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EIDLPaymentMember_pp0p0" style="width: 25%; text-align: right" title="2023">1,546</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: bottom; text-align: left"> </td><td style="vertical-align: bottom; text-align: left">2024</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInFourYears_c20220630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EIDLPaymentMember_pp0p0" style="text-align: right" title="2024">3,208</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: bottom; text-align: left"> </td><td style="vertical-align: bottom; text-align: left">2025</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInFiveYears_c20220630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EIDLPaymentMember_pp0p0" style="text-align: right" title="2025">3,331</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: bottom; text-align: left"> </td><td style="vertical-align: bottom; text-align: left">2026</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInFourAndFiveYears_c20220630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EIDLPaymentMember_pp0p0" style="text-align: right" title="2026">3,457</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: bottom; padding-bottom: 1pt; text-align: left"> </td><td style="vertical-align: bottom; padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt">Thereafter</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueThereafter_c20220630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EIDLPaymentMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Thereafter">148,018</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: bottom; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; vertical-align: bottom; text-align: left"><span style="font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--OperatingLeasesFutureMinimumPaymentsDue_c20220630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EIDLPaymentMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">159,560</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 1546 3208 3331 3457 148018 159560 <table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--USBankPaymentMember_zpZZs1mKqml4" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto" summary="xdx: Disclosure - COMMITMENTS AND CONTINGENCIES (Details 2)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: bottom; text-align: left"> </td><td style="vertical-align: bottom; text-align: left"><span id="xdx_8BF_zfLMUFpbAVH9" style="display: none">Schedule of principal U.S. Bank payment</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: left; font-weight: bold; vertical-align: bottom"><span style="font-size: 8pt">Fiscal Year</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold; vertical-align: bottom"><span style="font-size: 8pt">Amount</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: bottom; width: 1%; text-align: left"> </td><td style="vertical-align: bottom; width: 69%; text-align: left">2023</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInThreeYears_c20220630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--USBankPaymentMember_pp0p0" style="width: 25%; text-align: right" title="2023">13,800</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: bottom; text-align: left"> </td><td style="vertical-align: bottom; text-align: left">2024</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInFourYears_c20220630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--USBankPaymentMember_pp0p0" style="text-align: right" title="2024">18,400</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: bottom; text-align: left"> </td><td style="vertical-align: bottom; text-align: left">2025</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInFiveYears_c20220630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--USBankPaymentMember_pp0p0" style="text-align: right" title="2025">18,400</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: bottom; padding-bottom: 1pt; text-align: left"> </td><td style="vertical-align: bottom; padding-bottom: 1pt; text-align: left">2026</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInFourAndFiveYears_c20220630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--USBankPaymentMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="2026">13,800</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: bottom; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; vertical-align: bottom; text-align: left"><span style="font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--OperatingLeasesFutureMinimumPaymentsDue_c20220630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--USBankPaymentMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">64,400</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 13800 18400 18400 13800 64400 <p id="xdx_801_eus-gaap--ShareholdersEquityAndShareBasedPaymentsTextBlock_z9Q7J3Xn6uD8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Note 5. <span style="text-decoration: underline"><span id="xdx_820_zkIipo9VnGVf">SHARE-BASED COMPENSATION</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The provisions of ASC 718-10-55 requires the measurement and recognition of compensation expense for all share-based payment awards made to our employees and directors, including employee stock options and RSUs, based on estimated fair values. The following table summarizes stock-based compensation expense related to employee stock options for the three months ended June 30, 2022 and 2021, which was allocated as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_88E_ecustom--ShareBasedCompensationTableTextBlock_zbOFU8eI0ozl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SHARE-BASED COMPENSATION (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 5.4pt"><span id="xdx_8BC_zREHtG2pINm1" style="display: none">Schedule of summarizes stock-based compensation</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt; text-align: justify"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Three Months Ended</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt; text-align: justify"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">June 30, 2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">June 30, 2021</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%; text-align: justify; padding-left: 5.4pt">Cost of sales</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--AllocatedShareBasedCompensationExpense_c20220401__20220630__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" style="width: 14%; text-align: right" title="Stock-based compensation expense related to grants of employee stock options">158</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--AllocatedShareBasedCompensationExpense_c20210401__20210630__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" style="width: 14%; text-align: right" title="Stock-based compensation expense related to grants of employee stock options">918</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 5.4pt">Sales and marketing</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--AllocatedShareBasedCompensationExpense_c20220401__20220630__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingAndMarketingExpenseMember_pp0p0" style="text-align: right" title="Stock-based compensation expense related to grants of employee stock options">1,656</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--AllocatedShareBasedCompensationExpense_c20210401__20210630__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingAndMarketingExpenseMember_pp0p0" style="text-align: right" title="Stock-based compensation expense related to grants of employee stock options">1,218</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 5.4pt">General and administrative</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--AllocatedShareBasedCompensationExpense_c20220401__20220630__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_pp0p0" style="text-align: right" title="Stock-based compensation expense related to grants of employee stock options">9,429</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--AllocatedShareBasedCompensationExpense_c20210401__20210630__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_pp0p0" style="text-align: right" title="Stock-based compensation expense related to grants of employee stock options">5,658</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 5.4pt">Research and development</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--AllocatedShareBasedCompensationExpense_c20220401__20220630__us-gaap--IncomeStatementLocationAxis__us-gaap--ResearchAndDevelopmentExpenseMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Stock-based compensation expense related to grants of employee stock options">1,118</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--AllocatedShareBasedCompensationExpense_c20210401__20210630__us-gaap--IncomeStatementLocationAxis__us-gaap--ResearchAndDevelopmentExpenseMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Stock-based compensation expense related to grants of employee stock options">546</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Stock-based compensation expense</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_984_eus-gaap--AllocatedShareBasedCompensationExpense_c20220401__20220630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Stock-based compensation expense related to grants of employee stock options">12,361</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_986_eus-gaap--AllocatedShareBasedCompensationExpense_c20210401__20210630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Stock-based compensation expense related to grants of employee stock options">8,340</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Share-based compensation cost for stock options is measured at the grant date, based on the fair value as calculated by the Black-Scholes-Merton ("BSM") option-pricing model. The BSM option-pricing model requires the use of actual employee exercise behavior data and the application of a number of assumptions, including expected volatility, risk-free interest rate and expected dividends. There were <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_do_c20220401__20220630_zvw9g2OVtsqb" title="Stock options granted"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_do_c20210401__20210630_zXbWlqRmztR1" title="Stock options granted"><span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_do_c20220401__20220630_zvRZELbA6vY7" title="Number of shares exercised"><span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_do_c20210401__20210630_zL2VlHGheay5" title="Number of shares exercised"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_do_c20220401__20220630_zT4mxBIEaEIg" title="Stock options forfeited"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_do_c20210401__20210630_zHQLGBEwCWnj" title="Stock options forfeited">no</span></span></span></span></span></span> stock options granted, exercised or forfeited during the three months ended June 30, 2022 and 2021.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of June 30, 2022, approximately $<span id="xdx_902_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_c20220630_pp0p0" title="Unrecognized compensation costs">182,000</span> of total unrecognized compensation costs related to nonvested stock options is expected to be recognized over a period of five years.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_88E_ecustom--ShareBasedCompensationTableTextBlock_zbOFU8eI0ozl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SHARE-BASED COMPENSATION (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 5.4pt"><span id="xdx_8BC_zREHtG2pINm1" style="display: none">Schedule of summarizes stock-based compensation</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt; text-align: justify"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Three Months Ended</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt; text-align: justify"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">June 30, 2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">June 30, 2021</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%; text-align: justify; padding-left: 5.4pt">Cost of sales</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--AllocatedShareBasedCompensationExpense_c20220401__20220630__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" style="width: 14%; text-align: right" title="Stock-based compensation expense related to grants of employee stock options">158</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--AllocatedShareBasedCompensationExpense_c20210401__20210630__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" style="width: 14%; text-align: right" title="Stock-based compensation expense related to grants of employee stock options">918</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 5.4pt">Sales and marketing</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--AllocatedShareBasedCompensationExpense_c20220401__20220630__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingAndMarketingExpenseMember_pp0p0" style="text-align: right" title="Stock-based compensation expense related to grants of employee stock options">1,656</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--AllocatedShareBasedCompensationExpense_c20210401__20210630__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingAndMarketingExpenseMember_pp0p0" style="text-align: right" title="Stock-based compensation expense related to grants of employee stock options">1,218</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 5.4pt">General and administrative</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--AllocatedShareBasedCompensationExpense_c20220401__20220630__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_pp0p0" style="text-align: right" title="Stock-based compensation expense related to grants of employee stock options">9,429</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--AllocatedShareBasedCompensationExpense_c20210401__20210630__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_pp0p0" style="text-align: right" title="Stock-based compensation expense related to grants of employee stock options">5,658</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 5.4pt">Research and development</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--AllocatedShareBasedCompensationExpense_c20220401__20220630__us-gaap--IncomeStatementLocationAxis__us-gaap--ResearchAndDevelopmentExpenseMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Stock-based compensation expense related to grants of employee stock options">1,118</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--AllocatedShareBasedCompensationExpense_c20210401__20210630__us-gaap--IncomeStatementLocationAxis__us-gaap--ResearchAndDevelopmentExpenseMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Stock-based compensation expense related to grants of employee stock options">546</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Stock-based compensation expense</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_984_eus-gaap--AllocatedShareBasedCompensationExpense_c20220401__20220630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Stock-based compensation expense related to grants of employee stock options">12,361</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_986_eus-gaap--AllocatedShareBasedCompensationExpense_c20210401__20210630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Stock-based compensation expense related to grants of employee stock options">8,340</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> </table> 158 918 1656 1218 9429 5658 1118 546 12361 8340 0 0 0 0 0 0 182000 <p id="xdx_802_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zw9D5DCbMa8b" style="font: 10pt Times New Roman, Times, Serif; margin: 0">Note 6. <span style="text-decoration: underline"><span id="xdx_82A_zNo0uDyQyFwk">RELATED PARTY TRANSACTION</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We paid consulting fees of $<span id="xdx_903_eus-gaap--RelatedPartyTransactionPurchasesFromRelatedParty_c20220401__20220630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--DirectorMember_pp0p0" title="Consulting fees paid">13,728</span> and $<span id="xdx_901_eus-gaap--RelatedPartyTransactionPurchasesFromRelatedParty_c20210401__20210630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--DirectorMember_pp0p0" title="Consulting fees paid">28,816</span> to an entity owned by one of our directors during the three months ended June 30, 2022 and 2021 respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> 13728 28816 <p id="xdx_804_eus-gaap--SubsequentEventsTextBlock_znQCG6lWTRec" style="font: 10pt Times New Roman, Times, Serif; margin: 0">Note 7. <span style="text-decoration: underline"><span id="xdx_821_zP5MCoxinAj2">SUBSEQUENT EVENTS</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-right: 0; margin-left: 0">We evaluated all of our activity as of the date the condensed interim financial statements were issued and concluded that no subsequent events have occurred that would require recognition in our financial statements or disclosed in the notes to our condensed interim financial statements.</p> EXCEL 44 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 45 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 46 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 47 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2 html 35 161 1 false 13 0 false 4 false false R1.htm 00000001 - Document - Cover Sheet http://encision.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Condensed Balance Sheets (Unaudited) Sheet http://encision.com/role/BalanceSheets Condensed Balance Sheets (Unaudited) Statements 2 false false R3.htm 00000003 - Statement - Condensed Balance Sheets (Unaudited) (Parenthetical) Sheet http://encision.com/role/BalanceSheetsParenthetical Condensed Balance Sheets (Unaudited) (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Condensed Statements of Operations (Unaudited) Sheet http://encision.com/role/StatementsOfOperations Condensed Statements of Operations (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Condensed Statements of Cash Flows (Unaudited) Sheet http://encision.com/role/StatementsOfCashFlows Condensed Statements of Cash Flows (Unaudited) Statements 5 false false R6.htm 00000006 - Disclosure - ORGANIZATION AND NATURE OF BUSINESS Sheet http://encision.com/role/OrganizationAndNatureOfBusiness ORGANIZATION AND NATURE OF BUSINESS Notes 6 false false R7.htm 00000007 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://encision.com/role/SummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 7 false false R8.htm 00000008 - Disclosure - Basic and Diluted Income and Loss per Common Share Sheet http://encision.com/role/BasicAndDilutedIncomeAndLossPerCommonShare Basic and Diluted Income and Loss per Common Share Notes 8 false false R9.htm 00000009 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://encision.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 9 false false R10.htm 00000010 - Disclosure - SHARE-BASED COMPENSATION Sheet http://encision.com/role/Share-basedCompensation SHARE-BASED COMPENSATION Notes 10 false false R11.htm 00000011 - Disclosure - RELATED PARTY TRANSACTION Sheet http://encision.com/role/RelatedPartyTransaction RELATED PARTY TRANSACTION Notes 11 false false R12.htm 00000012 - Disclosure - SUBSEQUENT EVENTS Sheet http://encision.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 12 false false R13.htm 00000013 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://encision.com/role/SummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 13 false false R14.htm 00000014 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://encision.com/role/SummaryOfSignificantAccountingPoliciesTables SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://encision.com/role/SummaryOfSignificantAccountingPolicies 14 false false R15.htm 00000015 - Disclosure - Basic and Diluted Income and Loss per Common Share (Tables) Sheet http://encision.com/role/BasicAndDilutedIncomeAndLossPerCommonShareTables Basic and Diluted Income and Loss per Common Share (Tables) Tables http://encision.com/role/BasicAndDilutedIncomeAndLossPerCommonShare 15 false false R16.htm 00000016 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables) Sheet http://encision.com/role/CommitmentsAndContingenciesTables COMMITMENTS AND CONTINGENCIES (Tables) Tables http://encision.com/role/CommitmentsAndContingencies 16 false false R17.htm 00000017 - Disclosure - SHARE-BASED COMPENSATION (Tables) Sheet http://encision.com/role/Share-basedCompensationTables SHARE-BASED COMPENSATION (Tables) Tables http://encision.com/role/Share-basedCompensation 17 false false R18.htm 00000018 - Disclosure - ORGANIZATION AND NATURE OF BUSINESS (Details Narrative) Sheet http://encision.com/role/OrganizationAndNatureOfBusinessDetailsNarrative ORGANIZATION AND NATURE OF BUSINESS (Details Narrative) Details http://encision.com/role/OrganizationAndNatureOfBusiness 18 false false R19.htm 00000019 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Sheet http://encision.com/role/SummaryOfSignificantAccountingPoliciesDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Details http://encision.com/role/SummaryOfSignificantAccountingPoliciesTables 19 false false R20.htm 00000020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1) Sheet http://encision.com/role/SummaryOfSignificantAccountingPoliciesDetails1 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1) Details http://encision.com/role/SummaryOfSignificantAccountingPoliciesTables 20 false false R21.htm 00000021 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Sheet http://encision.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Details http://encision.com/role/SummaryOfSignificantAccountingPoliciesTables 21 false false R22.htm 00000022 - Disclosure - BASIC AND DILUTED INCOME AND LOSS PER COMMON SHARE (Details) Sheet http://encision.com/role/BasicAndDilutedIncomeAndLossPerCommonShareDetails BASIC AND DILUTED INCOME AND LOSS PER COMMON SHARE (Details) Details 22 false false R23.htm 00000023 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details) Sheet http://encision.com/role/CommitmentsAndContingenciesDetails COMMITMENTS AND CONTINGENCIES (Details) Details http://encision.com/role/CommitmentsAndContingenciesTables 23 false false R24.htm 00000024 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details 1) Sheet http://encision.com/role/CommitmentsAndContingenciesDetails1 COMMITMENTS AND CONTINGENCIES (Details 1) Details http://encision.com/role/CommitmentsAndContingenciesTables 24 false false R25.htm 00000025 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details 2) Sheet http://encision.com/role/CommitmentsAndContingenciesDetails2 COMMITMENTS AND CONTINGENCIES (Details 2) Details http://encision.com/role/CommitmentsAndContingenciesTables 25 false false R26.htm 00000026 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative) Sheet http://encision.com/role/CommitmentsAndContingenciesDetailsNarrative COMMITMENTS AND CONTINGENCIES (Details Narrative) Details http://encision.com/role/CommitmentsAndContingenciesTables 26 false false R27.htm 00000027 - Disclosure - SHARE-BASED COMPENSATION (Details) Sheet http://encision.com/role/Share-basedCompensationDetails SHARE-BASED COMPENSATION (Details) Details http://encision.com/role/Share-basedCompensationTables 27 false false R28.htm 00000028 - Disclosure - SHARE-BASED COMPENSATION (Details Narrative) Sheet http://encision.com/role/Share-basedCompensationDetailsNarrative SHARE-BASED COMPENSATION (Details Narrative) Details http://encision.com/role/Share-basedCompensationTables 28 false false R29.htm 00000029 - Disclosure - RELATED PARTY TRANSACTION (Details Narrative) Sheet http://encision.com/role/RelatedPartyTransactionDetailsNarrative RELATED PARTY TRANSACTION (Details Narrative) Details http://encision.com/role/RelatedPartyTransaction 29 false false All Reports Book All Reports ecia_10q-063022.htm ecia-20220630.xsd ecia-20220630_cal.xml ecia-20220630_def.xml ecia-20220630_lab.xml ecia-20220630_pre.xml ex10x9.htm ex31x1.htm ex31x2.htm ex32x1.htm http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 49 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "ecia_10q-063022.htm": { "axisCustom": 0, "axisStandard": 4, "contextCount": 35, "dts": { "calculationLink": { "local": [ "ecia-20220630_cal.xml" ] }, "definitionLink": { "local": [ "ecia-20220630_def.xml" ] }, "inline": { "local": [ "ecia_10q-063022.htm" ] }, "labelLink": { "local": [ "ecia-20220630_lab.xml" ] }, "presentationLink": { "local": [ "ecia-20220630_pre.xml" ] }, "schema": { "local": [ "ecia-20220630.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 250, "entityCount": 1, "hidden": { "http://encision.com/20220630": 2, "http://fasb.org/us-gaap/2022": 12, "http://xbrl.sec.gov/dei/2022": 5, "total": 19 }, "keyCustom": 7, "keyStandard": 154, "memberCustom": 6, "memberStandard": 7, "nsprefix": "ecia", "nsuri": "http://encision.com/20220630", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "ecia_10q-063022.htm", "contextRef": "From2022-04-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://encision.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "ecia_10q-063022.htm", "contextRef": "From2022-04-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ecia_10q-063022.htm", "contextRef": "From2022-04-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000010 - Disclosure - SHARE-BASED COMPENSATION", "role": "http://encision.com/role/Share-basedCompensation", "shortName": "SHARE-BASED COMPENSATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ecia_10q-063022.htm", "contextRef": "From2022-04-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ecia_10q-063022.htm", "contextRef": "From2022-04-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000011 - Disclosure - RELATED PARTY TRANSACTION", "role": "http://encision.com/role/RelatedPartyTransaction", "shortName": "RELATED PARTY TRANSACTION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ecia_10q-063022.htm", "contextRef": "From2022-04-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ecia_10q-063022.htm", "contextRef": "From2022-04-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000012 - Disclosure - SUBSEQUENT EVENTS", "role": "http://encision.com/role/SubsequentEvents", "shortName": "SUBSEQUENT EVENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ecia_10q-063022.htm", "contextRef": "From2022-04-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "ecia_10q-063022.htm", "contextRef": "From2022-04-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000013 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "role": "http://encision.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "ecia_10q-063022.htm", "contextRef": "From2022-04-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "us-gaap:InventoryPolicyTextBlock", "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "ecia_10q-063022.htm", "contextRef": "From2022-04-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000014 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "role": "http://encision.com/role/SummaryOfSignificantAccountingPoliciesTables", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:InventoryPolicyTextBlock", "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "ecia_10q-063022.htm", "contextRef": "From2022-04-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "ecia_10q-063022.htm", "contextRef": "From2022-04-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000015 - Disclosure - Basic and Diluted Income and Loss per Common Share (Tables)", "role": "http://encision.com/role/BasicAndDilutedIncomeAndLossPerCommonShareTables", "shortName": "Basic and Diluted Income and Loss per Common Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "ecia_10q-063022.htm", "contextRef": "From2022-04-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "ecia_10q-063022.htm", "contextRef": "From2022-04-012022-06-30_custom_LeasePaymentMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000016 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)", "role": "http://encision.com/role/CommitmentsAndContingenciesTables", "shortName": "COMMITMENTS AND CONTINGENCIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "ecia_10q-063022.htm", "contextRef": "From2022-04-012022-06-30_custom_LeasePaymentMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "ecia_10q-063022.htm", "contextRef": "From2022-04-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "ecia:ShareBasedCompensationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000017 - Disclosure - SHARE-BASED COMPENSATION (Tables)", "role": "http://encision.com/role/Share-basedCompensationTables", "shortName": "SHARE-BASED COMPENSATION (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "ecia_10q-063022.htm", "contextRef": "From2022-04-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "ecia:ShareBasedCompensationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "ecia_10q-063022.htm", "contextRef": "AsOf2022-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RetainedEarningsAccumulatedDeficit", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000018 - Disclosure - ORGANIZATION AND NATURE OF BUSINESS (Details Narrative)", "role": "http://encision.com/role/OrganizationAndNatureOfBusinessDetailsNarrative", "shortName": "ORGANIZATION AND NATURE OF BUSINESS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:NatureOfOperations", "body", "html" ], "baseRef": "ecia_10q-063022.htm", "contextRef": "From2022-04-01to2022-06-30", "decimals": "0", "lang": null, "name": "us-gaap:ProceedsFromStockOptionsExercised", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryPolicyTextBlock", "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "ecia_10q-063022.htm", "contextRef": "AsOf2022-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterials", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000019 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)", "role": "http://encision.com/role/SummaryOfSignificantAccountingPoliciesDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryPolicyTextBlock", "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "ecia_10q-063022.htm", "contextRef": "AsOf2022-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterials", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "ecia_10q-063022.htm", "contextRef": "AsOf2022-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000002 - Statement - Condensed Balance Sheets (Unaudited)", "role": "http://encision.com/role/BalanceSheets", "shortName": "Condensed Balance Sheets (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "ecia_10q-063022.htm", "contextRef": "AsOf2022-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "ecia_10q-063022.htm", "contextRef": "From2022-04-01to2022-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1)", "role": "http://encision.com/role/SummaryOfSignificantAccountingPoliciesDetails1", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ecia:ScheduleOfServicePerformsElectricalEngineeringActivitiesForExternalEntitiesTableTextBlock", "us-gaap:SegmentReportingPolicyPolicyTextBlock", "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "ecia_10q-063022.htm", "contextRef": "From2022-04-01to2022-06-30", "decimals": "0", "lang": null, "name": "us-gaap:DepreciationAndAmortization", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:ConcentrationRiskCreditRisk", "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "ecia_10q-063022.htm", "contextRef": "AsOf2022-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashFDICInsuredAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000021 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "role": "http://encision.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:ConcentrationRiskCreditRisk", "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "ecia_10q-063022.htm", "contextRef": "AsOf2022-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashFDICInsuredAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "ecia_10q-063022.htm", "contextRef": "From2022-04-01to2022-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000022 - Disclosure - BASIC AND DILUTED INCOME AND LOSS PER COMMON SHARE (Details)", "role": "http://encision.com/role/BasicAndDilutedIncomeAndLossPerCommonShareDetails", "shortName": "BASIC AND DILUTED INCOME AND LOSS PER COMMON SHARE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "ecia_10q-063022.htm", "contextRef": "From2022-04-01to2022-06-30", "decimals": "INF", "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "ecia_10q-063022.htm", "contextRef": "AsOf2022-06-30_custom_LeasePaymentMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000023 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)", "role": "http://encision.com/role/CommitmentsAndContingenciesDetails", "shortName": "COMMITMENTS AND CONTINGENCIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "ecia_10q-063022.htm", "contextRef": "AsOf2022-06-30_custom_LeasePaymentMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "ecia_10q-063022.htm", "contextRef": "AsOf2022-06-30_custom_EIDLPaymentMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000024 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details 1)", "role": "http://encision.com/role/CommitmentsAndContingenciesDetails1", "shortName": "COMMITMENTS AND CONTINGENCIES (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "ecia_10q-063022.htm", "contextRef": "AsOf2022-06-30_custom_EIDLPaymentMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "ecia_10q-063022.htm", "contextRef": "AsOf2022-06-30_custom_USBankPaymentMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000025 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details 2)", "role": "http://encision.com/role/CommitmentsAndContingenciesDetails2", "shortName": "COMMITMENTS AND CONTINGENCIES (Details 2)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "ecia_10q-063022.htm", "contextRef": "AsOf2022-06-30_custom_USBankPaymentMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "ecia_10q-063022.htm", "contextRef": "From2021-08-012021-08-04_custom_SBAMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProceedsFromLoans", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000026 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)", "role": "http://encision.com/role/CommitmentsAndContingenciesDetailsNarrative", "shortName": "COMMITMENTS AND CONTINGENCIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "ecia_10q-063022.htm", "contextRef": "From2021-08-012021-08-04_custom_SBAMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProceedsFromLoans", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ecia:ShareBasedCompensationTableTextBlock", "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "ecia_10q-063022.htm", "contextRef": "From2022-04-01to2022-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000027 - Disclosure - SHARE-BASED COMPENSATION (Details)", "role": "http://encision.com/role/Share-basedCompensationDetails", "shortName": "SHARE-BASED COMPENSATION (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ecia:ShareBasedCompensationTableTextBlock", "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "ecia_10q-063022.htm", "contextRef": "From2022-04-01to2022-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "span", "span", "span", "span", "span", "span", "p", "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "ecia_10q-063022.htm", "contextRef": "From2022-04-01to2022-06-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000028 - Disclosure - SHARE-BASED COMPENSATION (Details Narrative)", "role": "http://encision.com/role/Share-basedCompensationDetailsNarrative", "shortName": "SHARE-BASED COMPENSATION (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "span", "span", "span", "span", "p", "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "ecia_10q-063022.htm", "contextRef": "From2022-04-01to2022-06-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "ecia_10q-063022.htm", "contextRef": "From2022-04-012022-06-30_srt_DirectorMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000029 - Disclosure - RELATED PARTY TRANSACTION (Details Narrative)", "role": "http://encision.com/role/RelatedPartyTransactionDetailsNarrative", "shortName": "RELATED PARTY TRANSACTION (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "ecia_10q-063022.htm", "contextRef": "From2022-04-012022-06-30_srt_DirectorMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "ecia_10q-063022.htm", "contextRef": "AsOf2022-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InventoryValuationReserves", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000003 - Statement - Condensed Balance Sheets (Unaudited) (Parenthetical)", "role": "http://encision.com/role/BalanceSheetsParenthetical", "shortName": "Condensed Balance Sheets (Unaudited) (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "ecia_10q-063022.htm", "contextRef": "AsOf2022-06-30", "decimals": "0", "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "ecia_10q-063022.htm", "contextRef": "From2022-04-01to2022-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000004 - Statement - Condensed Statements of Operations (Unaudited)", "role": "http://encision.com/role/StatementsOfOperations", "shortName": "Condensed Statements of Operations (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "ecia_10q-063022.htm", "contextRef": "From2022-04-01to2022-06-30", "decimals": "0", "lang": null, "name": "us-gaap:SellingAndMarketingExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "ecia_10q-063022.htm", "contextRef": "From2022-04-01to2022-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000005 - Statement - Condensed Statements of Cash Flows (Unaudited)", "role": "http://encision.com/role/StatementsOfCashFlows", "shortName": "Condensed Statements of Cash Flows (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "ecia_10q-063022.htm", "contextRef": "From2022-04-01to2022-06-30", "decimals": "0", "lang": null, "name": "us-gaap:DepreciationDepletionAndAmortization", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ecia_10q-063022.htm", "contextRef": "From2022-04-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000006 - Disclosure - ORGANIZATION AND NATURE OF BUSINESS", "role": "http://encision.com/role/OrganizationAndNatureOfBusiness", "shortName": "ORGANIZATION AND NATURE OF BUSINESS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ecia_10q-063022.htm", "contextRef": "From2022-04-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ecia_10q-063022.htm", "contextRef": "From2022-04-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000007 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "role": "http://encision.com/role/SummaryOfSignificantAccountingPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ecia_10q-063022.htm", "contextRef": "From2022-04-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ecia_10q-063022.htm", "contextRef": "From2022-04-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000008 - Disclosure - Basic and Diluted Income and Loss per Common Share", "role": "http://encision.com/role/BasicAndDilutedIncomeAndLossPerCommonShare", "shortName": "Basic and Diluted Income and Loss per Common Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ecia_10q-063022.htm", "contextRef": "From2022-04-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ecia_10q-063022.htm", "contextRef": "From2022-04-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000009 - Disclosure - COMMITMENTS AND CONTINGENCIES", "role": "http://encision.com/role/CommitmentsAndContingencies", "shortName": "COMMITMENTS AND CONTINGENCIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ecia_10q-063022.htm", "contextRef": "From2022-04-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 13, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://encision.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://encision.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r345" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://encision.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r345" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://encision.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://encision.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://encision.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://encision.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r344" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://encision.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r342", "r344", "r345" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://encision.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://encision.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://encision.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://encision.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://encision.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r343" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://encision.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r331" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://encision.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r344" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://encision.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r344" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://encision.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r346" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://encision.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://encision.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r334" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://encision.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://encision.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://encision.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://encision.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://encision.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://encision.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://encision.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://encision.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r337" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://encision.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r333" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://encision.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://encision.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://encision.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r333" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://encision.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r350" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://encision.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://encision.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r333" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://encision.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://encision.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r347" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://encision.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r345" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://encision.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://encision.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r333" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://encision.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r333" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://encision.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r333" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://encision.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r333" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://encision.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://encision.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r348" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://encision.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://encision.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://encision.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://encision.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r344" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://encision.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r338" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://encision.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r339" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://encision.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r332" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://encision.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r336" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://encision.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r335" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://encision.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r340" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://encision.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r341" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://encision.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://encision.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r349" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://encision.com/role/Cover" ], "xbrltype": "booleanItemType" }, "ecia_AntidilutiveSecuritiesExcludedFromComputationOfNetIncomePerOutstandingUnit": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Antidilutive employee stock options" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfNetIncomePerOutstandingUnit", "nsuri": "http://encision.com/20220630", "presentation": [ "http://encision.com/role/BasicAndDilutedIncomeAndLossPerCommonShareDetails" ], "xbrltype": "perShareItemType" }, "ecia_EIDLMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "EIDL [Member]" } } }, "localname": "EIDLMember", "nsuri": "http://encision.com/20220630", "presentation": [ "http://encision.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "ecia_EIDLPaymentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "E I D L Payment [Member]" } } }, "localname": "EIDLPaymentMember", "nsuri": "http://encision.com/20220630", "presentation": [ "http://encision.com/role/CommitmentsAndContingenciesDetails1", "http://encision.com/role/CommitmentsAndContingenciesTables" ], "xbrltype": "domainItemType" }, "ecia_EquipmentAndPatentsNet": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Equipment and patents, net" } } }, "localname": "EquipmentAndPatentsNet", "nsuri": "http://encision.com/20220630", "presentation": [ "http://encision.com/role/SummaryOfSignificantAccountingPoliciesDetails1" ], "xbrltype": "monetaryItemType" }, "ecia_ExtinguishmentOfDebtIncome": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Extinguishment of debt income" } } }, "localname": "ExtinguishmentOfDebtIncome", "nsuri": "http://encision.com/20220630", "presentation": [ "http://encision.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ecia_LeasePaymentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lease Payment [Member]" } } }, "localname": "LeasePaymentMember", "nsuri": "http://encision.com/20220630", "presentation": [ "http://encision.com/role/CommitmentsAndContingenciesDetails", "http://encision.com/role/CommitmentsAndContingenciesTables" ], "xbrltype": "domainItemType" }, "ecia_NetLossIncomePerSharebasicAndDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net (loss) income per share\u2014basic and diluted" } } }, "localname": "NetLossIncomePerSharebasicAndDiluted", "nsuri": "http://encision.com/20220630", "presentation": [ "http://encision.com/role/StatementsOfOperations" ], "xbrltype": "perShareItemType" }, "ecia_PPPLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "PPPLoan [Member]" } } }, "localname": "PPPLoanMember", "nsuri": "http://encision.com/20220630", "presentation": [ "http://encision.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "ecia_PropertyPlantAndEquipmentGrossExcludingCustomerSiteEquipment": { "auth_ref": [], "calculation": { "http://encision.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Furniture, fixtures and equipment, at cost" } } }, "localname": "PropertyPlantAndEquipmentGrossExcludingCustomerSiteEquipment", "nsuri": "http://encision.com/20220630", "presentation": [ "http://encision.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "ecia_SBAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SBA [Member]" } } }, "localname": "SBAMember", "nsuri": "http://encision.com/20220630", "presentation": [ "http://encision.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "ecia_ScheduleOfServicePerformsElectricalEngineeringActivitiesForExternalEntitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of service performs electrical engineering activities for external entities" } } }, "localname": "ScheduleOfServicePerformsElectricalEngineeringActivitiesForExternalEntitiesTableTextBlock", "nsuri": "http://encision.com/20220630", "presentation": [ "http://encision.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "ecia_ShareBasedCompensationTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of summarizes stock-based compensation" } } }, "localname": "ShareBasedCompensationTableTextBlock", "nsuri": "http://encision.com/20220630", "presentation": [ "http://encision.com/role/Share-basedCompensationTables" ], "xbrltype": "textBlockItemType" }, "ecia_USBankPaymentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "U S Bank Payment [Member]" } } }, "localname": "USBankPaymentMember", "nsuri": "http://encision.com/20220630", "presentation": [ "http://encision.com/role/CommitmentsAndContingenciesDetails2", "http://encision.com/role/CommitmentsAndContingenciesTables" ], "xbrltype": "domainItemType" }, "srt_DirectorMember": { "auth_ref": [ "r140" ], "lang": { "en-us": { "role": { "label": "Director [Member]" } } }, "localname": "DirectorMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://encision.com/role/RelatedPartyTransactionDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r137", "r165", "r166", "r210", "r211", "r284", "r323", "r324" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://encision.com/role/StatementsOfOperations", "http://encision.com/role/SummaryOfSignificantAccountingPoliciesDetails1" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r137", "r165", "r166", "r210", "r211", "r284", "r323", "r324" ], "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://encision.com/role/StatementsOfOperations", "http://encision.com/role/SummaryOfSignificantAccountingPoliciesDetails1" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r30", "r276" ], "calculation": { "http://encision.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r141", "r142" ], "calculation": { "http://encision.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts receivable" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/BalanceSheets", "http://encision.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r9", "r157" ], "calculation": { "http://encision.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedLabel": "Accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net income to net cash (used in) operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r227" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Stock-based compensation expense related to grants of employee stock options" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/Share-basedCompensationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r97" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Effect of dilutive securities" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/BasicAndDilutedIncomeAndLossPerCommonShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_Assets": { "auth_ref": [ "r12", "r73", "r120", "r129", "r135", "r144", "r169", "r170", "r171", "r172", "r173", "r174", "r175", "r176", "r177", "r178", "r179", "r244", "r246", "r253", "r274", "r276", "r300", "r313" ], "calculation": { "http://encision.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "TOTAL ASSETS" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r5", "r29", "r73", "r144", "r169", "r170", "r171", "r172", "r173", "r174", "r175", "r176", "r177", "r178", "r179", "r244", "r246", "r253", "r274", "r276" ], "calculation": { "http://encision.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r76" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.", "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/SummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CapitalExpenditureDiscontinuedOperations": { "auth_ref": [ "r0" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of capital expenditure attributable to discontinued operations.", "label": "Patent and capital expenditures" } } }, "localname": "CapitalExpenditureDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/SummaryOfSignificantAccountingPoliciesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r2", "r8", "r64" ], "calculation": { "http://encision.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": { "auth_ref": [ "r65", "r298" ], "lang": { "en-us": { "role": { "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.", "label": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r57", "r64", "r67" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodEndLabel": "Cash, end of fiscal quarter", "periodStartLabel": "Cash, beginning of fiscal year" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "auth_ref": [ "r57", "r254" ], "calculation": { "http://encision.com/role/StatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Net (decrease) increase in cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFDICInsuredAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.", "label": "Federally insured limit" } } }, "localname": "CashFDICInsuredAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r37", "r304", "r319" ], "calculation": { "http://encision.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and contingencies (Note 4)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r162", "r163", "r164", "r167", "r327" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common stock, par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/BalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common stock and additional paid-in capital, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common stock and additional paid-in capital, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r16", "r203" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common stock and additional paid-in capital, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStocksIncludingAdditionalPaidInCapital": { "auth_ref": [ "r16", "r17", "r208" ], "calculation": { "http://encision.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of par value plus amounts in excess of par value or issuance value for common stock issued.", "label": "Common stock and additional paid-in capital, no par value: 100,000,000 shares authorized; 11,719,543 issued and outstanding at June 30, 2022 and March 31, 2022" } } }, "localname": "CommonStocksIncludingAdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r108", "r311" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Concentration of Credit Risk" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CostOfRevenue": { "auth_ref": [ "r49", "r73", "r144", "r169", "r170", "r171", "r173", "r174", "r175", "r176", "r177", "r178", "r179", "r253" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.", "label": "Total cost of revenue", "verboseLabel": "Cost of revenue" } } }, "localname": "CostOfRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/StatementsOfOperations", "http://encision.com/role/SummaryOfSignificantAccountingPoliciesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfRevenueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "COST OF REVENUE:" } } }, "localname": "CostOfRevenueAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_CostOfSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing cost of sales.", "label": "Cost of Sales [Member]" } } }, "localname": "CostOfSalesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/Share-basedCompensationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentDecreaseForgiveness": { "auth_ref": [ "r72" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Decrease for amounts of indebtedness forgiven by the holder of the debt instrument.", "label": "Debt Forgiveness" } } }, "localname": "DebtInstrumentDecreaseForgiveness", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r180", "r198", "r199", "r257", "r259", "r260" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Principal amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateDuringPeriod": { "auth_ref": [ "r34", "r193", "r257" ], "lang": { "en-us": { "role": { "documentation": "The average effective interest rate during the reporting period.", "label": "Interest rate" } } }, "localname": "DebtInstrumentInterestRateDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentMaturityDate": { "auth_ref": [ "r35", "r183", "r250" ], "lang": { "en-us": { "role": { "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.", "label": "Debt Instrument, Maturity Date" } } }, "localname": "DebtInstrumentMaturityDate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "dateItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r36", "r72", "r75", "r180", "r181", "r182", "r183", "r184", "r185", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r193", "r194", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r204", "r205", "r206", "r207", "r256", "r257", "r259", "r260", "r310" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-Term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanDisclosureLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Defined Benefit Plan Disclosure [Line Items]" } } }, "localname": "DefinedBenefitPlanDisclosureLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/CommitmentsAndContingenciesDetails", "http://encision.com/role/CommitmentsAndContingenciesDetails1", "http://encision.com/role/CommitmentsAndContingenciesDetails2", "http://encision.com/role/CommitmentsAndContingenciesTables" ], "xbrltype": "stringItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r62", "r156" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation expense" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationAndAmortization": { "auth_ref": [ "r62", "r156" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.", "label": "Depreciation, Depletion and Amortization, Nonproduction", "verboseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/SummaryOfSignificantAccountingPoliciesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r62", "r118" ], "calculation": { "http://encision.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation and amortization" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r45", "r81", "r82", "r83", "r84", "r85", "r88", "r91", "r94", "r95", "r96", "r100", "r101", "r248", "r249", "r306", "r321" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Basic net income (loss) per share" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/BasicAndDilutedIncomeAndLossPerCommonShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r45", "r81", "r82", "r83", "r84", "r85", "r91", "r94", "r95", "r96", "r100", "r101", "r248", "r249", "r306", "r321" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Diluted net income (loss) per share" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/BasicAndDilutedIncomeAndLossPerCommonShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r97", "r98", "r99", "r102" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Basic and Diluted Income and Loss per Common Share" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/BasicAndDilutedIncomeAndLossPerCommonShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r32" ], "calculation": { "http://encision.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued compensation" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": { "auth_ref": [ "r228" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.", "label": "Unrecognized compensation costs" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/Share-basedCompensationDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r251", "r252" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value of Financial Instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r10", "r154" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Accumulated amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/BalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r154", "r285" ], "calculation": { "http://encision.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Patents, net of accumulated amortization of $290,077 at June 30, 2022 and $282,081 at March 31, 2022" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r50" ], "calculation": { "http://encision.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpenseMember": { "auth_ref": [ "r46" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing general and administrative expense.", "label": "General and Administrative Expense [Member]" } } }, "localname": "GeneralAndAdministrativeExpenseMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/Share-basedCompensationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r48", "r73", "r120", "r128", "r131", "r134", "r136", "r144", "r169", "r170", "r171", "r173", "r174", "r175", "r176", "r177", "r178", "r179", "r253" ], "calculation": { "http://encision.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "GROSS PROFIT", "verboseLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/StatementsOfOperations", "http://encision.com/role/SummaryOfSignificantAccountingPoliciesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "auth_ref": [ "r155", "r160" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.", "label": "Long-Lived Assets" } } }, "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r120", "r128", "r131", "r134", "r136" ], "calculation": { "http://encision.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.", "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest", "totalLabel": "(LOSS) INCOME BEFORE PROVISION FOR INCOME TAXES" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r159", "r161" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/Share-basedCompensationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r161" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement." } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/Share-basedCompensationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r74", "r86", "r87", "r119", "r236", "r242", "r243", "r322" ], "calculation": { "http://encision.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Provision for income taxes" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r40", "r234", "r235", "r238", "r239", "r240", "r241" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r61" ], "calculation": { "http://encision.com/role/StatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "verboseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r61" ], "calculation": { "http://encision.com/role/StatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "auth_ref": [ "r61" ], "calculation": { "http://encision.com/role/StatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.", "label": "Accrued compensation and other accrued liabilities" } } }, "localname": "IncreaseDecreaseInAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r61" ], "calculation": { "http://encision.com/role/StatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventories" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingAssets": { "auth_ref": [ "r61" ], "calculation": { "http://encision.com/role/StatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of assets used to generate operating income.", "label": "Increase (Decrease) in Operating Assets", "negatedLabel": "Right of use asset, net" } } }, "localname": "IncreaseDecreaseInOperatingAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Change in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r61" ], "calculation": { "http://encision.com/role/StatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedLabel": "Prepaid expenses and other assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsFiniteLivedPolicy": { "auth_ref": [ "r68", "r153", "r281", "r282", "r283", "r285" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.", "label": "Patents" } } }, "localname": "IntangibleAssetsFiniteLivedPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r42", "r117", "r255", "r258", "r307" ], "calculation": { "http://encision.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedLabel": "Interest expense, net" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r56", "r59", "r66" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Cash paid during the three months for interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryFinishedGoods": { "auth_ref": [ "r22" ], "calculation": { "http://encision.com/role/SummaryOfSignificantAccountingPoliciesDetails": { "order": 2.0, "parentTag": "us-gaap_InventoryGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.", "label": "Finished goods" } } }, "localname": "InventoryFinishedGoods", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryGross": { "auth_ref": [ "r27" ], "calculation": { "http://encision.com/role/SummaryOfSignificantAccountingPoliciesDetails": { "order": 1.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Inventory, Gross", "totalLabel": "Total gross inventories" } } }, "localname": "InventoryGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r3", "r27", "r276" ], "calculation": { "http://encision.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://encision.com/role/SummaryOfSignificantAccountingPoliciesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventories, net of reserve for obsolescence of $34,948 at June 30, 2022 and $36,000 at March 31, 2022", "totalLabel": "Total net inventories" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/BalanceSheets", "http://encision.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryPolicyTextBlock": { "auth_ref": [ "r7", "r25", "r69", "r103", "r146", "r148", "r150", "r279" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.", "label": "Inventories" } } }, "localname": "InventoryPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryRawMaterials": { "auth_ref": [ "r23" ], "calculation": { "http://encision.com/role/SummaryOfSignificantAccountingPoliciesDetails": { "order": 1.0, "parentTag": "us-gaap_InventoryGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Raw materials" } } }, "localname": "InventoryRawMaterials", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryValuationReserves": { "auth_ref": [ "r27", "r149" ], "calculation": { "http://encision.com/role/SummaryOfSignificantAccountingPoliciesDetails": { "order": 2.0, "parentTag": "us-gaap_InventoryNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of valuation reserve for inventory.", "label": "Inventories, reserve for obsolescence", "negatedLabel": "Less reserve for obsolescence" } } }, "localname": "InventoryValuationReserves", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/BalanceSheetsParenthetical", "http://encision.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWriteDown": { "auth_ref": [ "r147" ], "calculation": { "http://encision.com/role/StatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.", "label": "(Recovery from) provision for inventory obsolescence, net change" } } }, "localname": "InventoryWriteDown", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r31", "r73", "r130", "r144", "r169", "r170", "r171", "r173", "r174", "r175", "r176", "r177", "r178", "r179", "r245", "r246", "r247", "r253", "r274", "r275" ], "calculation": { "http://encision.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r21", "r73", "r144", "r253", "r276", "r303", "r317" ], "calculation": { "http://encision.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "TOTAL LIABILITIES AND SHAREHOLDERS\u2019 EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LIABILITIES AND SHAREHOLDERS\u2019 EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r6", "r33", "r73", "r144", "r169", "r170", "r171", "r173", "r174", "r175", "r176", "r177", "r178", "r179", "r245", "r246", "r247", "r253", "r274", "r275", "r276" ], "calculation": { "http://encision.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Long-term liability:" } } }, "localname": "LiabilitiesNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilityForUncertainTaxPositionsCurrent": { "auth_ref": [ "r32" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount recognized for uncertainty in income taxes classified as current.", "label": "Uncertain tax positions" } } }, "localname": "LiabilityForUncertainTaxPositionsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r36" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-Term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r36", "r168" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_NatureOfOperations": { "auth_ref": [ "r105", "r114" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.", "label": "ORGANIZATION AND NATURE OF BUSINESS" } } }, "localname": "NatureOfOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/OrganizationAndNatureOfBusiness" ], "xbrltype": "textBlockItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r57" ], "calculation": { "http://encision.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash (used in) generated by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from financing activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r57" ], "calculation": { "http://encision.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash (used in) generated by investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows (used in) investing activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r57", "r60", "r63" ], "calculation": { "http://encision.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash (used in) generated by operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows (used in) operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r1", "r38", "r39", "r41", "r44", "r63", "r73", "r80", "r81", "r82", "r83", "r84", "r86", "r87", "r92", "r120", "r128", "r131", "r134", "r136", "r144", "r169", "r170", "r171", "r173", "r174", "r175", "r176", "r177", "r178", "r179", "r249", "r253", "r305", "r320" ], "calculation": { "http://encision.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net income" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/OrganizationAndNatureOfBusinessDetailsNarrative", "http://encision.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r81", "r82", "r83", "r84", "r88", "r89", "r93", "r96", "r120", "r128", "r131", "r134", "r136" ], "calculation": { "http://encision.com/role/StatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net (loss) income", "totalLabel": "NET (LOSS) INCOME" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/BasicAndDilutedIncomeAndLossPerCommonShareDetails", "http://encision.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "Recently Issued Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r51" ], "calculation": { "http://encision.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "totalLabel": "Interest expense, extinguishment of debt income and other income (expense), net" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://encision.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "OPERATING EXPENSES:" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r120", "r128", "r131", "r134", "r136" ], "calculation": { "http://encision.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating income (loss)", "totalLabel": "OPERATING (LOSS) INCOME" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/StatementsOfOperations", "http://encision.com/role/SummaryOfSignificantAccountingPoliciesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r265" ], "calculation": { "http://encision.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating Lease, Liability", "verboseLabel": "Accrued lease liability" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r265" ], "calculation": { "http://encision.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Accrued lease liability" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r264" ], "calculation": { "http://encision.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Right of use asset" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDue": { "auth_ref": [ "r261", "r262" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.", "label": "Total" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/CommitmentsAndContingenciesDetails", "http://encision.com/role/CommitmentsAndContingenciesDetails1", "http://encision.com/role/CommitmentsAndContingenciesDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears": { "auth_ref": [ "r261", "r262" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "2025" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInFiveYears", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/CommitmentsAndContingenciesDetails", "http://encision.com/role/CommitmentsAndContingenciesDetails1", "http://encision.com/role/CommitmentsAndContingenciesDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourAndFiveYears": { "auth_ref": [ "r261", "r262" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth and fifth fiscal years following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "2026" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInFourAndFiveYears", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/CommitmentsAndContingenciesDetails1", "http://encision.com/role/CommitmentsAndContingenciesDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears": { "auth_ref": [ "r261", "r262" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "2024" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInFourYears", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/CommitmentsAndContingenciesDetails", "http://encision.com/role/CommitmentsAndContingenciesDetails1", "http://encision.com/role/CommitmentsAndContingenciesDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears": { "auth_ref": [ "r261", "r262" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "2023" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInThreeYears", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/CommitmentsAndContingenciesDetails", "http://encision.com/role/CommitmentsAndContingenciesDetails1", "http://encision.com/role/CommitmentsAndContingenciesDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter": { "auth_ref": [ "r261", "r262" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Thereafter" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueThereafter", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/CommitmentsAndContingenciesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [ "r32" ], "calculation": { "http://encision.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other accrued liabilities" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssets": { "auth_ref": [ "r11", "r299", "r312" ], "calculation": { "http://encision.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets classified as other.", "label": "Other assets" } } }, "localname": "OtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r52" ], "calculation": { "http://encision.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other income (expense), net" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireIntangibleAssets": { "auth_ref": [ "r53" ], "calculation": { "http://encision.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.", "label": "Payments to Acquire Intangible Assets", "negatedLabel": "Patent costs" } } }, "localname": "PaymentsToAcquireIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r53" ], "calculation": { "http://encision.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Acquisition of property and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r15", "r202" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred stock, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r15", "r276" ], "calculation": { "http://encision.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred stock, no par value: 10,000,000 shares authorized; none issued and outstanding" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r4", "r28", "r151", "r152" ], "calculation": { "http://encision.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid expenses and other assets" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromLoans": { "auth_ref": [ "r58" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash received from principal payments made on loans related to operating activities.", "label": "Proceed from loan" } } }, "localname": "ProceedsFromLoans", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromStockOptionsExercised": { "auth_ref": [ "r54", "r229" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.", "label": "Stock options exercised" } } }, "localname": "ProceedsFromStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/OrganizationAndNatureOfBusinessDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Product Information [Line Items]" } } }, "localname": "ProductInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/SummaryOfSignificantAccountingPoliciesDetails1" ], "xbrltype": "stringItemType" }, "us-gaap_ProductMember": { "auth_ref": [ "r211" ], "lang": { "en-us": { "role": { "documentation": "Article or substance produced by nature, labor or machinery.", "label": "Product [Member]" } } }, "localname": "ProductMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/StatementsOfOperations", "http://encision.com/role/SummaryOfSignificantAccountingPoliciesDetails1" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r158", "r276", "r309", "r318" ], "calculation": { "http://encision.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "totalLabel": "Equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equipment:" } } }, "localname": "PropertyPlantAndEquipmentNetAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r158", "r328", "r329" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property and Equipment" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ProvisionForDoubtfulAccounts": { "auth_ref": [ "r47", "r145" ], "calculation": { "http://encision.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.", "label": "(Recovery from) doubtful accounts, net change" } } }, "localname": "ProvisionForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r212", "r268", "r269" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/CommitmentsAndContingenciesDetails", "http://encision.com/role/CommitmentsAndContingenciesDetails1", "http://encision.com/role/CommitmentsAndContingenciesDetails2", "http://encision.com/role/CommitmentsAndContingenciesTables", "http://encision.com/role/RelatedPartyTransactionDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/RelatedPartyTransactionDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Purchases during the period (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.", "label": "Consulting fees paid" } } }, "localname": "RelatedPartyTransactionPurchasesFromRelatedParty", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/RelatedPartyTransactionDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r212", "r268", "r271", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/CommitmentsAndContingenciesDetails", "http://encision.com/role/CommitmentsAndContingenciesDetails1", "http://encision.com/role/CommitmentsAndContingenciesDetails2", "http://encision.com/role/CommitmentsAndContingenciesTables", "http://encision.com/role/RelatedPartyTransactionDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r266", "r267", "r269", "r272", "r273" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "RELATED PARTY TRANSACTION" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/RelatedPartyTransaction" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfSecuredDebt": { "auth_ref": [ "r55" ], "calculation": { "http://encision.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to repay long-term debt that is wholly or partially secured by collateral. Excludes repayments of tax exempt secured debt.", "label": "Repayments of Secured Debt", "negatedLabel": "(Paydown of) secured notes" } } }, "localname": "RepaymentsOfSecuredDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r232", "r280", "r330" ], "calculation": { "http://encision.com/role/StatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.", "label": "Research and Development Expense [Member]" } } }, "localname": "ResearchAndDevelopmentExpenseMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/Share-basedCompensationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "auth_ref": [ "r232" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.", "label": "Research and Development Expenses" } } }, "localname": "ResearchAndDevelopmentExpensePolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r18", "r208", "r276", "r316", "r325", "r326" ], "calculation": { "http://encision.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated (deficit)", "negatedLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/BalanceSheets", "http://encision.com/role/OrganizationAndNatureOfBusinessDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "auth_ref": [ "r70", "r71" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.", "label": "Revenue Recognition" } } }, "localname": "RevenueRecognitionPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r43", "r73", "r115", "r116", "r127", "r132", "r133", "r137", "r138", "r139", "r144", "r169", "r170", "r171", "r173", "r174", "r175", "r176", "r177", "r178", "r179", "r253", "r308" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Total revenue", "verboseLabel": "Net revenue" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/StatementsOfOperations", "http://encision.com/role/SummaryOfSignificantAccountingPoliciesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenuesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NET REVENUE:" } } }, "localname": "RevenuesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": { "auth_ref": [ "r213", "r214", "r215", "r216", "r217" ], "lang": { "en-us": { "role": { "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Defined Benefit Plans Disclosures [Table]" } } }, "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/CommitmentsAndContingenciesDetails", "http://encision.com/role/CommitmentsAndContingenciesDetails1", "http://encision.com/role/CommitmentsAndContingenciesDetails2", "http://encision.com/role/CommitmentsAndContingenciesTables" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r96" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of basic and diluted net loss per share" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/BasicAndDilutedIncomeAndLossPerCommonShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock": { "auth_ref": [ "r263" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.", "label": "Schedule of principal U.S. Bank payment" } } }, "localname": "ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/CommitmentsAndContingenciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r7", "r24", "r25", "r26" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Schedule of inventory" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfProductInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line.", "label": "Schedule of Product Information [Table]" } } }, "localname": "ScheduleOfProductInformationTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/SummaryOfSignificantAccountingPoliciesDetails1" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r270", "r271" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/RelatedPartyTransactionDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SecuredDebt": { "auth_ref": [ "r14", "r302", "r315" ], "calculation": { "http://encision.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date, including the current and noncurrent portions, of collateralized debt obligations (with maturities initially due after one year or beyond the operating cycle, if longer). Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.", "label": "Secured Debt", "verboseLabel": "Secured notes" } } }, "localname": "SecuredDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_SecuredDebtCurrent": { "auth_ref": [ "r13", "r301", "r314" ], "calculation": { "http://encision.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of the portion of long-term, collateralized debt obligations due within one year or the operating cycle, if longer. Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.", "label": "Secured notes" } } }, "localname": "SecuredDebtCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "auth_ref": [ "r121", "r122", "r123", "r124", "r125", "r126", "r138" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for segment reporting.", "label": "Segment Reporting" } } }, "localname": "SegmentReportingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SellingAndMarketingExpense": { "auth_ref": [], "calculation": { "http://encision.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.", "label": "Sales and marketing" } } }, "localname": "SellingAndMarketingExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingAndMarketingExpenseMember": { "auth_ref": [ "r46" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing selling and marketing expense.", "label": "Selling and Marketing Expense [Member]" } } }, "localname": "SellingAndMarketingExpenseMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/Share-basedCompensationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ServiceMember": { "auth_ref": [ "r211" ], "lang": { "en-us": { "role": { "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service.", "label": "Service [Member]" } } }, "localname": "ServiceMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/StatementsOfOperations", "http://encision.com/role/SummaryOfSignificantAccountingPoliciesDetails1" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r61" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Stock based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [ "r221" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.", "label": "Stock options forfeited" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/Share-basedCompensationDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": { "auth_ref": [ "r219" ], "lang": { "en-us": { "role": { "documentation": "Net number of share options (or share units) granted during the period.", "label": "Stock options granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/Share-basedCompensationDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r218", "r222", "r223", "r224", "r225", "r226", "r230", "r231" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Stock-Based Compensation" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock": { "auth_ref": [ "r209", "r231" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).", "label": "SHARE-BASED COMPENSATION" } } }, "localname": "ShareholdersEquityAndShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/Share-basedCompensation" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/Share-basedCompensationDetails", "http://encision.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r77", "r78", "r79", "r104", "r284" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/Share-basedCompensationDetails", "http://encision.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r15", "r16", "r203", "r208", "r220" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Number of shares exercised" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/Share-basedCompensationDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockOptionPlanExpense": { "auth_ref": [ "r62" ], "calculation": { "http://encision.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for option under share-based payment arrangement.", "label": "Stock-based compensation expense related to stock options" } } }, "localname": "StockOptionPlanExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r16", "r19", "r20", "r73", "r143", "r144", "r253", "r276" ], "calculation": { "http://encision.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "totalLabel": "Total shareholders\u2019 equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Shareholders\u2019 equity:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r277", "r278" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental disclosures of cash flow information:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_UnrecognizedTaxBenefits": { "auth_ref": [ "r233", "r237" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrecognized tax benefits.", "label": "Unrecognized tax benefits" } } }, "localname": "UnrecognizedTaxBenefits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r106", "r107", "r109", "r110", "r111", "r112", "r113" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates in the Preparation of Financial Statements" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r90", "r96" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted average shares\u2014diluted", "verboseLabel": "Weighted-average diluted shares" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/BasicAndDilutedIncomeAndLossPerCommonShareDetails", "http://encision.com/role/StatementsOfOperations" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r88", "r96" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted average shares\u2014basic", "verboseLabel": "Weighted-average basic shares outstanding" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://encision.com/role/BasicAndDilutedIncomeAndLossPerCommonShareDetails", "http://encision.com/role/StatementsOfOperations" ], "xbrltype": "sharesItemType" } }, "unitCount": 4 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(16))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258" }, "r102": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "https://asc.fasb.org/topic&trid=2144383" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "270", "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e543-108305" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r114": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org/topic&trid=2134479" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.BB)", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "https://asc.fasb.org/topic&trid=2126998" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.CC)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r164": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751" }, "r167": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r209": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809" }, "r231": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org/topic&trid=2228938" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "10B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(Note 3)", "Topic": "840", "URI": "https://asc.fasb.org/extlink&oid=123403562&loc=d3e38371-112697" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "840", "URI": "https://asc.fasb.org/extlink&oid=123406913&loc=d3e41502-112717" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "840", "URI": "https://asc.fasb.org/extlink&oid=123406913&loc=d3e41502-112717" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r273": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org/topic&trid=2122745" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r278": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "330", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(a)", "Topic": "920", "URI": "https://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(b)", "Topic": "920", "URI": "https://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(a)", "Topic": "920", "URI": "https://asc.fasb.org/extlink&oid=120155617&loc=SL120155638-234783" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(1)(a))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(10))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r331": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12" }, "r332": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r333": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r334": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r335": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r336": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r337": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r338": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r339": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" }, "r341": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r342": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r343": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r344": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r345": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r346": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r347": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r348": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405" }, "r349": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(4))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(5))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r76": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537" } }, "version": "2.1" } ZIP 50 0001079973-22-000963-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001079973-22-000963-xbrl.zip M4$L#!!0 ( !M9#%5F%JBQ?0@ +=% 1 96-I82TR,#(R,#8S,"YX MR=?/3TO?0@G!! W9;J5]<5A!A M3N!2-KNMC.UJTVZ;9@7]]./?_HK@[^;OU2KJ4N*YUZ@3.%6338,?4!_[Y!K= M$48XE@'_ 7W&7JA:@B[U"$?MP)][1!(@Q#U=H_<7]:L)JE8+Z/U,F!OP\=#, M]#Y(.1?7M=K3T],%"Q;X*>"/XL()_&(*;8EE*#)ME\O+Y*^8^#T53B;\\6?O MB_A^.:2_S@C[&+8QYCKW_Z]*D645/6'.=RPKU4]55-D2=8D$PS4*F&GS(A,7.V^%V9"6PR MOZ_%Q"U6NI?U0\Q*4U:7[/ )XES,@D4-",#?:*2,H:C.,)YGS%,L)I'2A+#% M++C,,T+C+E-5KN9$[&6-25L"KN0[ EM> W)-D97,9?6R7FW44TGB4)P)0?!1 M%2%J-D?Z+S]W1*B5M!$O,9D6IZBCEVR!%M MZ1S'C 40"D!/6E3;?$YAKD/#7V[4I+CF@4=&8#A2/R (]^M6Q%H[@$120=2] MK<0_E1;0&>EQR90R&G661%L=555LA6I@\#,2N:GM,F^H" 5Q+?9C]'O.B0"Y MR/H>-"2""IV_3]0AK?50SD1R9PFK*DU5]4#D),0.$#3(_'=0236ZE P16N%I8^*33^WL7CH>L'3 M'@C6)#T"[PLBH/2A2&'I$;#X##/Z1V17D[E]J$XYL::M4%!&1(+%,28]*A_4 M6@MUJQ<($(,':WC7[)M?FB/3ZJ-FOX/ZS=%X:""KBUICV^P;MEU*+.S0]S%? M65.;SAA45PYFLNDX0<@D;(D&@4<=2M+P*,:K1^;[763L\?U]<_B;0L(V[_IF MUVPW^R/4;+>M<7]D]N_0P.J9;=,H)T M+*@# ="A7@@9PX3-JD_@N1<(,2 < MMII^P.P'6%O31;TPOQZHC[M 19H1;/A0HAO%RJ,FI1[-X[TO=("B'DH)F'( ME5'>![?#2MG5_;X[NC?[(CI):VXHBQNB7-ERB>5=5 M6WM7G<+ 2AR9F"2P T2MU^N7N8SUK^;0J+::MJ$\?C\P^G:TKI32X4,"-A$7 MBGNY&G$,+G76#C]$U#N\ONOPH=%KCL#9@^9P]!L:#9O@\'9I/6Z'$T&^AC < M8Z&22+HX[[3J?=S(+\,MV_AE#*D$&9]50BFI;XN4..>41<7*H_K5^>41[+"3 M/LJYK2B&PPA/O-.02R3TN'WW'-SB'LJ)6O%Z=1.YDZ7TZ+U_?JU;;A0U->TF M;,?9]#CEMO7: KC.L3I$8NJ)/N;J>'9! M"IU]Y83T2.4V\@7.PM"[I!.4]5)._(J5"(FS3JDJ4A$]=KD=_REE1=+%&W!' M4:B?@5Q=#UTC?VQP.G2H_@;>42!VDN>9LGHPGB^FA MS)U\0,EBMJ-UL&/VQNJQ# 6-$33T+%L.!,8PJ35@NHRJGY*E54\5O(5> M3P]5[C#D2+G_AHK6V_6BL!Q;VG*''<5P*>MJ=MSAC:+(-(X@DSO(*(A,XPV9 M_0[?*2Y.$= C=>I1QEL1H3O5V-Z Z7GTN)QPKE'JY4;OY-V:O""S'IK<0<91 M:,H>+0?>O^X'J2BS'J3J-Z5;]8"G=MZ2E&K-UPFA&IW!E&'+B] MM*]_<8A=_8@F4]%.#]R"TG:Z5Z9&/"G2EK--V+PS]0P;(C4G&7'\(M8A@7@=X)5JO2?^1-U/4P;">K:/0CU/O9N]K4@>JBRI;D%>0_:D@3N* MDKP;\N3[R3CI9[?^KMW QY29DOB*$\863@3DUU!QW_$@G-]68G446'0F&V:G MM]?B?8378/#8;F'VN-?D_:378+3=:FZ;NMGP&@Q4:.?Q?U4F#@:#7H#9MI6[ MC:_"T+@$6@T\]>Z+N<;7D,X5"V@1PE@Z7J@NO+=#(0.?J]4?P2:0!FJX.)R?8;IM0# M!7F? ?@\4?H2\0U+BQMZQ)K:A"^HHPR>!MP7AD<_ MH*I&[@;<6$K"F:++J"GZ7&=$EK+E!^ B6,=VW6% :3!;$52I5W5.H:,YJYX$4UOHZ, %$')H54/*AV:]HAD\3H M#'<=Q_\>^YM:7"_#SS\!4$L#!!0 ( !M9#%7RA(PF4 P .6 5 M96-I82TR,#(R,#8S,%]C86PN>&ULU5W=<^(X$G^_JOT??-S+[ ,AD)G9G>SD MMAQ"M+O=FD4#X+O PSZ\J?FX M]OL_?_J;Q?Y]_7N];MTCZ+G7UAUVZEU_CG^S!F )KZT'Z$," DQ^L[X!+^3? MX'OD06*U\7+EP0"R/VPN?&U]NFA>/5KUNH+>;]!W,9F-NSN]BR!8T>M&X_GY M^<+':_",R7=ZX>"EFL)) (*0[K1=OES&_S;B7SWD?[_F_ST""BWF+Y]>OU!T M4^/7C2_[?'6!R5.C=7G9;/RGWYLX"[@$=>1SOSFPMI7B6K+DFE^^?&E$?]TV M3;5\>23>]AI7C:TY.\WLKRBG_9XE%%W3R+P>=D 0T2Z]C"5LP3_5M\WJ_*MZ MLU6_:EZ\4+>V=7[D08(].(9SB_]D[.VNRKH;XIV $];@?VRT,>N0S-)(;$'@ M_*8&'028]E;K\O/5)=?]CT2CX'7%.B9%O%_5K$;)Z]X"C_MHLH PH++K9S8^ M@QTC0* ?+&" '. 5,BI3\C06\B$#ETP['<>IG0$ M"9MXEMB?+-C D(^DHII.@X K1D'4%]G5VCAR%F\F=[B"Z(GZ!X==YP'?Y5,Y M]&G4+Z4=(E_L-+:-H/8VKF*RLX:TQ3[#0JPI7D M$7

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�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end